2025 Annual Meeting | P7 - Poster Session 07

Date Monday 04/07/25

Time 05:00 PM - 06:00 PM PDT Add To Calendar

Location San Diego Convention Center | Exhibit Hall A

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) General Neurology, Cerebrovascular Disease and Interventional Neurology, Headache, Movement Disorders, Epilepsy/Clinical Neurophysiology (EEG), Multiple Sclerosis, Child Neurology and Developmental Neurology, Neuromuscular and Clinical Neurophysiology (EMG), Aging, Dementia, and Behavioral Neurology, Neuro-rehabilitation, Infectious Disease, ��ɫ��, Research, and Methodology, Autoimmune Neurology, Neuro Trauma and Critical Care, Neurohospitalist

Learning Objectives View the latest research on a variety of topics. Posters are available to view in-person or online.

CME Available 0.00 CME credit

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student, Business Administrator

Teaching Styles Interactive

Program Materials Program Evaluations

Event Timeline
05:00 PM - 06:00 PM PDT	Abstract	1-001 - Diagnostic Delay and Perceptions of Multiple Sclerosis in Hispanic/Latinx Patients Jerusalem Wogayehu
05:00 PM - 06:00 PM PDT	Abstract	1-002 - Amantadine for Multiple Sclerosis-related Fatigue: A Systematic Review and Meta-analysis of Randomized Controlled Trials Pedro Fraiman, MD
05:00 PM - 06:00 PM PDT	Abstract	1-003 - Hidden Problems in Multiple Sclerosis: Gaps Between Patient Experience and Outcome Assessments Andreas Lysandropoulos
05:00 PM - 06:00 PM PDT	Abstract	1-005 - A Retrospective Evaluation of Ocrelizumab and Rituximab Discontinuation in a Canadian Relapsing Multiple Sclerosis Cohort David J. Hunt, MD
05:00 PM - 06:00 PM PDT	Abstract	1-006 - Importance of Autonomy in People with Multiple Sclerosis: Self-determination and Its Relationship with Clinical Factors Lara Bardoneschi
05:00 PM - 06:00 PM PDT	Abstract	1-007 - The Impact of Central Nervous System Inflammatory Demyelinating Diseases on Job Employment in Thailand Ekdanai Uawithya, MD
05:00 PM - 06:00 PM PDT	Abstract	1-008 - Fear of Progression in Multiple Sclerosis: Evaluation of Existing Patient-reported Outcomes (PRO) Instruments Naomi Suminski
05:00 PM - 06:00 PM PDT	Abstract	1-009 - Integrating Lived Experience and Actionable Opportunities for System Change in MS Care: A Nonprofit's Commitment to Health Literacy and Innovative Interventions Yahaira Rivera
05:00 PM - 06:00 PM PDT	Abstract	1-010 - Corneal Confocal Microscopy as a Tool for Detecting Axonal Degeneration in Multiple Sclerosis and Correlation with Severity: A Meta-analysis Ali M. Al-Salahat, MBBS
05:00 PM - 06:00 PM PDT	Abstract	1-011 - Patient Reported Attitudes Towards Multiple Sclerosis Treatment Dianna Higgins Cronin, MA
05:00 PM - 06:00 PM PDT	Abstract	1-012 - Comparing First-line Natalizumab and Ocrelizumab Use for the Treatment of Multiple Sclerosis: A Komodo Health Claims Database Study Danette J. Rutledge, PhD
05:00 PM - 06:00 PM PDT	Abstract	1-013 - Real-world-data on Ofatumumab as First-line Treatment in Early RMS (AIOLOS study) Gereon Nelles, MD, PhD, FAAN
05:00 PM - 06:00 PM PDT	Abstract	1-014 - ENABLE: The First Phase 4 Observational Study for Patients with Relapsing MS Treated with Ublituximab in Real World Clinical Setting Edward Fox, MD, PhD, FAAN
05:00 PM - 06:00 PM PDT	Abstract	1-015 - Retrospective Evaluation of Infusion Tolerability: Ublituximab Real-world Observational Survey (ENAMOR) Edward Fox, MD, PhD, FAAN
05:00 PM - 06:00 PM PDT	Abstract	1-016 - Continuous Ofatumumab Treatment Up to 7 Years Shows a Consistent Safety Profile and Delays Disability Progression in People with Relapsing Multiple Sclerosis Gabriel Pardo, MD, FAAN
05:00 PM - 06:00 PM PDT	Abstract	1-017 - No Association Between Decreases in Serum Immunoglobulin (Ig) Levels Below Lower Limit of Normal (LLN) and Serious Infections (SI) with Long-term Ublituximab (UBL) Treatment in Patients with Relapsing Multiple Sclerosis (RMS) Bruce A. Cree, MD, PhD, MAS, FAAN
05:00 PM - 06:00 PM PDT	Abstract	2-001 - Case Report of a Unique Structural Cause for Rapidly Progressive Orthostatic Syncope Austin Layton, DO
05:00 PM - 06:00 PM PDT	Abstract	2-002 - Ruptured Lumbar Dermoid Cyst With Intracranial Fat Dissemination: A Case Report Zixin Yi, BS
05:00 PM - 06:00 PM PDT	Abstract	2-003 - Recurrent Propofol-Induced Seizure-Like Phenomena: Unmasking a Rare Neurological Complication in Anesthesia Varsha Nandwana, MD
05:00 PM - 06:00 PM PDT	Abstract	2-004 - Analysis of Cognition and Medication Management in Patients with Parkinson's Disease Logan Drucker
05:00 PM - 06:00 PM PDT	Abstract	2-005 - The Many Faces of Facial Paralysis Roxana M. Dragomir, MD
05:00 PM - 06:00 PM PDT	Abstract	2-006 - Different Aspect of Double Dissociation of Aphasic Seong-eun Hwang
05:00 PM - 06:00 PM PDT	Abstract	2-007 - Novel Single-Molecule Counting Technology for Ultrasensitive Detection of Blood-Based Neurological Biomarkers Hayato Kimura, PhD
05:00 PM - 06:00 PM PDT	Abstract	2-008 - Identifying candidate molecular biomarkers in idiopathic intracranial hypertension patients Alexandra J. Sinclair, MD
05:00 PM - 06:00 PM PDT	Abstract	2-009 - Analytical Performance of the Quest AD-Detect® Phosphorylated tau217 (p-tau217), Plasma Assay Bhairavi Vajaria, PhD
05:00 PM - 06:00 PM PDT	Abstract	2-010 - Blood-Brain Barrier Dysfunction and CSF Immunoglobulin Synthesis in Down Syndrome Regression Disorder Shermila Pia, MD
05:00 PM - 06:00 PM PDT	Abstract	2-011 - Physiological Predictors of Postural Orthostatic Tachycardia in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Helena Huhmar
05:00 PM - 06:00 PM PDT	Abstract	2-012 - Biochemical Assay to Aid in the Diagnosis of SORD Deficiency Matthew Schultz, PhD
05:00 PM - 06:00 PM PDT	Abstract	3-001 - Fifth Known Case of the Second Rarest Disease: Ribose 5-phosphate Isomerase Deficiency Sagi Elhassan, MD
05:00 PM - 06:00 PM PDT	Abstract	3-002 - Trendelenburg Reversal of Coma in Spontaneous Intracranial Hypotension Tony Zhang, MBChB
05:00 PM - 06:00 PM PDT	Abstract	3-003 - Pseudobulbar Affect: A Sequelae of CHANTER Syndrome Stone Leachman, Medical student
05:00 PM - 06:00 PM PDT	Abstract	3-004 - Delayed Post-hypoxic Leukoencephalopathy: An Elusive Diagnosis Bojun Chen, MD, PhD
05:00 PM - 06:00 PM PDT	Abstract	3-005 - Seizure Alert: An Interdisciplinary Protocol for the Timely Administration of Anti-epileptic Medication in the Setting of Status Epilepticus Chiemela Onyekere, MD
05:00 PM - 06:00 PM PDT	Abstract	3-006 - Levamisole-associated Toxic Multifocal Inflammatory Leukoencephalopathy: A Case Report Lingxuan Li
05:00 PM - 06:00 PM PDT	Abstract	3-007 - An Atypical Case of High-grade Glioma with Symmetric Cortical and Bilateral Deep Gray Matter Involvement Jennifer A. Fokas, MD
05:00 PM - 06:00 PM PDT	Abstract	3-008 - Peyote Poisoning Mimicking Autoimmune Encephalitis with Polyneuropathy: A Case Report Guangming Zhu, MD, PhD
05:00 PM - 06:00 PM PDT	Abstract	3-009 - Numb Chin Syndrome Recognition Leads to Metastatic Cancer Diagnosis Robert Fekete, MD
05:00 PM - 06:00 PM PDT	Abstract	3-010 - Paroxysmal Sympathetic Hyperactivity, Generalized Dystonia, and Rigidity as Sequelae Following Hydrocephalus Mhd Majd Mardini, MD
05:00 PM - 06:00 PM PDT	Abstract	3-011 - CSF aSyn-SAA and Alzheimer's Disease Biomarkers: Presentation and Progression in the Dementia with Lewy Bodies Consortium David G. Coughlin, MD
05:00 PM - 06:00 PM PDT	Abstract	3-012 - Clinical Diagnostic Laboratory Experience With Alzheimer’s Disease Blood Biomarker Testing: Insights Into Healthcare Provider Test Utilization and Patient Results Justine Coppinger, Other
05:00 PM - 06:00 PM PDT	Abstract	3-014 - CSF Levels of NPTX2 are Associated With Decreased Rate of Brain Atrophy Over Time in Cognitively Unimpaired Individuals Juan P. Vázquez, MD
05:00 PM - 06:00 PM PDT	Abstract	3-015 - Neuropathological Correlates of Amnestic Dysfunction in Fronto-Temporal Lobar Degeneration (FTLD) Medha Tandon, MBBS
05:00 PM - 06:00 PM PDT	Abstract	3-016 - A Blood Biomarker-guided Precision Medicine Approach for Individualized Neurodegenerative Disease Risk Reduction and Treatment: The Future of Preventive Neurology? Kellyann Niotis, MD
05:00 PM - 06:00 PM PDT	Abstract	3-017 - Evaluating Future IVD Plasma P-Tau 181 and ApoE4 Immunoassays for Rule Out of Amyloid Pathology in a Multi-Center Study Reflective of Routine Clinical Practice Imke Kirste, PhD
05:00 PM - 06:00 PM PDT	Abstract	3-020 - Hyperkinesia in a Young Female With Co-Occurring PSEN1 and HTT Mutations: Examining the Relationship Between Early-onset Familial Alzheimer’s and Huntington’s Diseases Sean Lee, MD
05:00 PM - 06:00 PM PDT	Abstract	4-001 - Longitudinal Goal Attainment Across Four Consecutive Botulinum Toxin Treatment Cycles in Adults with Upper Limb Spasticity Katherine Sommer, PhD
05:00 PM - 06:00 PM PDT	Abstract	4-002 - Effectiveness of Hippotherapy in Balance Rehabilitation for Stroke Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials Ahmed Negida, MD, PhD
05:00 PM - 06:00 PM PDT	Abstract	4-003 - Effectiveness and Safety of ABAStroke in Cognitive Rehabilitation for Post-stroke Patients: A Randomized Controlled Study Pawel Wrona, MD
05:00 PM - 06:00 PM PDT	Abstract	4-004 - Individualized fMRI-Neuromodulation to Strengthen Swallowing Networks Targeted Towards Head and Neck Cancer Survivors, ALS, and Anterior Cervical Discectomy and Fusion Surgery Patients T. Dorina Papageorgiou, PhD, FAAN
05:00 PM - 06:00 PM PDT	Abstract	4-005 - High-definition Transcranial Direct Current Stimulation Targeting Different Brain Regions Leads to Differential Effects on Cognitive Functions and Event-related Potentials in Patients with Primary Progressive Aphasia Hsueh-Sheng Chiang, MD, PhD
05:00 PM - 06:00 PM PDT	Abstract	4-006 - Outcomes of a Three Week Interdisciplinary Intensive Outpatient Treatment Program for Mild-Moderate Traumatic Brain Injury in Veterans and First Responders Vaughn E. Bryant, PhD
05:00 PM - 06:00 PM PDT	Abstract	5-001 - NeuroOwls: A Branch of the Osler Apprenticeship and Its Impact on Medical Student Preparedness and Performance in the 3rd Year Neurology Clerkship Nicki Karimi-Mostowfi, MD
05:00 PM - 06:00 PM PDT	Abstract	5-002 - Balancing Growth and Performance: Student Experiences with Hidden Curriculum and Psychological Safety in a Neurology Clerkship Ashlee Joan Macalino
05:00 PM - 06:00 PM PDT	Abstract	5-003 - Emotional Burden in Third-Year Medical Students During the Neurology Clerkship Sydney L. Short
05:00 PM - 06:00 PM PDT	Abstract	5-004 - Teaching Scaffolds as a Tool to Optimize High Yield Learning on the Wards During Neurology Clerkship Clare M. Lambert, MD
05:00 PM - 06:00 PM PDT	Abstract	5-005 - Cultivating a Feedback Culture for Medical School Students During Clinical Rotations Yohan Kim, DO
05:00 PM - 06:00 PM PDT	Abstract	5-006 - Enhancing Pre-Clinical Neurology ��ɫ��: The Role of Role-Playing and Hands-On Workshops in Mastering Peripheral Nerve Injury Christopher Beskow
05:00 PM - 06:00 PM PDT	Abstract	5-007 - En Bloc Dissection and Plastination of the Central Nervous System for Neuroanatomy ��ɫ�� Gavin Hoffman, Medical Student
05:00 PM - 06:00 PM PDT	Abstract	5-008 - Understanding Medical Students' Experiences and Perceptions of Neuroanatomy Teaching in the Preclinical Curriculum Marinos G. Sotiropoulos, MD
05:00 PM - 06:00 PM PDT	Abstract	5-009 - Quality Assessment and Linguistic Analysis of Biases in Letters of Recommendation for International Medical Graduates Applying to U.S. Neurology Residency Programs Zoe Landau, MD
05:00 PM - 06:00 PM PDT	Abstract	5-010 - Enhancing Early Clinical Exposure through a Procedural Workshop in Neurology and Neuroscience for Medical Students Janet Nguyen
05:00 PM - 06:00 PM PDT	Abstract	5-011 - Teach a Student to Fish: Incorporating Iterative Drawing as a Learning Modality in a Medical Neuroscience Curriculum John S. Taylor, Jr., MD
05:00 PM - 06:00 PM PDT	Abstract	5-012 - Neurological Coma Examination Training in Medical ��ɫ�� Emma Streveler, MD
05:00 PM - 06:00 PM PDT	Abstract	5-013 - The Use of Microlearning Videos to Increase Comfortability with the Neurological Examination of Patients with Altered Levels of Consciousness Sabrina Bitar, MD
05:00 PM - 06:00 PM PDT	Abstract	5-014 - Re-weighting MDS-UPDRS Parts II and III Items to Improve Assessment of Motor Decline in Untreated Parkinson’s Disease Samuel Dickson
05:00 PM - 06:00 PM PDT	Abstract	5-015 - Re-weighting MDS-UPDRS Part II and PDQ-39 Items to Detect Maximal Decline in Activities of Daily Living in Untreated Parkinson's disease Gilbert J. L'Italien
05:00 PM - 06:00 PM PDT	Abstract	5-016 - Comparative Safety of Istradefylline in Parkinson’s Disease: A Systematic Review of Randomized Controlled Trials and Real-world Studies Sagari R. Bette, MD
05:00 PM - 06:00 PM PDT	Abstract	5-017 - A Retrospective Analysis of Advance Care Planning in an Interdisciplinary Movement Disorders Supportive Care Clinic Angela A. Hong, MD
05:00 PM - 06:00 PM PDT	Abstract	5-018 - The Influence of Sex on Hospice Care Preferences Among Persons with Parkinson’s Disease Whitley W. Aamodt, MD
05:00 PM - 06:00 PM PDT	Abstract	5-019 - Impact of Best Practice Advisory on Reducing Contraindicated Medications and Improving Medication Management in Hospitalized Patients with Parkinson’s Disease Zhimin Xu, MD, PhD
05:00 PM - 06:00 PM PDT	Abstract	5-020 - Efficacy and Safety of IPX203 in Parkinson's Patients: A Systematic Review and Meta-analysis Ahmed Negida, MD, PhD
05:00 PM - 06:00 PM PDT	Abstract	5-021 - Acute Effects of Oral Levodopa on Seated Mean Arterial Blood Pressure in Parkinson’s Disease Katherine Longardner, MD
05:00 PM - 06:00 PM PDT	Abstract	5-022 - Successful Treatment of Sialorrhea with Daxibotulinum Toxin A Han Lee, MD
05:00 PM - 06:00 PM PDT	Abstract	5-023 - Protocol to Help Neurologists Manage Subcutaneous Apomorphine Therapy Skin Nodules: Expert Roundtable Recommendations Stuart H. Isaacson, MD, FAAN
05:00 PM - 06:00 PM PDT	Abstract	5-024 - Impact of Concomitant Therapy with a Dopamine Agonist on Converting Parkinson’s Disease Patients from Immediate-release Carbidopa-levodopa to CREXONT® Simon Allard, PhD
05:00 PM - 06:00 PM PDT	Abstract	5-025 - Interdisciplinary Models of Care Across the Parkinson’s Foundation Designated U.S. Centers: A Survey of Current Practices Victor D. Armengol, MD
05:00 PM - 06:00 PM PDT	Abstract	5-026 - Opicapone as First-line Strategy for the Treatment of Wearing-off in Patients with Parkinson's Disease Joaquim J. Ferreira
05:00 PM - 06:00 PM PDT	Abstract	5-027 - Long-term Follow-up of Opicapone Use as Add-on to Levodopa in Parkinson’s Patients Without Motor Fluctuations: Findings from the EPSILON Study Joaquim J. Ferreira
05:00 PM - 06:00 PM PDT	Abstract	5-028 - Pharmacokinetic-pharmacodynamic Modeling of Amantadine Extended-release Capsule Effects on Dyskinesia in Parkinson Disease Zhao Wang
05:00 PM - 06:00 PM PDT	Abstract	5-029 - Parkinson Disease and Anxiety: Activity Limitation and Treatment Opportunities John Acquaviva, DO
05:00 PM - 06:00 PM PDT	Abstract	5-030 - Efficacy of the Ketogenic Diet with and Without Medium-chain Triglyceride (MCT) Supplementation in Parkinson's Disease: A Systematic Review and Single-arm Meta-analysis Aishwarya Koppanatham, MBBS
05:00 PM - 06:00 PM PDT	Abstract	5-032 - Improvement of Troublesome Dyskinesia in People with Parkinson’s Disease Treated with Foslevodopa/Foscarbidopa Linda Harmer, Other
05:00 PM - 06:00 PM PDT	Abstract	6-001 - Medical Student Essay Award: Saying Goodbye to the Colored Haired Woman Xaida Wright, MD
05:00 PM - 06:00 PM PDT	Abstract	6-002 - Medical Student Essay Award: The Hour of Consciousness Daria Hoang, BA
05:00 PM - 06:00 PM PDT	Abstract	6-003 - Medical Student Essay Award: Shaped by Liminal Space Courtney N. Nguyen
05:00 PM - 06:00 PM PDT	Abstract	6-004 - Medical Student Essay Award: The Echo of Time: Reflections on Thatha's Alzheimer's and Parkinson's Dementia Kiran K. Sankarappan, BS
05:00 PM - 06:00 PM PDT	Abstract	6-005 - Association Between DMD Genotype and Neurodevelopmental Concerns in Childhood-Onset Dystrophinopathy Using Population-Based Surveillance Data Andrea He
05:00 PM - 06:00 PM PDT	Abstract	6-006 - Correction of Duchenne Muscular Dystrophy Mutations by CRISPR/Cas9 Gene Editing Using Homology-Independent Targeted Integration Stefan Nicolau, MD
05:00 PM - 06:00 PM PDT	Abstract	6-007 - LEOPARD-DMD: Six-Month Results of Longitudinal Study of Disease Progression of Duchenne Muscular Dystrophy through the Patient and Caregiver Perspective Christina Shupe
05:00 PM - 06:00 PM PDT	Abstract	6-008 - Effectiveness of Ataluren in Patients with nmDMD: Confirmatory Evidence from the STRIDE Registry Christian Werner
05:00 PM - 06:00 PM PDT	Abstract	6-009 - Study Design of Subcutaneous Efgartigimod PH20 in Juvenile Generalized Myasthenia Gravis Kristin Heerlein
05:00 PM - 06:00 PM PDT	Abstract	6-010 - Development of a Clinical Tool to Aid in the Diagnosis of Duchenne Muscular Dystrophy Megan A. Waldrop, MD
05:00 PM - 06:00 PM PDT	Abstract	6-011 - Not Just a Statin Target: Anti-HMGCR Myopathy in a Child With EBV Snigdha Kanadibhotla, BS
05:00 PM - 06:00 PM PDT	Abstract	6-013 - X-Linked Charcot-Marie-Tooth Disease in a 14-Year-Old Boy Presenting with Transient Neurological Symptoms and Leukoencephalopathy Victoria Mazo, MD
05:00 PM - 06:00 PM PDT	Abstract	6-014 - A Phase 3, Open-Label, Single-Arm, Multicenter Study to Evaluate Ravulizumab Administered Intravenously in Pediatric Patients With Anti-Acetylcholine Receptor Antibody-Positive (AChR-Ab+) Generalized Myasthenia Gravis (gMG) Gwendolyn E. Niebler, DO
05:00 PM - 06:00 PM PDT	Abstract	6-015 - Pediatric HSVE: Where Clinical Progress Meets Radiological Surprise Clara Abouelsaad, DO
05:00 PM - 06:00 PM PDT	Abstract	6-016 - A Case of Probable Kleine-Levin Syndrome Presenting as Encephalitis: Case Report Evelyn Lazar, MD
05:00 PM - 06:00 PM PDT	Abstract	6-017 - Unusual Clinical and Imaging Features of MOGAD in Two Pediatric Patients Xiaoting Wang, MD
05:00 PM - 06:00 PM PDT	Abstract	6-018 - Status MOGanosus: A Case of Cerebral Cortical Encephalitis-related MOGAD Mimicking Hemiplegic Migraine Michael S. Kung, MD
05:00 PM - 06:00 PM PDT	Abstract	6-019 - Febrile Status Epilepticus developing in refractory Kawasaki disease without meningoencephalitis triggered by Parvovirus B19 infection Zain Y. Khan, MBBS
05:00 PM - 06:00 PM PDT	Abstract	6-020 - Real-World Experiences with VMAT2 Inhibitors in Pediatric Hyperkinetic Movement Disorders Joseph S. Kass, MD, JD, FAAN
05:00 PM - 06:00 PM PDT	Abstract	7-001 - Radionuclide Perfusion Scintigraphy in Diagnosis of Brain Death: A Retrospective Cohort Study Jonah Kaziyev, BS
05:00 PM - 06:00 PM PDT	Abstract	7-002 - Protocolized Management of Catastrophic Brain Injury and Impact on Organ Procurement After Brain Death Michael Chojnacki
05:00 PM - 06:00 PM PDT	Abstract	7-003 - CARES: A Holistic Approach to Pediatric Brain Death Determination Hannah Wiest
05:00 PM - 06:00 PM PDT	Abstract	7-004 - Time to Loss of Heartbeat After Removal of Organ Support in Non-donor Brain Dead Patients Miriam Quinlan, MD, MPH
05:00 PM - 06:00 PM PDT	Abstract	7-005 - Acute Ischemic Stroke Incidence and Characteristics After Cardiac Arrest Marina T. Marques, MD
05:00 PM - 06:00 PM PDT	Abstract	7-006 - Predicting Neurological Recovery from Coma Post-cardiac Arrest Using Natural Language Processing Parker Houston, BS
05:00 PM - 06:00 PM PDT	Abstract	7-007 - Eye Movements as a Prognostic Indicator of Neurologic Outcomes in Cardiac Arrest Patients in the Intensive Care Unit Cameron Hill
05:00 PM - 06:00 PM PDT	Abstract	7-008 - Mortality Prediction of Patients with Hypoxic-Ischemic Encephalopathy after Cardiac Arrest: Development of a Nomogram GyeongMo Sohn, MD
05:00 PM - 06:00 PM PDT	Abstract	7-009 - Cardiac Arrest Neuroprognostication Quality Improvement (CAN-QI) Project to Measure and Implement Reliable and Systematic Utilization of Evidenced-based Guidelines Diana Marzouk, DO
05:00 PM - 06:00 PM PDT	Abstract	7-010 - Periodic Oral Automatism in Post-anoxic Coma Margil Ranpariya, MBBS
05:00 PM - 06:00 PM PDT	Abstract	8-001 - Relapse, Non-Relapse and Treatment Outcomes in a Real-World Neuromyelitis Optica Spectrum Disorder Cohort Shamik Bhattacharyya, MD, FAAN
05:00 PM - 06:00 PM PDT	Abstract	8-002 - The Association of HLA-DQB104 and DQB103 with Neuromyelitis Optica Spectrum Disorders: A Case-Control Study Considering Genetic Ancestry Jairo A. Gaitan Alfonso, MD
05:00 PM - 06:00 PM PDT	Abstract	8-003 - Seasonal Variations in MOG Antibody-Associated Disease: A Big Data Analysis from a Large Neuroimmunology Laboratory Database Nisa Vorasoot, MD
05:00 PM - 06:00 PM PDT	Abstract	8-004 - Factors Associated with MOG-IgG Serostatus Change Katherine Havard-Coiro, MD
05:00 PM - 06:00 PM PDT	Abstract	8-005 - Late Adult Onset Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Clinical Characterization and Predictors of Outcome Eoin P. Flanagan, MBBCh, FAAN
05:00 PM - 06:00 PM PDT	Abstract	8-006 - A Gene Linked to Transverse Myelitis Is Associated with Increased Entry of AQP4 into Exosomes Monique Anderson, MD, PhD
05:00 PM - 06:00 PM PDT	Abstract	8-008 - The Total Economic Impact of Anti-Aquaporin-4 Antibody-Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD) on Patients and Caregivers in the United States Benjamin J. Osborne, MD, FAAN
05:00 PM - 06:00 PM PDT	Abstract	8-009 - ACT with NMOSD: A Targeted Mental Health Intervention for NMOSD Patients and Caregivers C Virginia OHayer, PhD
05:00 PM - 06:00 PM PDT	Abstract	8-010 - The Risk of Hepatitis B and Tuberculosis Reactivation in Patients with Neuromyelitis Optica Spectrum Disorder Treated with B-Cell Depletion Therapy Xi Wang
05:00 PM - 06:00 PM PDT	Abstract	8-011 - Key Drivers of Health-Related Quality-of-Life (HRQoL) Among Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD): Findings from a Global Systematic Literature Review (SLR) Kristina R. Patterson, MD, PhD
05:00 PM - 06:00 PM PDT	Abstract	8-013 - Patient Preferences for Treatment Features in Neuromyelitis Optica Spectrum Disorder (NMOSD): Results From a Discrete Choice Experiment (DCE) Justin Abbatemarco, MD
05:00 PM - 06:00 PM PDT	Abstract	8-014 - Cognitive Assessment in Neuromyelitis Optica Spectrum Disorders: A Systematic Review and Meta-Analysis Rebeca O. Silva, Student
05:00 PM - 06:00 PM PDT	Abstract	8-015 - Immunosuppression in Neuromyelitis Optica Spectrum Disorder: A Trial Sequential Analysis and Updated Meta-Analysis Artur Menegaz de Almeida, MS
05:00 PM - 06:00 PM PDT	Abstract	8-016 - The Urgent Need for Evidence Over Anecdote: Equipoise in the ExTINGUISH Clinical Trial in Anti-NMDAR Encephalitis Yoji Hoshina, MD
05:00 PM - 06:00 PM PDT	Abstract	8-017 - Clinical and Radiological Features of Anti-MOG Associated Cerebral Cortical Encephalitis hazal c. manazoglu, MD
05:00 PM - 06:00 PM PDT	Abstract	8-018 - Clinical and Radiological Outcomes in People with Aquaporin-4 IgG Positive Neuromyelitis Optica Spectrum Disorder Following Ravulizumab Treatment (AMAZE) Darin T. Okuda, MD, FAAN
05:00 PM - 06:00 PM PDT	Abstract	8-019 - Utility of the CNS Demyelinating Disease Panel in Patients Presenting with Atypical Demyelinating Attacks Manisha Ramprasad
05:00 PM - 06:00 PM PDT	Abstract	8-020 - Cross-Reactive Antibodies to Butyrophilins in Myelin Oligodendrocyte Glycoprotein Antibody Disease. Shuhei Nishiyama, MD, PhD
05:00 PM - 06:00 PM PDT	Abstract	9-001 - Exploring the Association of Disease Modifying Therapies for Multiple Sclerosis and BTK Inhibitors with Epilepsy Afsaneh Shirani, MD, FAAN
05:00 PM - 06:00 PM PDT	Abstract	9-002 - Neurocognitive Function and Psychiatric Comorbidities in Patients with Epilepsy with Eyelid Myoclonia Hannah Padilla
05:00 PM - 06:00 PM PDT	Abstract	9-003 - Final Neuropsychological Outcomes Following Epilepsy Laser Interstitial Thermal Therapy: A Multicenter Cohort Patrick Landazuri, MD, FAAN
05:00 PM - 06:00 PM PDT	Abstract	9-004 - Multimodal Prognostic Model to Predict Post-Stroke Epilepsy Vijaya R. Dasari
05:00 PM - 06:00 PM PDT	Abstract	9-005 - Cognitive Screening Results in People with Epilepsy Based on Self-Reported Cognitive Complaints Marissa Kellogg, MD, MPH, FAAN
05:00 PM - 06:00 PM PDT	Abstract	9-006 - Minds in Balance, Fertility at Risk: Epilepsy and ADHD Drugs' Hidden Impacts Arisma Arora, MBBS
05:00 PM - 06:00 PM PDT	Abstract	9-007 - Relationships Between Heart-health, Cardiorespiratory Fitness, and Attention-related Activation in Adults with Idiopathic Generalized Epilepsy Jakaiya S. Bryant
05:00 PM - 06:00 PM PDT	Abstract	9-008 - Comorbidities In Patients With Epilepsy And Their Impact In Seizure Control: Experience in an Specialized Healthcare Center Fernando Vasquez Lopez, MD
05:00 PM - 06:00 PM PDT	Abstract	9-009 - Epilepsy and Stroke: A Mendelian Randomization study Alain Z. Lekoubou Looti, MD
05:00 PM - 06:00 PM PDT	Abstract	9-010 - The Epileptic Heart: Exploring Cardiac Alterations in Epileptic Patients. Claudia Mayela Torres Romero, MD
05:00 PM - 06:00 PM PDT	Abstract	9-012 - Levels of Evidence of Comorbid Epileptic Seizures in Patients with Functional Seizures. Shruti N. Iyer, MBBS
05:00 PM - 06:00 PM PDT	Abstract	9-013 - Associated Medical Factors as Predictors of Functional Neurological Disorders: A Retrospective Cohort Study James Kelbert
05:00 PM - 06:00 PM PDT	Abstract	9-014 - How do Smoking, Vaping, and Nicotine Affect People with Epilepsy and Seizures? A Scoping Review Kaitlyn Stoehr, MS5
05:00 PM - 06:00 PM PDT	Abstract	9-015 - An Overview of Psychiatric Disorders and Treatment in Patients with Lennox-Gastaut Syndrome in a LATAM Specialized Center Fernando Vasquez Lopez, MD
05:00 PM - 06:00 PM PDT	Abstract	9-016 - Neurologic and Psychiatric Comorbidities Associated with Drug-Resistant Epilepsy Hira Pervez, MD, MBBS
05:00 PM - 06:00 PM PDT	Abstract	9-017 - Mast Cell Mayhem: Seizures as a Neurologic Complication of Systemic Mastocytosis Manali Desai, DO
05:00 PM - 06:00 PM PDT	Abstract	10-001 - A Case of Mistaken Identity: Posterior Reversible Encephalopathy Syndrome or Progressive Multifocal Leukoencephalopathy? Shikhar Khurana, MD
05:00 PM - 06:00 PM PDT	Abstract	10-002 - Progressive Multifocal Leukoencephalopathy (PML) Treated with Pembrolizumab in an AIDS Patient Who Received Recent Immunosuppressive Chemotherapy for EBV-Associated Lymphoma Akbal S. Gill, DO
05:00 PM - 06:00 PM PDT	Abstract	10-003 - “Immuncompetent” PML in Context of Acquired Interferon Gamma Deficiency Treated with Pembrolizumab Gerard Mullane, MB BCh BAO
05:00 PM - 06:00 PM PDT	Abstract	10-004 - Silent Susceptibility: A Case of Progressive Multifocal Leukoencephalopathy in Occult Immunosuppression Benjamin Rees, BS
05:00 PM - 06:00 PM PDT	Abstract	10-005 - Cortical Blindness and Apraxia in a Liver Transplant Patient - Disentangling a Diagnostic Dilemma Sushma Helagalli Paramashivaiah, MBBS
05:00 PM - 06:00 PM PDT	Abstract	10-006 - Clinical Characteristics and Outcomes of Infectious Encephalitis in Hispanic Pediatric Patients: A Retrospective Analysis Alicia A. Velez
05:00 PM - 06:00 PM PDT	Abstract	10-007 - Broad, Agnostic Pathogen Detection through Metagenomic Next Generation Sequencing (mNGS) of Cerebrospinal Fluid (CSF) to Diagnose CNS Infections Steve Miller, MD, PhD
05:00 PM - 06:00 PM PDT	Abstract	10-009 - Perplexing Case of Aseptic Meningitis with Cytotoxic Lesions of the Corpus Callosum, Multifocal Cranial Nerve Enhancement, and Longitudinally Extensive Transverse Myelitis in an Unvaccinated Healthy Young Woman Jason Gandhi, MD
05:00 PM - 06:00 PM PDT	Abstract	11-001 - Challenges in Diagnosing Rhabdomyolysis: Lesson Learned from a Patient with a Mitochondrial DNA Mutation Michio Hirano, MD, FAAN
05:00 PM - 06:00 PM PDT	Abstract	11-002 - So Father, So Son: Anti-NF155 Autoimmune Nodopathy in Father and Son Roopa Sharma, MD
05:00 PM - 06:00 PM PDT	Abstract	11-003 - A Novel Mutation Associated with Reducing Body Myopathy Morgan Jordan, DO
05:00 PM - 06:00 PM PDT	Abstract	11-004 - Small Fiber Neuropathy with Ganglioside Antibody: A Case Report Maricel Gener, Medical Student
05:00 PM - 06:00 PM PDT	Abstract	11-005 - Secondary Neurolymphomatosis after 11 Years of Remission of CNS Lymphoma: A Case Report Haley Riley, DO
05:00 PM - 06:00 PM PDT	Abstract	11-007 - Importance of Biopsy Despite Genetic Testing Advancements, a Rare Case of Late-onset Congenital Centronuclear Myopathy Daniel Micheli, MD
05:00 PM - 06:00 PM PDT	Abstract	11-008 - Lessons and Questions from a Case of Initially Seronegative Myasthenia Gravis Ima M. Ebong, MD, FAAN
05:00 PM - 06:00 PM PDT	Abstract	11-009 - Hydroxychloroquine Leading to Myopathy with Bulbar Involvement in an 80-year-old Nicole Rigler, MD
05:00 PM - 06:00 PM PDT	Abstract	11-010 - Comorbid Functional Stridor Unveiling Anti-GQ1b Antibody Syndrome: Case Report and Literature Review Mohammad Jahangiri, MD
05:00 PM - 06:00 PM PDT	Abstract	11-011 - A Rare Hematologic Presentation of a Patient with Myasthenia Gravis Status Post Thymectomy Ayesha Quadri
05:00 PM - 06:00 PM PDT	Abstract	11-012 - Anti-GQ1b-positive Miller Fisher Syndrome in a Patient with Unilateral Trochlear Nerve Palsy: A Case Report Kevin W. Dang, MD
05:00 PM - 06:00 PM PDT	Abstract	11-013 - Needle Aponeurotomy of Dupuytren’s Contracture Causing 4th Digital Neuropathy Stephen Jaworski, MD
05:00 PM - 06:00 PM PDT	Abstract	11-014 - Concurrent Inclusion Body Myositis and Late Onset Pompe Disease: A Case Report Brianna Brun
05:00 PM - 06:00 PM PDT	Abstract	11-015 - Dropped Head Syndrome: A Rare Presentation of Mitochondrial Disease Shima Shahjouei, MD, MPH
05:00 PM - 06:00 PM PDT	Abstract	11-016 - A Rare Mimic of Guillain-Barré Syndrome (GBS): Organophosphate Intermediate Syndrome (OPIMS) Bruno Mourao Pacheco, MD
05:00 PM - 06:00 PM PDT	Abstract	11-017 - A Case Report of Immune Checkpoint Inhibitor-related Myofasciitis Zezheng Sun, MD
05:00 PM - 06:00 PM PDT	Abstract	11-018 - A Case of Acute on Chronic Presentation of Seronegative Immune-mediated Necrotizing Myopathy with Bulbar and Axial Weakness JoBeth D. Bingham, DO
05:00 PM - 06:00 PM PDT	Abstract	11-019 - Anti-neutrophil Cytoplasmic Antibody (ANCA)-associated Vasculitis Presenting with Neuromyopathy Han Wang, MD
05:00 PM - 06:00 PM PDT	Abstract	11-020 - Electro-sonographic Evaluation of the Posterior Cutaneous Nerve of the Forearm: A Case of Neuroma-in-continuity Following Stabbing Injury Abdalmalik Bin Khunayfir, MD
05:00 PM - 06:00 PM PDT	Abstract	11-021 - The Phase 3 PREVAIL Study Assessing the Efficacy and Safety of Subcutaneous Gefurulimab in Adults with Generalized Myasthenia Gravis: Trial in Progress Joachim Scholz, MD
05:00 PM - 06:00 PM PDT	Abstract	11-022 - Long-term Safety and Efficacy of Nipocalimab in Generalized Myasthenia Gravis: Vivacity-MG3 Open-label Extension Phase Results Constantine Farmakidis, MD, FAAN
05:00 PM - 06:00 PM PDT	Abstract	11-023 - Ravulizumab in Patients with Generalized Myasthenia Gravis (gMG) from Japan: Real-world Outcomes Benjamin Yungher, PhD
05:00 PM - 06:00 PM PDT	Abstract	11-024 - Immunological Profiling of Thymectomy Tissues in Myasthenia Gravis: The Role of Th17-Related Molecules and Follicular T Helper Cells Doruk Arslan, MD
05:00 PM - 06:00 PM PDT	Abstract	11-025 - Solutions to Address the Unmet Needs of the gMG Patient Journey in the US: A Multistakeholder Delphi Consensus Study Judith Thompson, PhD
05:00 PM - 06:00 PM PDT	Abstract	11-026 - Effgartigimod Helps Avert Post-Thymectomy Crises in Patients with Myasthenia Gravis Classified as MGFA IIIb or Higher Yun Wang, MD
05:00 PM - 06:00 PM PDT	Abstract	11-027 - Efficacy and Safety of Iptacopan in Patients with Generalized Myasthenia Gravis: Study Design Srikanth Muppidi, MD, FAAN
05:00 PM - 06:00 PM PDT	Abstract	11-028 - Change in Concomitant Immunosuppressive Therapies for Generalized Myasthenia Gravis in Patients Receiving Complement C5 Inhibitor Therapies: A Retrospective Analysis of Registry Data Lida Zeinali, MD
05:00 PM - 06:00 PM PDT	Abstract	11-029 - Long-term Use of Oral Corticosteroids and Overall Survival Among Patients with Myasthenia Gravis: A Nationwide Population-based Study Kavita Gandhi, MS, BSPharm
05:00 PM - 06:00 PM PDT	Abstract	11-030 - Long-term Outcomes of Steroid Dosing Regimens and Withdrawal in Myasthenia Gravis: A Single-center Cohort Study Yangyu Huang, MD
05:00 PM - 06:00 PM PDT	Abstract	11-031 - Eculizumab for Treatment of Refractory Thymomatous Acetylcholine Receptor Antibody Positive Generalized Myasthenia Gravis Divya Menghani, MBBS
05:00 PM - 06:00 PM PDT	Abstract	11-032 - Phase 3 Trial Investigating Impact of Intravenous Efgartigimod in Anti-Acetylcholine Receptor Antibody Negative Generalized Myasthenia Gravis James F. Howard, Jr., MD, FAAN
05:00 PM - 06:00 PM PDT	Abstract	11-034 - Design of KYSA-6, a Phase 2, Open-label, Multicenter Study of KYV-101, a Novel Fully Human Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy in Refractory Generalized Myasthenia Gravis Aiden Haghikia, MD
05:00 PM - 06:00 PM PDT	Abstract	12-001 - Psilocybin’s Effects on Headache Frequency are Not Related to Acute Psychedelic Effects or Measures of Mental Health: Secondary Analysis of Clinical Trials in Migraine and Cluster Headache Emmanuelle Schindler, MD, PhD
05:00 PM - 06:00 PM PDT	Abstract	12-002 - A Preliminary Analysis of the Acceptability and Feasibility of Biofeedback-Assisted Relaxation Delivered by Physical Therapists for Patients with Migraine Mia T. Minen, MD, FAAN
05:00 PM - 06:00 PM PDT	Abstract	12-003 - Efficacy of OnabotulinumtoxinA Treatment in Episodic Migraine Malak AlMojel, MD
05:00 PM - 06:00 PM PDT	Abstract	12-004 - Efficacy of Olanzapine as an Abortive Treatment for Status Migrainosus: A Retrospective Chart Review Hira Khan, MD
05:00 PM - 06:00 PM PDT	Abstract	12-005 - Effects of Omega-3 and -6 Fatty Acid Supplementation in Patients with Migraine: Systematic Review and Meta-Analysis of Randomized Clinical Trials Christoper A. Alarcon Ruiz, MD
05:00 PM - 06:00 PM PDT	Abstract	12-006 - Sphenopalatine Ganglion (SPG) Block as Short-Term Migraine Prophylaxis During Pregnancy: A Case Report Sara Zeccardi, NP
05:00 PM - 06:00 PM PDT	Abstract	12-007 - Pilot Study on the Efficacy of Incobotulinumtoxin-A for Refractory Chronic Migraine José María Benítez Salazar
05:00 PM - 06:00 PM PDT	Abstract	12-008 - Melatonin Compared to Other Treatments for Episodic Migraine: A Systematic Review and Network Meta-Analysis Felipe A. Gouhie
05:00 PM - 06:00 PM PDT	Abstract	12-009 - BHV-2100, a First-in-Class TRPM3 Antagonist in Development for the Treatment of Migraine Christopher Jensen, PharmD
05:00 PM - 06:00 PM PDT	Abstract	13-001 - Validation and Adaptation of the Western Aphasia Battery Test in Filipino (WAB-Pinoy): A Pilot Study Joycel Angelique F. Chua, MD
05:00 PM - 06:00 PM PDT	Abstract	13-003 - Angioplasty and Stenting vs Aggressive Medical Management in Intracranial Atherosclerotic Stenosis: Updated Meta-Analysis of RCTs Abdulaziz A. Boqaeid, MBBS
05:00 PM - 06:00 PM PDT	Abstract	13-004 - Intravenous Thrombolysis Alone versus Endovascular Thrombectomy Alone versus Intravenous Thrombolysis plus Endovascular Thrombectomy for Ischemic Stroke Beyond the 4.5-Hour Window: A Network Meta-Analysis of Randomized Clinical Trials Marina Vilardo
05:00 PM - 06:00 PM PDT	Abstract	13-005 - Endovascular Treatment in Large Vessel Stroke Patients in Early vs Late Window: Systematic Review and Meta-Analysis Ahmed Shaheen, Sr.
05:00 PM - 06:00 PM PDT	Abstract	13-006 - Emergent Intracranial Stenting for Acute Large Vessel Occlusion Secondary to Intracranial Atherosclerotic Disease Sydney M. Shaffer, MD
05:00 PM - 06:00 PM PDT	Abstract	13-007 - Assessing the Efficacy of Intra-Arterial and Intravenous Thrombolysis in Acute Spinal Cord Infarctions: A Systematic Review of Case Reports. Ahmed Negida, MD, PhD
05:00 PM - 06:00 PM PDT	Abstract	13-008 - Long-term Efficacy and Safety of Endovascular Thrombectomy for Acute Ischemic Stroke with Large Vessel Occlusion: A Systematic Review and Meta-Analysis Megha Joshi, MBBS
05:00 PM - 06:00 PM PDT	Abstract	13-009 - Tenecteplase Versus Alteplase in Patients with Acute Ischemic Stroke: A Systematic Review and Meta-analysis of Randomized Controlled Trials Brandon Lucke-Wold
05:00 PM - 06:00 PM PDT	Abstract	13-010 - Efficacy and Safety of Fibrinolytics in Patients with Acute Ischaemic Stroke and Transient Ischaemic Attack: A Network Meta-Analysis of Randomized Controlled Trials Aisha Rizwan Ahmed, MBBS
05:00 PM - 06:00 PM PDT	Abstract	13-013 - Intracranial and Extracranial Systemic Complications with Alteplase vs Tenecteplase among Large Vessel Occlusion Stroke Patients Undergoing Thrombectomy Veronica Bohl
05:00 PM - 06:00 PM PDT	Abstract	13-015 - Adjunctive Argatroban Therapy in Patients with Acute Ischemic Stroke: A Systematic Review and Meta-analysis of Randomized Controlled Trials Muhammad W. Ansari, MD
05:00 PM - 06:00 PM PDT	Abstract	13-018 - Futile Recanalization in Basilar Artery Occlusion: A Retrospective Single-Center Study Syed A. Hussain, MBBS
05:00 PM - 06:00 PM PDT	Abstract	13-019 - Safety and Efficacy of Endovascular Interventions for Chronic Carotid Artery Occlusion: A Multi-Center Case Series Jenny Huynh
05:00 PM - 06:00 PM PDT	Abstract	13-020 - Efficacy and Safety of Replase for Acute Ischemic Stroke: a Systematic Review and Meta-Analysis Natasha Maranhao Vieira Rodrigues
05:00 PM - 06:00 PM PDT	Abstract	14-001 - Predictors of Disease Progression in Primary Progressive Aphasia (PPA) Catherine Norise, MD
05:00 PM - 06:00 PM PDT	Abstract	14-002 - Clinical Correlations of the Cyclic Alternating Pattern of Encephalopathy Christine Smith
05:00 PM - 06:00 PM PDT	Abstract	14-003 - Associations of Adverse Childhood Experiences, Inflammation, and Cognition in Older Black Adults Deborah Rose, MD
05:00 PM - 06:00 PM PDT	Abstract	14-004 - Facilitators and Barriers to Deep Brain Stimulation Surgery in Latino Patients: A Single-center Study Ashley Madera, MD
05:00 PM - 06:00 PM PDT	Abstract	14-005 - Comparison of Outcomes Between the Immunocompetent and Immunocompromised in Acute Ischemic Stroke Siara M. Clos, MD
05:00 PM - 06:00 PM PDT	Abstract	14-006 - Implementing Screening for Post-Stroke Cognitive Impairment in an Outpatient Stroke Clinic: A Step Beyond Subjective Cognitive Complaints Ruta Uttarkar
05:00 PM - 06:00 PM PDT	Abstract	14-008 - Factors Associated with Discharge Disposition and Outcomes from Intracerebral Hemorrhage in the ERICH study Lovisa Ljungberg, MD
05:00 PM - 06:00 PM PDT	Abstract	14-009 - Benzodiazepine Initiation Effect on Mortality Among Medicare Beneficiaries Post Acute Ischemic Stroke Madhav Sankaranarayanan
05:00 PM - 06:00 PM PDT	Abstract	14-010 - The Impact of Insulin Resistance on Clinical Outcomes After Acute Ischemic Stroke Endovascular Treatment Tuqa Asedi, MD
05:00 PM - 06:00 PM PDT	Abstract	14-011 - SmartRehab: Enhancing Stroke Recovery through Automated Telerehabilitation Faddi G. Saleh Velez, MD
05:00 PM - 06:00 PM PDT	Abstract	14-012 - Delivery of Stanniocalcin-2 Enhances Post-Stroke Recovery in Aged Rodent Models and Highlights Age-Related Decline in Human CSF Matine Azadian
05:00 PM - 06:00 PM PDT	Abstract	14-013 - Cognitive Limitations after Hemorrhagic Stroke are Related to Anxiety Saami Zakaria, MD
05:00 PM - 06:00 PM PDT	Abstract	14-015 - Can We Improve Detection of Hemi-Neglect and Right-Sided Large Vessel Occlusion Stroke? Logan D. Hilton, MD
05:00 PM - 06:00 PM PDT	Abstract	14-016 - Sex-Specific Lesion Network Mapping of Depression Post-Stroke Anna K. Bonkhoff, MD

Faculty Disclosures
Joycel Angelique F. Chua, MD	Dr. CHUA has nothing to disclose.
Sagi Elhassan, MD	Dr. Elhassan has nothing to disclose.
Sultana M. Mojadidi, MD	Ms. Mojadidi has nothing to disclose.
Austin Layton, DO	Dr. Layton has nothing to disclose.
Maria Montenegro	Maria Montenegro has nothing to disclose.
Rula M. Saeed, MD	Dr. Saeed has nothing to disclose.
Aparna M. Prabhu, MD	Dr. Prabhu has nothing to disclose.
Shikhar Khurana, MD	Dr. Khurana has nothing to disclose.
Philippe-Antoine Bilodeau, MD	Dr. Bilodeau has nothing to disclose.
Shamik Bhattacharyya, MD, FAAN	Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroLambda. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Merck. The institution of Dr. Bhattacharyya has received research support from Alexion Pharmaceuticals. The institution of Dr. Bhattacharyya has received research support from National Institute of Health. The institution of Dr. Bhattacharyya has received research support from UCB. The institution of Dr. Bhattacharyya has received research support from Genentech. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care.
Michael Levy, MD, PhD, FAAN	Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Levy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Levy has received research support from National Institutes Health.
Mattia Wruble, MD	The institution of Dr. Wruble has received research support from Alexion. The institution of Dr. Wruble has received research support from Roche.
Sathya Narasimhan, MD	Dr. Narasimhan has nothing to disclose.
Farrah J. Mateen, MD, PhD, FAAN	Dr. Mateen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Mateen has received research support from Genentech. The institution of Dr. Mateen has received research support from Amgen. The institution of Dr. Mateen has received research support from TG Therapeutics. Dr. Mateen has received intellectual property interests from a discovery or technology relating to health care.
Danielle Kei Pua, MD	Dr. Pua has nothing to disclose.
Afsaneh Shirani, MD, FAAN	Dr. Shirani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics.
Jack P. Antel, MD, FAAN	Dr. Antel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi, roche, biogen, wave,nervgen. The institution of Dr. Antel has received research support from Novartis canada bristol myers squib. Dr. Antel has a non-compensated relationship as a past president with ACTRIMS that is relevant to AAN interests or activities.
G.R. Wayne Moore, MD	The institution of Dr. Moore has received research support from MS Canada.
Olaf Stuve, MD, PhD, FAAN	Dr. Stuve has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurological Diseases. Dr. Stuve has received research support from US Department of Veterans Affairs. Dr. Stuve has received research support from National Multiple Sclerosis Society (US). Dr. Stuve has received research support from Merck KGaA.
Amy L. Brewster, PhD	Dr. Brewster has nothing to disclose.
Nil Saez Calveras, MD	Dr. Saez Calveras has nothing to disclose.
MOEIN YAQUBI, PhD	Mr. YAQUBI has nothing to disclose.
Emanuele Barca, MD, PhD	Dr. Barca has nothing to disclose.
Nuri Jacoby, MD, FAAN	Dr. Jacoby has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Jacoby has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for N/A.
Ali Naini, PhD	Dr. Naini has received personal compensation for serving as an employee of Columbia University.
Michael L. Miller, MD, PhD	Dr. Miller has nothing to disclose.
Kurenai Tanji, MD, PhD	Dr. Tanji has nothing to disclose.
Saba Tadesse, None	Ms. Tadesse has nothing to disclose.
Michio Hirano, MD, FAAN	Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Biopharma SRL. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision Biosciences. Dr. Hirano has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Biopharma SRL. Dr. Hirano has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apollo Communication. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Envision Communications. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ��ɫ��. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Cure SMA. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Muscular Dystrophy Association. The institution of Dr. Hirano has received research support from UCB. The institution of Dr. Hirano has received research support from Cyclerion. The institution of Dr. Hirano has received research support from Astellas. The institution of Dr. Hirano has received research support from Tisento Therapeutics. The institution of Dr. Hirano has received research support from Stealth Biotherapeutics. The institution of Dr. Hirano has received research support from Abliva. Dr. Hirano has received intellectual property interests from a discovery or technology relating to health care. Dr. Hirano has received intellectual property interests from a discovery or technology relating to health care. Dr. Hirano has received personal compensation in the range of $0-$499 for serving as a Study Section Reviewer with NIH. Dr. Hirano has a non-compensated relationship as a Research Advisory Board member with Muscular Dystrophy Association that is relevant to AAN interests or activities. Dr. Hirano has a non-compensated relationship as a Scientific and Medical Advisory Board member with United Mitochondrial Disease Foundation that is relevant to AAN interests or activities. Dr. Hirano has a non-compensated relationship as a Scientific Advisory Board member with Barth Syndrome Foundation that is relevant to AAN interests or activities.
Lynne Turner-Stokes, MD	Prof. Turner-Stokes has nothing to disclose.
Jorge Jacinto	Jorge Jacinto has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz, Ipsen, Allergan. Jorge Jacinto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merz, Allergan, Ipsen.
Klemens Fheodoroff, MD	Dr. Fheodoroff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen, Merz. Dr. Fheodoroff has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen, Merz.
Mathieu Beneteau	Mr. BENETEAU has received personal compensation for serving as an employee of IPSEN.
Pascal Maisonobe	Pascal Maisonobe has received personal compensation for serving as an employee of ipsen pharma. Pascal Maisonobe has received personal compensation for serving as an employee of Ipsen.
Christian Hannes	Dr. Hannes has received personal compensation for serving as an employee of Ipsen. Dr. Hannes has stock in Ipsen.
Stephen Ashford	Stephen Ashford has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Stephen Ashford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Stephen Ashford has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. The institution of Stephen Ashford has received research support from Ipsen.
Isabel Friedenberg, MD	Ms. Friedenberg has nothing to disclose.
Mercedes P. Jacobson, MD	The institution of Dr. Jacobson has received research support from Engage. The institution of Dr. Jacobson has received research support from XENON. The institution of Dr. Jacobson has received research support from SK Life Sciences.
Nicki Karimi-Mostowfi, MD	Miss Karimi-Mostowfi has nothing to disclose.
Rachel Marie E. Salas, MD, MEd, FAAN	Dr. Salas has received personal compensation for serving as an employee of HMPGlobal. Dr. Salas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Learning Network. Dr. Salas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for PRIME. Dr. Salas has received publishing royalties from a publication relating to health care.
Jerusalem Wogayehu	Miss Wogayehu has nothing to disclose.
Robert K. Shin, MD, FAAN	Dr. Shin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Shin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sandoz. Dr. Shin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Shin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS. Dr. Shin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Shin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for TG Therapeutics. Dr. Shin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Shin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen.
Luis G. Manrique, MD	Dr. Manrique has nothing to disclose.
Benjamin J. Osborne, MD, FAAN	Dr. Osborne has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Osborne has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Osborne has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Osborne has received publishing royalties from a publication relating to health care.
Jonah Kaziyev, BS	Mr. Kaziyev has nothing to disclose.
Ali Daneshmand, MD	Dr. Daneshmand has nothing to disclose.
David M. Greer, MD, FAAN	Dr. Greer has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme, Inc. Dr. Greer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for multiple. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has a non-compensated relationship as a Treasurer-Elect with American Neurological Association that is relevant to AAN interests or activities. Dr. Greer has a non-compensated relationship as a President with Neurocritical Care Society that is relevant to AAN interests or activities.
Sheena Patel, Medical Student	Ms. Patel has nothing to disclose.
Carina Hou, BA	Ms. Hou has nothing to disclose.
Emmanuelle Schindler, MD, PhD	Dr. Schindler has received intellectual property interests from a discovery or technology relating to health care.
Christopher C. Gottschalk, MD	Dr. Gottschalk has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Gottschalk has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Gottschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Gottschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Gottschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spherix Global Insights. Dr. Gottschalk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Gottschalk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tonix. Dr. Gottschalk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Impel. Dr. Gottschalk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vectura Fertin. Dr. Gottschalk has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of the Northeast (HCNE). The institution of Dr. Gottschalk has received research support from Rehaler.
Deepak C. DSouza, MD	Prof. DSouza has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atai. Prof. DSouza has received personal compensation in the range of $0-$499 for serving as a Consultant for Inverready. Prof. DSouza has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for France Foundation. Prof. DSouza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Northwell. Prof. DSouza has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for France Foundation. Prof. DSouza has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Psychopharmacology. The institution of Prof. DSouza has received research support from Boehringer Ingelheim. The institution of Prof. DSouza has received research support from NIDA. The institution of Prof. DSouza has received research support from VA CS&RD. The institution of Prof. DSouza has received research support from Wallace Research. The institution of Prof. DSouza has received research support from Takeda. Prof. DSouza has received research support from Cerevel. Prof. DSouza has received publishing royalties from a publication relating to health care.
Saul Reyes, MD	Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BIIB. Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen.
Jairo A. Gaitan Alfonso, MD	Dr. Gaitan Alfonso has nothing to disclose.
Jaime Toro, MD, FAAN	Dr. Toro has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Watch Neurology .
Juliana Lago, PhD	Dr. Lago has nothing to disclose.
Helena Groot	Helena Groot has nothing to disclose.
Daniela S. Rodriguez	Ms. Rodriguez has nothing to disclose.
Carolina Restrepo-Aristizabal	No disclosure on file
Cesar Franco Ruiz, MD	Dr. Franco Ruiz has nothing to disclose.
MARIANA TORRES BUSTAMANTE, MD	Dr. TORRES BUSTAMANTE has nothing to disclose.
Angie Montejo	No disclosure on file
Luisa Marquez	No disclosure on file
Diana Narvaez, PhD	Dr. Narvaez has nothing to disclose.
Juan P. Rodriguez noriega, MD	Dr. Rodriguez noriega has nothing to disclose.
David F. Cuellar Giraldo, Jr., MD	Dr. Cuellar Giraldo has nothing to disclose.
Habib Georges Moutran Barroso, MD	Dr. Moutran Barroso has nothing to disclose.
Fabian Cortés-Muñoz	No disclosure on file
Daniel León Tramontini	Mr. León Tramontini has nothing to disclose.
Thomas F. Medina Ramirez	Mr. Medina Ramirez has nothing to disclose.
Laura A. Serna	Miss Serna has nothing to disclose.
Machteld E. Hillen, MD, FAAN	The institution of Dr. Hillen has received research support from Genentech.
Erin M. Feinstein, DO	Dr. Feinstein has nothing to disclose.
Ahmed Sabra, MD	Mr. Sabra has nothing to disclose.
Sudheesh Ramachandran, MBBS	Dr. Ramachandran has nothing to disclose.
Roopa Sharma, MD	Dr. Sharma has nothing to disclose.
Chenchen Xie, PhD	Dr. Xie has nothing to disclose.
Changqing Li	Prof. Li has nothing to disclose.
You Wang	No disclosure on file
Honghao Cao	No disclosure on file
Moaz E. Abouelmagd, MD	Dr. Abouelmagd has nothing to disclose.
Asmaa Z. Zakria	Dr. Zakria has nothing to disclose.
Ahmed Elshahat, MD	Dr. Elshahat has nothing to disclose.
Belal M. Hamed, Jr., Medical student	Dr. Hamed has nothing to disclose.
Ismail A. Ibrahim	Mr. Ibrahim has nothing to disclose.
Ahmed S. AbdelAziz, MD	Dr. AbdelAziz has nothing to disclose.
Michael Chojnacki	Mr. Chojnacki has nothing to disclose.
Corinna Fukushima, MD	Dr. Fukushima has nothing to disclose.
Sayona John, MD, FAAN	Dr. John has nothing to disclose.
Tony Zhang, MBChB	Dr. Zhang has nothing to disclose.
Sara Hooshmand, MD	Dr. Hooshmand has nothing to disclose.
Nathaniel P. Rogers, Jr., MD	Dr. Rogers has nothing to disclose.
David Sohutskay, MD, PhD	An immediate family member of Dr. Sohutskay has received personal compensation for serving as an employee of Abbott. An immediate family member of Dr. Sohutskay has received personal compensation for serving as an employee of EBR Systems.
Michel Toledano, MD	Dr. Toledano has nothing to disclose.
Jeremy K. Cutsforth-Gregory, MD, FAAN	Dr. Cutsforth-Gregory has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Cutsforth-Gregory has received publishing royalties from a publication relating to health care.
Rafid Mustafa, MD	Dr. Mustafa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Dr. Mustafa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PicnicHealth. Dr. Mustafa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon Biosciences. Dr. Mustafa has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon Biosciences.
Zixin Yi, BS	Ms. Yi has nothing to disclose.
Manisha Koneru, MD	Dr. Koneru has nothing to disclose.
Corey Mossop, MD	Dr. Mossop has nothing to disclose.
Todd L. Siegal, MD	Dr. Siegal has nothing to disclose.
Ashlee Joan Macalino	Ms. Macalino has nothing to disclose.
Meredith Pescatello	Mrs. Pescatello has nothing to disclose.
Christopher J. Mooney, PhD	Dr. Mooney has nothing to disclose.
Robert I. Thompson-Stone, MD, FAAN	Dr. Thompson-Stone has received personal compensation in the range of $500-$4,999 for serving as a Krabbe Disease expert with Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC). Dr. Thompson-Stone has a non-compensated relationship as a Editorial Board Member with Neurology: ��ɫ�� Journal that is relevant to AAN interests or activities.
Hannah Padilla	Miss Padilla has nothing to disclose.
Eva Alden, PhD	Dr. Alden has nothing to disclose.
Isha Snehal, MBBS	Dr. Snehal has nothing to disclose.
Jeffrey W. Britton, MD, FAAN	Dr. Britton has received personal compensation in the range of $0-$499 for serving as a Online course with American Clinical Neurophysiology Society.
Lily Wong-Kisiel, MD, FAAN	Dr. Wong-Kisiel has nothing to disclose.
Elaine C. Wirrell, MD, FAAN	Dr. Wirrell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biocodex. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Encoded. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRIN. Dr. Wirrell has received publishing royalties from a publication relating to health care.
Kelsey M. Smith, MD	The institution of Dr. Smith has received research support from CURE Epilepsy. The institution of Dr. Smith has received research support from UCB Pharmaceuticals.
Akbal S. Gill, DO	Dr. Gill has nothing to disclose.
Lyle Ostrow, MD, PhD	The institution of Dr. Ostrow has received research support from NINDS. The institution of Dr. Ostrow has received research support from CDC National ALS Registry (ATSDR).
Filipe P. Sarmento, MD	Dr. Sarmento has nothing to disclose.
Pedro Fraiman, MD	Dr. Fraiman has a non-compensated relationship as a Neurology Resident & Fellow Section Editorial Board Member with Neurology Journal that is relevant to AAN interests or activities.
Murilo Cruccioli	Mr. Cruccioli has nothing to disclose.
Pedro H. Teixeira	Mr. Teixeira has nothing to disclose.
Regina Carneiro Leão	Miss Carneiro Leão has nothing to disclose.
Caio R. Lima	Mr. Lima has nothing to disclose.
Milena L. Loures, Student	Ms. Loures has nothing to disclose.
Jorge F. Pitanga, MS	Mr. Pitanga has nothing to disclose.
Mia T. Minen, MD, FAAN	The institution of Dr. Minen has received research support from NIH. Dr. Minen has received intellectual property interests from a discovery or technology relating to health care. Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a First Contact-Primary Care Advisory Board Member with American Headache Society . Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PCORI grant on migraine evidence based map for stakeholders with ECRI .
Julia Dorf	Miss Dorf has nothing to disclose.
Alexis George	Ms. George has nothing to disclose.
Kristina M. Fanning, PhD	The institution of Dr. Fanning has received research support from Abbvie. The institution of Dr. Fanning has received research support from NYC Langone Health . The institution of Dr. Fanning has received research support from Uiversity of SC - Irvine. The institution of Dr. Fanning has received research support from AESARA.
Ryan Bostic	Ryan Bostic has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for MIST Research.
Peter Schultz, PT	Mr. Schultz has nothing to disclose.
Nisa Vorasoot, MD	Dr. Vorasoot has nothing to disclose.
Matthew Edmond	Mr. Edmond has nothing to disclose.
Laura Cacciaguerra, MD, PhD	Dr. Cacciaguerra has nothing to disclose.
John Chen	John Chen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. John Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. John Chen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB.
Sean J. Pittock, MD, FAAN	Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care.
Eoin P. Flanagan, MBBCh, FAAN	The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Merck. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology that is relevant to AAN interests or activities.
Miriam Quinlan, MD, MPH	Dr. Quinlan has nothing to disclose.
Hannah Wiest	Ms. Wiest has nothing to disclose.
Ilana Harwayne-Gidansky, MD	Dr. Harwayne-Gidansky has nothing to disclose.
John A. Pugh, MD	Dr. Pugh has nothing to disclose.
Varsha Nandwana, MD	Dr. Nandwana has nothing to disclose.
Aashit K. Shah, MD, FAAN	Dr. Shah has stock in Abbot, Abbivie, Gilead, Johnson and Johnson, Pfizer. The institution of Dr. Shah has received research support from Xenon Pharma.
Muhammad Hussain, MD	Dr. Hussain has nothing to disclose.
Stone Leachman, Medical student	Mr. Leachman has nothing to disclose.
Kaitlyn Novotny	Ms. Novotny has nothing to disclose.
Sannah Vasaya, DO	Dr. Vasaya has nothing to disclose.
Aroucha Vickers, DO, FAAN	Dr. Vickers has nothing to disclose.
Paul H. Janda, DO, JD, Wharton MBA, FAAN	Dr. Janda has nothing to disclose.
Malak AlMojel, MD	Dr. AlMojel has nothing to disclose.
Jasem Y. Al-Hashel, MD	Dr. Al-Hashel has nothing to disclose.
Raed Alroughani, MD, FAAN	Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, AstraZeneca, Novartis, Merck, Roche, Sanofi. Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AstraZeneca, Biogen, Novartis, Merck, Roche, Sanofi.
Samar F. Ahmed, MD	Dr. Ahmed has nothing to disclose.
Gerard Mullane, MB BCh BAO	Dr. Mullane has nothing to disclose.
Killian O'Rourke, MD	Dr. O'Rourke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Pawel Wrona, MD	Dr. Wrona has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Wrona has received research support from ABAStroke Company.
Agnieszka Slowik, MD, FAAN	Dr. Slowik has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer, . Dr. Slowik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Slowik has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Bartlomiej M. Piechowski-Jozwiak, MD	Dr. Piechowski-Jozwiak has nothing to disclose.
Tomasz Homa, MD	Mr. Homa has received research support from ABAStroke Company.
Ewa Wlodarczyk, MD	Dr. Wlodarczyk has nothing to disclose.
Paulina E. Sarba, MD	Miss Sarba has received research support from ABAStroke Company.
Abdulaziz A. Boqaeid, MBBS	Dr. Boqaeid has nothing to disclose.
Muna Alnamlah, MBBS	Dr. Alnamlah has nothing to disclose.
Mohammed Alqahtani	Mohammed Alqahtani has nothing to disclose.
Adel Alhazzani, MD, FRCPC, FAAN	Dr. Alhazzani has nothing to disclose.
MUHNNAD ASIRI	No disclosure on file
Fawaz F. Alotaibi, MBBS	Dr. Alotaibi has nothing to disclose.
Ahmed Alkhiri	Mr. Alkhiri has nothing to disclose.
Shatha S. Alqurashi	Ms. Alqurashi has nothing to disclose.
Fahad S. Al-Ajlan, MD	Dr. Al-Ajlan has nothing to disclose.
Sydney L. Short	Mrs. Short has nothing to disclose.
Saadia Akhtar	Miss Akhtar has nothing to disclose.
Mallory H. Johnson, Medical student	Miss Johnson has nothing to disclose.
Lillian R. Sims, PhD	Dr. Sims has nothing to disclose.
Kimberly S. Jones, MD, FAAN	Dr. Jones has nothing to disclose.
Patrick Landazuri, MD, FAAN	Dr. Landazuri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuropace. Dr. Landazuri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuropace. Dr. Landazuri has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Federal Public Defender - District of Kansas. Dr. Landazuri has received publishing royalties from a publication relating to health care.
Caleb Pearson, PhD	Dr. Pearson has received publishing royalties from a publication relating to health care.
Jennifer Gess, PhD	Dr. Gess has nothing to disclose.
David Denney, PhD	Dr. Denney has nothing to disclose.
Bradley Folley	No disclosure on file
Christian LoBue, PhD	The institution of Dr. LoBue has received research support from Department of Defense. The institution of Dr. LoBue has received research support from NIH.
Melissa Sutcliffe, PhD	Dr. Sutcliffe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for National Academy of Neuropsychology. Dr. Sutcliffe has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Miller, Dawson, Sigal, & Ward. The institution of Dr. Sutcliffe has received research support from PCORI. The institution of Dr. Sutcliffe has received research support from NICHD. The institution of Dr. Sutcliffe has received research support from NINDS.
Taylor Abel, MD	Dr. Abel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical .
James Baumgartner	No disclosure on file
Joseph S. Neimat, MD	Dr. Neimat has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MonterisInc. .
Viktoras Palys, MD, FAANS, FCNS	Dr. Palys has nothing to disclose.
Andreas Lysandropoulos	Andreas Lysandropoulos has nothing to disclose.
Naomi Suminski	Naomi Suminski has received personal compensation for serving as an employee of Parexel.
Tjalf Ziemssen, MD, FAAN	Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS . Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Dresden Internation University. The institution of Dr. Ziemssen has received research support from Novartis. The institution of Dr. Ziemssen has received research support from Merck. The institution of Dr. Ziemssen has received research support from Sanofi. The institution of Dr. Ziemssen has received research support from BMS. The institution of Dr. Ziemssen has received research support from Roche.
Morgan Jordan, DO	Dr. Jordan has nothing to disclose.
Lee Kugelmann	Lee Kugelmann has nothing to disclose.
Marie Rivera, MD	Dr. Rivera has nothing to disclose.
Kyle W. Ruffing, MD, FAAN	Dr. Ruffing has nothing to disclose.
Benjamin Rees, BS	Mr. Rees has nothing to disclose.
Gillian R. Naro, MD	Dr. Naro has nothing to disclose.
Bojun Chen, MD, PhD	Dr. Chen has nothing to disclose.
Debolina Kanjilal, MD	Ms. Kanjilal has nothing to disclose.
Margaret Beigel, DO	Dr. Beigel has nothing to disclose.
Rami Ibrahim, MD	Dr. Ibrahim has nothing to disclose.
Hira Khan, MD	Dr. Khan has nothing to disclose.
Sahil Sardana, MD	Dr. Sardana has nothing to disclose.
Muhammad Saim	Mr. Saim has nothing to disclose.
Praveer Vyas, MPH	Mr. Vyas has nothing to disclose.
Andrea S. Synowiec, DO, FAAN	Dr. Synowiec has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Amgen. Dr. Synowiec has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. Dr. Synowiec has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Allergan. Dr. Synowiec has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven.
Logan Drucker	Mr. Drucker has nothing to disclose.
Joanna Weller	Joanna Weller has nothing to disclose.
Matthew Jo	Matthew Jo has nothing to disclose.
Kaylee A. Reilly	Ms. Reilly has nothing to disclose.
Mark Gudesblatt, MD	The institution of Dr. Gudesblatt has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for genentech. The institution of Dr. Gudesblatt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Myassar Zarif	Myassar Zarif has nothing to disclose.
Gursimer Anand	Gursimer Anand has nothing to disclose.
Maleeha Vij	Maleeha Vij has nothing to disclose.
Jeffrey A. Cohen, MD	Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSI. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celltrion.
Amy Kunchok, MBBS	Dr. Kunchok has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology:Open Access Journal .
Katherine Havard-Coiro, MD	Dr. Havard-Coiro has nothing to disclose.
Mahsa Ghajarzadeh, MD, PhD	Dr. GHAJARZADEH has nothing to disclose.
Kathryn Fitzgerald, PhD	Dr. Fitzgerald has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Setpoint Medical. The institution of Dr. Fitzgerald has received research support from NIH. The institution of Dr. Fitzgerald has received research support from National MS Society.
Ellen M. Mowry, MD, FAAN	Dr. Mowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octave. Dr. Mowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SetPoint. The institution of Dr. Mowry has received research support from Genentech/Roche. The institution of Dr. Mowry has received research support from Biogen. Dr. Mowry has received publishing royalties from a publication relating to health care.
Yishang Huang, research data anlayst	Miss Huang has nothing to disclose.
Bardia Nourbakhsh, MD	Dr. Nourbakhsh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics . Dr. Nourbakhsh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alkermes. The institution of Dr. Nourbakhsh has received research support from Genentech. The institution of Dr. Nourbakhsh has received research support from National MS Society . The institution of Dr. Nourbakhsh has received research support from Department of Defense. The institution of Dr. Nourbakhsh has received research support from NIH. The institution of Dr. Nourbakhsh has received research support from Axsome Therapeutics. The institution of Dr. Nourbakhsh has received research support from TG Therapeutics .
Marina Vilardo	Miss Vilardo has nothing to disclose.
Lucas P. Mitre	Dr. Mitre has nothing to disclose.
AHMET GÜNKAN, MD	Dr. GÜNKAN has nothing to disclose.
Dominique H. Montecino, MD	Dr. Montecino has nothing to disclose.
Filipe V. Ribeiro, MD	Ms. Ribeiro has nothing to disclose.
Bruna Leles Vieira de Souza, MD	Miss Leles Vieira de Souza has nothing to disclose.
Ocilio R. Goncalves, MS	Mr. Goncalves has nothing to disclose.
Raphael Camerotte	Raphael Camerotte has nothing to disclose.
Ana Santos, MD	Ms. Santos has nothing to disclose.
Anthony Hong, MD	Dr. Hong has nothing to disclose.
Clare M. Lambert, MD	Dr. Lambert has nothing to disclose.
Jeffrey Dewey, MD, MHS, FAAN	Dr. Dewey has received personal compensation in the range of $500-$4,999 for serving as a Expert Medication Request Reviewer with Megallan.
Vijaya R. Dasari	Miss Dasari has nothing to disclose.
Vineet Punia, MD	Dr. Punia has nothing to disclose.
Nicholas Thompson	The institution of Nicholas Thompson has received research support from EMD Serono.
Maricel Gener, Medical Student	Ms. Gener has nothing to disclose.
Lawrence A. Zeidman, MD, FAAN	Dr. Zeidman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Zeidman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Zeidman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Zeidman has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Smith Blake Hill LLC. The institution of Dr. Zeidman has received research support from Octapharma. Dr. Zeidman has received publishing royalties from a publication relating to health care.
Sandesh Reddy	Sandesh Reddy has nothing to disclose.
Rohan Vemu, MSE	Mr. Vemu has nothing to disclose.
Cameron Noorbakhsh, BA	Mr. Noorbakhsh has nothing to disclose.
Anthony Kaspa Allam	Mr. Allam has nothing to disclose.
Peyton Presto, PhD	Dr. Presto has nothing to disclose.
erich M. sturgis, MD	The institution of Dr. sturgis has received research support from Cancer Prevention Research Institute of Texas. The institution of Dr. sturgis has received research support from NIH/NCI. The institution of Dr. sturgis has received research support from NIH/NIDCR.
Katherine Hutcheson, PhD	Prof. Hutcheson has nothing to disclose.
Emmanouil Froudarakis	Emmanouil Froudarakis has nothing to disclose.
James P. Orengo, MD, PhD	Dr. Orengo has nothing to disclose.
Sarah Heilbronner, PhD	Dr. Heilbronner has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Society for Neuroscience. The institution of Dr. Heilbronner has received research support from National Institutes of Health.
Kelly R. Bijanki, PhD	The institution of Dr. Bijanki has received research support from National Institutes of Health. Dr. Bijanki has received intellectual property interests from a discovery or technology relating to health care. Dr. Bijanki has received intellectual property interests from a discovery or technology relating to health care.
susan hilsenbeck, PhD	Dr. hilsenbeck has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AACR. Dr. hilsenbeck has stock in Genetex. The institution of Dr. hilsenbeck has received research support from NIH, CPRIT.
T. Dorina Papageorgiou, PhD, FAAN	The institution of Dr. Papageorgiou has received research support from McNair Foundation. The institution of Dr. Papageorgiou has received research support from TIRR - Mission Connect. The institution of Dr. Papageorgiou has received research support from McNair Medical Institute. The institution of Dr. Papageorgiou has received research support from Center for Alzheimer's and Neurodegenerative Disease. The institution of Dr. Papageorgiou has received research support from Naman Basic Science Faculty Award .
Imad R. Khan, MD	The institution of Dr. Khan has received research support from National Institute of Neurological Diseases and Stroke. The institution of Dr. Khan has received research support from National Heart Lung and Blood Institute. The institution of Dr. Khan has received research support from National Institute of Neurological Diseases and Stroke.
Julius Latorre, MD, FAAN	Dr. Latorre has nothing to disclose.
Peter J. Papadakos, MD	Dr. Papadakos has received publishing royalties from a publication relating to health care. Dr. Papadakos has received publishing royalties from a publication relating to health care.
Debra Roberts, MD, PhD	Dr. Roberts has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Buckland Law Firm.
Benjamin P. George, MD	Dr. George has nothing to disclose.
Erin Barnes, MD	An immediate family member of Dr. Barnes has received personal compensation for serving as an employee of Go2For Lung Cancer. The institution of Dr. Barnes has received research support from NIH.
Lily Chau, MD	Dr. Chau has nothing to disclose.
Panayiotis N. Varelas, MD, PhD, FAAN	Dr. Varelas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Varelas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astra Zeneca -Alexion - Portola. Dr. Varelas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Varelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca- Alexion-Portola. Dr. Varelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus. Dr. Varelas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Varelas has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Giammarco, Mullins & Horton P.C. The institution of Dr. Varelas has received research support from Marinus. The institution of Dr. Varelas has received research support from Bayer. Dr. Varelas has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Varelas has received personal compensation in the range of $5,000-$9,999 for serving as a Rep to the RUC meeting with AAN. Dr. Varelas has received personal compensation in the range of $500-$4,999 for serving as a Speaker at the Annual Meeting with AAN. Dr. Varelas has a non-compensated relationship as a President - Past President with Neurocritical Care Society that is relevant to AAN interests or activities.
Manaz Rezayee	Ms. Rezayee has nothing to disclose.
Megan L. Callahan, PsyD, ABPP	Dr. Callahan has nothing to disclose.
Samantha P. Martin, MA	Miss Martin has nothing to disclose.
Juanita Johnson, RN	Ms. Johnson has nothing to disclose.
David C. McCarthy, Jr., MD	Dr. McCarthy has nothing to disclose.
Marcella A. Coutts, MD	Dr. Coutts has nothing to disclose.
Kimford J. Meador, MD, FAAN	The institution of Dr. Meador has received research support from NIH. The institution of Dr. Meador has received research support from The Epilepsy Consortium.
Marissa Kellogg, MD, MPH, FAAN	The institution of Dr. Kellogg has received research support from VA & DoD.
Beth Leeman-Markowski, MD, MA, MMSc	Dr. Leeman-Markowski has received research support from FACES Foundation. Dr. Leeman-Markowski has received research support from Veterans Administration - CSRD Career Development Award-2.
Hsueh-Sheng Chiang, MD, PhD	The institution of Dr. Chiang has received research support from NIH/NIDCD. The institution of Dr. Chiang has received research support from Texas Alzheimer's Research and Care Consortium.
John Hart, MD	The institution of Dr. Hart has received research support from Department of Defense.
Brendan J. Kelley, MD, FAAN	Dr. Kelley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Kelley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Labcorp. Dr. Kelley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esai.
Trung P. Nguyen, MD	The institution of Dr. Nguyen has received research support from National Institute on Aging. The institution of Dr. Nguyen has received research support from Texas Alzheimer's Research and Care Consortium. The institution of Dr. Nguyen has received research support from Biogen.
Alexander Frolov, MD	Dr. Frolov has nothing to disclose.
Ashna Adhikari	Ms. Adhikari has nothing to disclose.
Christine H. Abasi, MS - SLP	Miss Abasi has nothing to disclose.
Katelyn A. Lucas-Mendoza	Mrs. Lucas-Mendoza has nothing to disclose.
Paulina V. Devora, MS	Mrs. Devora has nothing to disclose.
Christine S. Dugas, PhD	Dr. Dugas has nothing to disclose.
Siara M. Clos, MD	Dr. Clos has nothing to disclose.
Sedat Gul, MD	Dr. Gul has nothing to disclose.
Aydan Kahriman, MD	Dr. Kahriman has nothing to disclose.
Michal Kawzowicz, MD	Mr. Kawzowicz has nothing to disclose.
Adeenah Ahmed, MD	Ms. Ahmed has nothing to disclose.
Hye Cho, Medical Student	Ms. Cho has nothing to disclose.
Justin Lui	Mr. Lui has nothing to disclose.
Brendan Daly, Medical Student	Mr. Daly has nothing to disclose.
Dan Draytsel	Mr. Draytsel has nothing to disclose.
Romario Gibson, MD	Dr. Gibson has nothing to disclose.
Heidi Hindsley, MD, PA	Ms. Hindsley has nothing to disclose.
Sara Abdelhafiz, MBBS	Dr. Abdelhafiz has nothing to disclose.
Makenzie L. Kramer	Ms. Kramer has nothing to disclose.
Corey A. McGraw, MD	The institution of Dr. McGraw has received research support from Novartis. The institution of Dr. McGraw has received research support from F. Hoffmann - La Roche. The institution of Dr. McGraw has received research support from Genentech. The institution of Dr. McGraw has received research support from Neurona Therapeutics. The institution of Dr. McGraw has received research support from Instituto Grifols, S.A..
Hesham Masoud, MD	Dr. Masoud has nothing to disclose.
Sanaea Z. Bhagwagar	An immediate family member of Miss Bhagwagar has received personal compensation for serving as an employee of three different biotech companies unrelated to the present submission.
Ryan Kimmis, MD	Dr. Kimmis has nothing to disclose.
Nour Shaheen, Sr., MBBS	Mr. Shaheen has nothing to disclose.
Ram K. Saha, MD	Dr. Saha has nothing to disclose.
Hafsa Arshad Azam Raja, MBBS	Ms. Raja has nothing to disclose.
Ahmed Shaheen, Sr.	Mr. Shaheen has nothing to disclose.
Marina T. Marques, MD	The institution of Miss Marques has received research support from American Heart Association.
Kevin Bao	Mr. Bao has nothing to disclose.
Matheus Otero, MD	Dr. Otero has nothing to disclose.
Katherine Peterson	Ms. Peterson has nothing to disclose.
Claude Hemphill III, MD, FAAN	Dr. Hemphill has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Hemphill has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Aurenar. Dr. Hemphill has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various legal firms. The institution of Dr. Hemphill has received research support from NIH/NINDS.
xiao hu, PhD	Dr. hu has nothing to disclose.
Gisele Silva	Gisele Silva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Gisele Silva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UNIFESP/HIAE.
M. B. Westover, MD, PhD	Dr. Westover has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Beacon Biosignals. Dr. Westover has stock in Beacon Biosignals. The institution of Dr. Westover has received research support from NIH. Dr. Westover has received publishing royalties from a publication relating to health care. Dr. Westover has a non-compensated relationship as a cofounder with Beacon Biosignals that is relevant to AAN interests or activities.
Jong W. Lee, MD, PhD	The institution of Dr. Lee has received research support from NIH. The institution of Dr. Lee has received research support from NIH. The institution of Dr. Lee has received research support from UCB. Dr. Lee has received personal compensation in the range of $10,000-$49,999 for serving as a Contract work with Teladoc.
Edilberto Amorim, MD	The institution of Dr. Amorim has received research support from American Heart Association. The institution of Dr. Amorim has received research support from Society of Critical Care Medicine. The institution of Dr. Amorim has received research support from Zoll Foundation. The institution of Dr. Amorim has received research support from Hellman Foundation. The institution of Dr. Amorim has received research support from Regents of the University of California. The institution of Dr. Amorim has received research support from Citizens United Against Epilepsy. The institution of Dr. Amorim has received research support from Regents of the University of California. The institution of Dr. Amorim has received research support from American Heart Association. The institution of Dr. Amorim has received research support from NIH. The institution of Dr. Amorim has received research support from Department of Defense. The institution of Dr. Amorim has received research support from Department of Defense. The institution of Dr. Amorim has received research support from American Heart Association.
Tahereh Neyaz	Ms. Neyaz has nothing to disclose.
Vinay Bhandaru, MS	Mr. Bhandaru has nothing to disclose.
Mathula Thangarajh, MD, PhD, FAAN	Dr. Thangarajh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Thangarajh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NS Pharma.
Madeline Rice, PhD	The institution of Dr. Rice has received research support from NIH.
Andrea He	The institution of Miss He has received research support from AAN.
Kristin M. Conway, PhD	Dr. Conway has nothing to disclose.
Natalie Street, MD	No disclosure on file
Katherine D. Mathews, MD, FAAN	Dr. Mathews has received personal compensation for serving as an employee of Avidity Bioscience. The institution of Dr. Mathews has received research support from NIH. The institution of Dr. Mathews has received research support from Centers for Disease Control and Prevention. The institution of Dr. Mathews has received research support from Muscular Dystrophy Association . The institution of Dr. Mathews has received research support from Friedreich's Ataxia Research Alliance . The institution of Dr. Mathews has received research support from Sarepta . The institution of Dr. Mathews has received research support from Pfizer. The institution of Dr. Mathews has received research support from Reata . The institution of Dr. Mathews has received research support from PTC Therapeutics, Inc. The institution of Dr. Mathews has received research support from Italfarmaco . The institution of Dr. Mathews has received research support from AMO. The institution of Dr. Mathews has received research support from FibroGen. The institution of Dr. Mathews has received research support from Capricor. The institution of Dr. Mathews has received research support from edgewise. The institution of Dr. Mathews has received research support from biogen.
Emma Ciafaloni, MD, FAAN	Dr. Ciafaloni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx, Alexion, Sarepta, UCB, Hoffman-LaRoche, Biogen. Dr. Ciafaloni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis, AnnJi Pharmaceutical, ML-BIO, Avidity. The institution of Dr. Ciafaloni has received research support from CDC, CureSMA, FDA, Orphazyme, Sarepta, PCORI, Neurogene. Dr. Ciafaloni has received publishing royalties from a publication relating to health care.
Yedatore S. Venkatesh, MD, FAAN	Dr. Venkatesh has nothing to disclose.
James F. Howard, Jr., MD, FAAN	Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx . Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron Pharmaceuticals. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN (Horizon Therapeutics). Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Ltd. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CorEvitas. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck EMD Serono. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian Therapeutics. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NMD Pharma. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for H. Lundbeck A/S. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Seismic Therapeutics. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vor Biopharma. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Academic CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PeerView CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Platform Q CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for MJH LifeSci. Dr. Howard has or had stock in Johnson & Johnson dividends.Dr. Howard has or had stock in Pfizer dividends. An immediate family member of Dr. Howard has or had stock in GlaxoSmithKline dividends.Dr. Howard has or had stock in Bristol Myer Squbb dividends.Dr. Howard has or had stock in AbbieVie Inc. The institution of Dr. Howard has received research support from Alexion Pharmaceuticals. The institution of Dr. Howard has received research support from argenx . The institution of Dr. Howard has received research support from UCB Biosciences. The institution of Dr. Howard has received research support from NIH. The institution of Dr. Howard has received research support from Centers for Disease Control/Research Triangle Institute. The institution of Dr. Howard has received research support from Cartestian Therapeutics. The institution of Dr. Howard has received research support from NMD Pharma. The institution of Dr. Howard has received research support from Ad Scientiam. The institution of Dr. Howard has received research support from Merck EMD Serono. Dr. Howard has a non-compensated relationship as a Scientific Advisiory Board member, Committee member with Myasthenia Gravis Foundation of America that is relevant to AAN interests or activities. Dr. Howard has a non-compensated relationship as a Committee member with American Assoc Neuromuscular and Electrodiagnostic Medicine that is relevant to AAN interests or activities.
Yohan Kim, DO	Dr. Kim has nothing to disclose.
Joseph Kim, MD	Dr. Kim has nothing to disclose.
Michael L. Palm, MD, FAAN	Dr. Palm has received personal compensation in the range of $0-$499 for serving as a Member of the UCNS Accreditation Council with United Council for Neurologic Subspecialties.
Shaun O. Smart, MD	Dr. Smart has nothing to disclose.
Chiemela Onyekere, MD	Dr. Onyekere has nothing to disclose.
Roxana M. Dragomir, MD	Dr. Dragomir has nothing to disclose.
Marc A. Swerdloff, MD	Dr. Swerdloff has nothing to disclose.
Karen Inzirillo, NP	Ms. Inzirillo has nothing to disclose.
Rebecca A. Frawley, DO	Dr. Frawley has nothing to disclose.
Saman Zafar, MD	Dr. Zafar has nothing to disclose.
Gabriella Garcia, MD	Dr. Garcia has nothing to disclose.
Sushma Helagalli Paramashivaiah, MBBS	Dr. Helagalli Paramashivaiah has nothing to disclose.
Alessandro Dinoto, MD	The institution of Dr. Dinoto has received research support from Encephalitis International . The institution of Dr. Dinoto has received research support from Autoimmune Encephalitis Alliance.
Alfonso S. Lopez, MD	Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech .
Cristina Valencia Sanchez, MD	Dr. Valencia Sanchez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG therapeutics. Dr. Valencia Sanchez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Valencia Sanchez has a non-compensated relationship as a member of the medical advisory board with The MOG Project that is relevant to AAN interests or activities.
Kai Guo, MD, PhD	Dr. Guo has nothing to disclose.
Smathorn Thakolwiboon, MD	Dr. Thakolwiboon has nothing to disclose.
Susan Horsman, PharmD	Dr. Horsman has nothing to disclose.
Stephanie Syc-Mazurek, MD, PhD	Dr. Syc-Mazurek has a non-compensated relationship as a Editorial Board Resident and Fellows Section with Neurology that is relevant to AAN interests or activities.
Nanthaya Tisavipat, MD	Miss Tisavipat has nothing to disclose.
Deena Tajfirouz, MD	Dr. Tajfirouz has nothing to disclose.
Eric R. Eggenberger, DO, FAAN	Dr. Eggenberger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Welch-Allyn. Dr. Eggenberger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Illinois Institute of Technology (IITT). Dr. Eggenberger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx.
Misha Pless, MD	Dr. Pless has nothing to disclose.
Kevin Chodnicki	Kevin Chodnicki has nothing to disclose.
Jan-Mendelt Tillema, MD	Dr. Tillema has nothing to disclose.
Vyanka Redenbaugh, MB BCh BAO	Dr. Redenbaugh has nothing to disclose.
Christoper A. Alarcon Ruiz, MD	Dr. Alarcon Ruiz has received research support from Universidad Científica del Sur.
Fatima d. Jimenez Mozo, Sr., Dra Fatima Jimenez	Dr. Jimenez Mozo has nothing to disclose.
Frank Mayta, PhD	Dr. Mayta has nothing to disclose.
Paola Goicochea, MD	Miss Goicochea has nothing to disclose.
Andrés Pacherres	Mr. Pacherres has nothing to disclose.
Fernando M. Runzer-Colmenares, MD	Dr. Runzer-Colmenares has nothing to disclose.
David J. Hunt, MD	Dr. Hunt has nothing to disclose.
Nathan Chu, MD	Dr. Chu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Donna Kuipers, RN	Ms. Kuipers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Ms. Kuipers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Ms. Kuipers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Ms. Kuipers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sentrex. Ms. Kuipers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apotex.
Kyra West	Ms. West has nothing to disclose.
Christopher E. Uy, MD	Dr. Uy has received personal compensation in the range of $500-$4,999 for serving as a IVIG for CNS Disease Task Force Member with Provincial Blood Coordinating Office (British Columbia).
Ana-Luiza Sayao, MD	Dr. Sayao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Sayao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serono. Dr. Sayao has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Sayao has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Sayao has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Serono. Dr. Sayao has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Virginia A. Devonshire, MD	Dr. Devonshire has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck- Serono. Dr. Devonshire has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Devonshire has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen . Dr. Devonshire has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for novartis. Dr. Devonshire has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for roche. Dr. Devonshire has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for biogen .
Alice J. Schabas, MD	Dr. Schabas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Schabas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Schabas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Schabas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen.
Pariwat Thaisetthawatkul, MD, FAAN	Dr. Thaisetthawatkul has nothing to disclose.
Jie Chen, MD, PhD	Dr. Chen has nothing to disclose.
P. James B. Dyck, MD, FAAN	Dr. Dyck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea/Ionis.
Haley Riley, DO	Dr. Riley has nothing to disclose.
Sydney M. Shaffer, MD	Dr. Shaffer has nothing to disclose.
Elizabeth G. Baumann, MD	Dr. Baumann has nothing to disclose.
Brijesh P. Mehta, MD	Dr. Mehta has nothing to disclose.
Norman Ajiboye, MD, FAAN	Dr. Ajiboye has nothing to disclose.
Haris Kamal, MD	Dr. Kamal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Microvention .
Stefan Nicolau, MD	The institution of Dr. Nicolau has received research support from Muscular Dystrophy association. The institution of Dr. Nicolau has received research support from American Brain Foundation. The institution of Dr. Nicolau has received research support from American Neuromuscular Foundation.
Kevin M. Flanigan, MD, FAAN	Dr. Flanigan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solid. Dr. Flanigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Armatus. Dr. Flanigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. Dr. Flanigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne. The institution of Dr. Flanigan has received research support from Ultragenyx . The institution of Dr. Flanigan has received research support from Solid Biosciences. The institution of Dr. Flanigan has received research support from Dyne Therapeutics. The institution of Dr. Flanigan has received research support from Avidity.
Tatyana Vetter, PhD	An immediate family member of Dr. Vetter has received personal compensation for serving as an employee of Nikon Instruments. The institution of Dr. Vetter has received research support from Diverge Translational Science Laboratory.
Anthony Stephenson, PhD	Dr. Stephenson has received personal compensation for serving as an employee of Forge Biologics. Dr. Stephenson has stock in Forge Biologics.
Gabrielle Dufresne	Miss Dufresne has nothing to disclose.
Emma C. Frair	Ms. Frair has nothing to disclose.
Breanna Trecha	Ms. Trecha has nothing to disclose.
Jessica E. Sarff	Miss Sarff has nothing to disclose.
Danny J. Japon	Mr. Japon has nothing to disclose.
Alicia A. Velez	Miss Velez has nothing to disclose.
Tito D. Mendoza	Mr. Mendoza has nothing to disclose.
Carlos A. Rodríguez Alarcón, MD	Dr. Rodríguez Alarcón has nothing to disclose.
Christopher Beskow	Mr. Beskow has nothing to disclose.
Jacob McLean, DO	Mr. McLean has nothing to disclose.
Nicholas A. Goska, DO	Mr. Goska has nothing to disclose.
Jenna L. Corley, DO	Mrs. Corley has nothing to disclose.
Reetul Patel	Mr. Patel has nothing to disclose.
William Pearson, Jr., PhD	The institution of Dr. Pearson has received research support from Kern Family Foundation. The institution of Dr. Pearson has received research support from VCOM. Dr. Pearson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with NIH.
Arisma Arora, MBBS	Miss Arora has nothing to disclose.
Tet Yap, MD, MBBS	Dr. Yap has nothing to disclose.
Callum J. Owen	An immediate family member of Mr. Owen has received personal compensation for serving as an employee of GSK. Mr. Owen has stock in GSK. An immediate family member of Mr. Owen has stock in GSK.
Azzra Maricar, Medical Student	Miss Maricar has nothing to disclose.
Parker Houston, BS	Mr. Houston has nothing to disclose.
Gerardo H. Velasquez	Mr. Velasquez has nothing to disclose.
Ori Lieberman, MD, PhD	Dr. Lieberman has received research support from UCSF.
Sophie Furlow, MEng	Ms. Furlow has received personal compensation for serving as an employee of Abbott.
Bo Zhou	No disclosure on file
Amanjot Bains	Ms. Bains has nothing to disclose.
Kinshuk Basu	Mr. Basu has nothing to disclose.
Marta Fernandes	Marta Fernandes has nothing to disclose.
Scott L. Silliman, MD	Dr. Silliman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Ramon E. Bautista, MD	Dr. Bautista has nothing to disclose.
Jade K. Hannan	Ms. Hannan has nothing to disclose.
Vaughn E. Bryant, PhD	Dr. Bryant has nothing to disclose.
Lakshmi Leishangthem, MD, MBBS	Dr. Leishangthem has nothing to disclose.
Amanda L. Hernandez, MD, PhD	Dr. Hernandez-Jones has nothing to disclose.
Alberto Varon Miller, MD	Dr. Varon Miller has nothing to disclose.
Christopher Edwards	Christopher Edwards has nothing to disclose.
Ruta Uttarkar	Ms. Uttarkar has nothing to disclose.
Erica M. Jones, MD, MPH	The institution of Dr. Jones has received research support from NIH KL2.
Seong-eun Hwang	Miss Hwang has nothing to disclose.
JungWan a. Kim, SLP	Prof. Kim has nothing to disclose.
Monique Anderson, MD, PhD	Dr. Anderson has nothing to disclose.
Natalia Drosu	Ms. Drosu has nothing to disclose.
Takahisa Mikami, MD	Dr. Mikami has nothing to disclose.
Natasha Bobrowski-Khoury, PhD	Dr. Bobrowski-Khoury has nothing to disclose.
Shuhei Nishiyama, MD, PhD	Dr. Nishiyama has nothing to disclose.
Seniha N. Ozudogru, MD	Dr. Ozudogru has nothing to disclose.
Sara Zeccardi, NP	Ms. Zeccardi has nothing to disclose.
Holly Bischof, RN, NP	Ms. Bischof has nothing to disclose.
Ogo-Oluwa Onifade, MD	Dr. Onifade has nothing to disclose.
Maria Sol Román	Maria Sol Román has nothing to disclose.
Lara Bardoneschi	Lara Bardoneschi has nothing to disclose.
Maria Laura Saladino	Maria Laura Saladino has nothing to disclose.
Sandra Vanotti	Sandra Vanotti has nothing to disclose.
Fernando J. Caceres, MD	No disclosure on file
Maria E. Balbuena	Mrs. Balbuena has nothing to disclose.
Felisa Leguizamon	No disclosure on file
Javier Hryb	Javier Hryb has nothing to disclose.
Florencia Daniele	Florencia Daniele has nothing to disclose.
Matías Herrera Fernandez	Matías Herrera Fernandez has nothing to disclose.
Ning Zhong, MD	Dr. Zhong has nothing to disclose.
Lingxuan Li	Miss Li has nothing to disclose.
Ekdanai Uawithya, MD	Mr. Uawithya has nothing to disclose.
Natnasak Apiraksattayakul	Mr. Apiraksattayakul has nothing to disclose.
Punchika Kosiyakul	Mrs. Kosiyakul has nothing to disclose.
Jiraporn Jitprapaikulsan, MD	Dr. Jitprapaikulsan has nothing to disclose.
Christina Shupe	Ms. Shupe has nothing to disclose.
Charlotte Engebrecht	Ms. Engebrecht has nothing to disclose.
Jennifer Weinstein	Jennifer Weinstein has nothing to disclose.
Anika Varma	Anika Varma has nothing to disclose.
Spencer Rosero	Spencer Rosero has nothing to disclose.
Charlotte Irwin	Ms. Irwin has nothing to disclose.
Preshetha Kanagaiah	Miss Kanagaiah has nothing to disclose.
Judith Monickaraj, MS	Ms. Monickaraj has nothing to disclose.
Alicia Brocht	Alicia Brocht has nothing to disclose.
Peggy Auinger	Ms. Auinger has nothing to disclose.
Debra Guntrum, MS, FNP	Ms. Guntrum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avexis. Ms. Guntrum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Ms. Guntrum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC.
Chad R. Heatwole, MD, FAAN	Dr. Heatwole has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Virginia Commonwealth University. Dr. Heatwole has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Legal Med. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Swan Bio. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony. Dr. Heatwole has received personal compensation in the range of $0-$499 for serving as a Consultant for Iris. Dr. Heatwole has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Recursion. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity Biosciences. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lupin. Dr. Heatwole has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for New York Central Mutual. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Penn Prop and Gas. The institution of Dr. Heatwole has received research support from Department of Defense. The institution of Dr. Heatwole has received research support from Novartis. The institution of Dr. Heatwole has received research support from MJFF. The institution of Dr. Heatwole has received research support from FARA. The institution of Dr. Heatwole has received research support from NIH. The institution of Dr. Heatwole has received research support from University of Miami. The institution of Dr. Heatwole has received research support from MDA. Dr. Heatwole has received intellectual property interests from a discovery or technology relating to health care.
Erika Alor	Ms. Alor has nothing to disclose.
Gavin Hoffman, Medical Student	Mr. Hoffman has nothing to disclose.
Marie-France Vugampore, MS	Mrs. Vugampore has nothing to disclose.
Bill Frank, DC	Dr. Frank has nothing to disclose.
carlos baptista, MD, PhD, MS MPH	Dr. baptista has nothing to disclose.
Maureen E. Stabio, PhD	Dr. Stabio has received publishing royalties from a publication relating to health care.
Jakaiya S. Bryant	Miss Bryant has nothing to disclose.
Jane B. Allendorfer, PhD	The institution of Dr. Allendorfer has received research support from National Institutes of Health. The institution of Dr. Allendorfer has received research support from Evelyn F. McKnight Brain Institute. The institution of Dr. Allendorfer has received research support from LivaNova, Inc. Dr. Allendorfer has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Cleveland Clinic. Dr. Allendorfer has received personal compensation in the range of $0-$499 for serving as a Examiner with University of Auckland. Dr. Allendorfer has received personal compensation in the range of $500-$4,999 for serving as a Speaker with International League Against Epilepsy. Dr. Allendorfer has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Department of Defense. Dr. Allendorfer has a non-compensated relationship as a Scientific Program Committee Member with American Epilepsy Society that is relevant to AAN interests or activities. Dr. Allendorfer has a non-compensated relationship as a Editorial Board Member with Epilepsy and Behavior Reports that is relevant to AAN interests or activities.
Brandon Mitchell, BS	Mr. Mitchell has nothing to disclose.
Jerzy P. Szaflarski, MD, PhD, FAAN	Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova Inc. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gidley, Sarli & Marusak, LLP. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firm. Dr. Szaflarski has stock in AdCel Biopharma, LLC. Dr. Szaflarski has stock in iFovea.
Lawrence W. Ver Hoef, MD	Dr. Ver Hoef has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Bowling & Christiansen. The institution of Dr. Ver Hoef has received research support from NIH. The institution of Dr. Ver Hoef has received research support from AES.
Adam M. Goodman, PhD	Dr. Goodman has nothing to disclose.
Roy C. Martin, PhD	Prof. Martin has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elseiver Publishers. The institution of Prof. Martin has received research support from NIH.
Charity J. Morgan, PhD	Dr. Morgan has nothing to disclose.
Ricardo Ortiz-Braidot, MS	Mr. Ortiz-Braidot has nothing to disclose.
Yun Lien, MSc	Miss Lien has nothing to disclose.
Jennifer B. Pilkington	Mrs. Pilkington has nothing to disclose.
Anna Moyana, GR, CERT -CNIN	Mrs. Moyana has nothing to disclose.
Thomas Buford, PhD	Dr. Buford has nothing to disclose.
Amy Miller, ACSM-CEP	Mrs. Miller has nothing to disclose.
Kären J. Fulton, NP	Ms. Fulton has nothing to disclose.
Goutham Selladurai, MBBS	Dr. Selladurai has nothing to disclose.
Lulu Wen, MD	Dr. Wen has nothing to disclose.
Miao Qu, MD	Dr. Qu has nothing to disclose.
Tong Si, PhD	Dr. Si has nothing to disclose.
Chuming Yan	Dr. yan has nothing to disclose.
Emily Crawford, PhD	Dr. Crawford has received personal compensation for serving as an employee of Delve Bio.
Huei-Yu F. Wang, PhD	Dr. Wang has received personal compensation for serving as an employee of Delve BIo.
Anna Uehara, PhD	Dr. Uehara has received personal compensation for serving as an employee of Delve Bio. An immediate family member of Dr. Uehara has received personal compensation for serving as an employee of Clear Labs.
Brian O'Donovan	Brian O'Donovan has received personal compensation for serving as an employee of Delve Bio.
Nick Gimbrone, PhD	Dr. Gimbrone has received personal compensation for serving as an employee of Delve Bio.
Greg Gydush	Mr. Gydush has received intellectual property interests from a discovery or technology relating to health care.
Sirisha Thippabhotla, PhD	Ms. Thippabhotla has nothing to disclose.
Timothy Blicharz, PhD	Dr. Blicharz has received personal compensation for serving as an employee of Delve Bio, Inc. Dr. Blicharz has received personal compensation for serving as an employee of Sherlock Biosciences. Dr. Blicharz has received personal compensation for serving as an employee of LumiraDx. Dr. Blicharz has stock in Delve Bio, Inc. Dr. Blicharz has stock in YourBio Health. Dr. Blicharz has received intellectual property interests from a discovery or technology relating to health care.
Peter Trefry	Mr. Trefry has nothing to disclose.
Niall Lennon, PhD	Dr. Lennon has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Nephron Research. Dr. Lennon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Illumina. Dr. Lennon has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Neogenomics. Dr. Lennon has stock in FYR Diagnostics. Dr. Lennon has stock in Everygene. The institution of Dr. Lennon has received research support from Pacific Biosciences. The institution of Dr. Lennon has received research support from Illumina.
Timothy DeSmet	Mr. DeSmet has nothing to disclose.
Michael DaSilva	Mr. DaSilva has nothing to disclose.
Wendy Brodeur	Mrs. Brodeur has nothing to disclose.
Evan T. McDaid	Mr. McDaid has nothing to disclose.
Lindsey Paul	Ms. Paul has nothing to disclose.
Crystal Dugan, MS	Ms. Dugan has nothing to disclose.
Raya C. DePina	Miss DePina has nothing to disclose.
James M. Harold, Jr.	Mr. Harold has nothing to disclose.
Owen Conroy	Mr. Conroy has received personal compensation for serving as an employee of Broad Institute.
Aja List, Testing Personnel	Ms. List has received personal compensation for serving as an employee of Broad Institute Genomics Platform.
Omkar Gandbhir	Mr. Gandbhir has received personal compensation for serving as an employee of The Broad Institute.
Casandra T. Connell, PDA	Ms. Connell has nothing to disclose.
Christopher M. Condron	Mr. Condron has nothing to disclose.
Coren Milbury, PhD	Dr. Milbury has received personal compensation for serving as an employee of Delve Bio.
Steve Miller, MD, PhD	Dr. Miller has received personal compensation for serving as an employee of Delve Bio.
David Leppert, MD	Dr. Leppert has received personal compensation for serving as an employee of GeNeuro. Dr. Leppert has received personal compensation for serving as an employee of GeNeuro. Dr. Leppert has received personal compensation for serving as an employee of Geneuro. Dr. Leppert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Leppert has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Leppert has received personal compensation in the range of $0-$499 for serving as a Consultant for Orion. Dr. Leppert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Leppert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quanterix. Dr. Leppert has stock in Novartis.
Sabine Schaedelin	Sabine Schaedelin has nothing to disclose.
Jette Battistini, MD	Jette Battistini, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for novartis. Jette Battistini, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Jette Battistini, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiese. Jette Battistini, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Mitsuru Watanabe	Mitsuru Watanabe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharma, Mitsubishi Tanabe Pharma, UCB Japan. Mitsuru Watanabe has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion Pharma, Argenx, UCB Japan, Novartis Pharma, Biogen Japan, Mitsubishi Tanabe Pharma, Chugai Pharmaceutical, Viatris, and Daiichi Sankyo. The institution of Mitsuru Watanabe has received research support from Japan. Mitsuru Watanabe has received publishing royalties from a publication relating to health care.
Fredrik L. Piehl, MD, PhD	Dr. Piehl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parexel/Chugai. The institution of Dr. Piehl has received research support from UCB. The institution of Dr. Piehl has received research support from Merck KGaA. Dr. Piehl has received personal compensation in the range of $10,000-$49,999 for serving as a member scientific advisory board with Swedish Medical products Agency.
Katharina Fink, MD	The institution of Dr. Fink has received research support from Swedish Research Council. The institution of Dr. Fink has received research support from ALF. The institution of Dr. Fink has received research support from CMED. Dr. Fink has received personal compensation in the range of $0-$499 for serving as a Lecturer with Swedish MS Society.
Ellen Iacobaeus, MD	No disclosure on file
Bjorn Evertsson, MD	Dr. Evertsson has received research support from Regionstockholm.
Mohsen Khademi, Sr., PhD	Dr. Khademi has nothing to disclose.
Matteo Gastaldi, MD, PhD	Dr. Gastaldi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alexion, Roche, UCB, J&J. The institution of Dr. Gastaldi has received research support from Italian Ministry of Health, FISM, AE alliance.
Giacomo Greco	Giacomo Greco has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Giacomo Greco has received personal compensation in the range of $0-$499 for serving as a Consultant for Amgen. Giacomo Greco has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Giacomo Greco has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Sara Mariotto, MD, PhD	Dr. Mariotto has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen, Sanofi, Alexion, Roche, TSF, Dynamics, UCB, Novartis, Amgen, AAN. The institution of Dr. Mariotto has received research support from Ministero della Salute Italiano. The institution of Dr. Mariotto has received research support from TSF. The institution of Dr. Mariotto has received research support from GJF. The institution of Dr. Mariotto has received research support from Lundbeck. The institution of Dr. Mariotto has received research support from Euroimmun. The institution of Dr. Mariotto has received research support from FISM.
Alessia Di Sapio	Alessia Di Sapio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Alessia Di Sapio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion . Alessia Di Sapio has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Alessia Di Sapio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Alessia Di Sapio has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi . The institution of Alessia Di Sapio has received research support from Ministero della Salute. The institution of Alessia Di Sapio has received research support from Sanofi.
Pascal Benkert	Pascal Benkert has nothing to disclose.
Aleksandra Maceski	Aleksandra Maceski has nothing to disclose.
Johanna Oechtering	The institution of Johanna Oechtering has received research support from Roche. The institution of Johanna Oechtering has received research support from Novartis. The institution of Johanna Oechtering has received research support from Swiss MS society.
Anne-Katrin Proebstel, MD	The institution of Dr. Proebstel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Proebstel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Proebstel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Proebstel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Proebstel has received research support from Biogen. Dr. Proebstel has received intellectual property interests from a discovery or technology relating to health care.
Roxanne Pretzsch, MD	Dr. Pretzsch has received research support from Swiss academy of arts and sciences. Dr. Pretzsch has received research support from Hertie foundation.
Daniel Anthony, PhD, MA	Dr. Anthony has received personal compensation for serving as an employee of University of Oxford. Dr. Anthony has received personal compensation for serving as an employee of Somerville College Oxford. Dr. Anthony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Anthony has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuroplast. Dr. Anthony has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Oxomics. The institution of Dr. Anthony has received research support from Numares. The institution of Dr. Anthony has received research support from MRC UK.
Jens Kuhle, MD	Dr. Kuhle has nothing to disclose.
Roberto Furlan	Roberto Furlan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Roberto Furlan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Roberto Furlan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Roberto Furlan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Roberto Furlan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Roberto Furlan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS.
Charlene J. Ong, MD	Dr. Ong has nothing to disclose.
Abrar Al-Faraj, MD	Dr. Al-Faraj has nothing to disclose.
Cameron Hill	Mr. Hill has nothing to disclose.
Ika Noviawaty, MD	Dr. Noviawaty has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz Pharmaceutical/CME Outfitter. The institution of Dr. Noviawaty has received research support from MARINUS. The institution of Dr. Noviawaty has received research support from UCB.
Leigh A. Mallinger, RA	Ms. Mallinger has nothing to disclose.
Wali Qayoumi, MD	Dr. Qayoumi has received personal compensation in the range of $0-$499 for serving as a Consultant for Atheneum. Dr. Qayoumi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint.
Daniel Micheli, MD	Dr. Micheli has nothing to disclose.
Vanessa S. Goodwill, MD	Dr. Goodwill has nothing to disclose.
Eyal Y. Kimchi, MD, PhD	The institution of Dr. Kimchi has received research support from NIH. The institution of an immediate family member of Dr. Kimchi has received research support from NIH.
Jennifer A. Fokas, MD	Dr. Fokas has nothing to disclose.
Dan Tong Jia, MD	Dr. Jia has nothing to disclose.
Karan S. Dixit, MD	Dr. Dixit has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Servier.
KuangHua Guo, MD, PhD	Dr. Guo has nothing to disclose.
Ahmed H. nada, MD	Dr. nada has nothing to disclose.
Nada K. Asar, MD	Dr. Asar has nothing to disclose.
Rand Ibrahim, MBBS	Dr. Ibrahim has nothing to disclose.
سَارّه A. Nada	Dr. Nada has nothing to disclose.
Rawan Ahmed, MD	Dr. ahmed has nothing to disclose.
Mostafa M. Meshref, MD	Dr. Meshref has nothing to disclose.
Hayato Kimura, PhD	Mr. Kimura has received personal compensation for serving as an employee of Fluxus, Inc..
Mariya Soban, Senior Research Associate	Mrs. Soban has received personal compensation for serving as an employee of Fluxus, inc..
Kumiko Hamano	Ms. Hamano has received personal compensation for serving as an employee of FUJIREBIO Inc..
Yukina Kawada	Ms. Kawada has received personal compensation for serving as an employee of FUJIREBIO Inc..
Ko Kobayashi	Mr. Kobayashi has received personal compensation for serving as an employee of Fluxus, Inc..
Kazuya Gomi	Mr. Gomi has received personal compensation for serving as an employee of FUJIREBIO INC..
Masayasu Imaizumi	Mr. Imaizumi has received personal compensation for serving as an employee of FUJIREBIO Inc..
KAZUSHIGE MORIYAMA, Resercher	Mr. MORIYAMA has nothing to disclose.
Gipshu Dave, Masters	Mr. Dave has received personal compensation for serving as an employee of Fluxus Inc..
Frank G. Zaugg, PhD	Mr. Zaugg has nothing to disclose.
Peter Wagner, PhD	Dr. Wagner has received personal compensation for serving as an employee of Fluxus Inc..
Johanna Sandlund, MD, PhD	Dr. Sandlund has received personal compensation for serving as an employee of Fluxus, Inc. Dr. Sandlund has stock in Fluxus, Inc.
Renee Tobias, MS	Ms. Tobias has received personal compensation for serving as an employee of Fluxus, Inc..
Valerie Brachet, PhD	Dr. Brachet has received personal compensation for serving as an employee of Fluxus inc..
Ryuhei Shiroma	Mr. Shiroma has received personal compensation for serving as an employee of Fujirebio.
José María Benítez Salazar	Mr. Benítez Salazar has nothing to disclose.
Juan Carlos Perez Garcia	No disclosure on file
Alicia Garmendia, MD, PhD	Dr. Garmendia has nothing to disclose.
Abel Lugo-Pelaez, Sr., MD	Dr. Lugo-Pelaez has nothing to disclose.
Ima M. Ebong, MD, FAAN	The institution of Dr. Ebong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. The institution of Dr. Ebong has received research support from Ad Scientiam.
Vishakhadatta Mathur Kumaraswamy, MD	The institution of Dr. Mathur Kumaraswamy has received research support from Woolsey Pharmaceuticals.
Irene C. Yator, MD	Ms. Yator has nothing to disclose.
Trevor T. Logan, MD	Dr. Logan has nothing to disclose.
Lovisa Ljungberg, MD	Dr. Ljungberg has nothing to disclose.
Stacie L. Demel, DO	Dr. Demel has nothing to disclose.
Padmini Sekar, MS	Ms. Sekar has received research support from University of Cincinnati.
Lee A. Gilkerson, RN	Ms. Gilkerson has nothing to disclose.
Daniel Woo, MD, FAAN	The institution of Dr. Woo has received research support from NIH.
Tasnim A. Elgazzar, MD	Ms. Elgazzar has nothing to disclose.
Abdullah AlDehaimi, IPC	No disclosure on file
Tala Abedalqader, MBBS	Dr. Abedalqader has nothing to disclose.
Abderrahman Ouban	No disclosure on file
Malik Kayal	No disclosure on file
Hawazen Almshhad	No disclosure on file
Atef Shibl, PhD	Prof. Shibl has nothing to disclose.
Wael Al- Kattan	No disclosure on file
Evanthia Bernitsas, MD, FAAN	Dr. Bernitsas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bernitsas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vanda. The institution of Dr. Bernitsas has received research support from Roche/Genentech.
Mayvis Rebeira, PhD	Ms. Rebeira has stock in Alexion, Astrazeneca Rare Disease.
Nicole Betor	Nicole Betor has received personal compensation for serving as an employee of Avalere Health.
Caitlin Dodd	Miss Dodd has received personal compensation for serving as an employee of Avalere Health.
Jesus Loreto, Caregiver	Mr. Loreto has nothing to disclose.
Ashleeashlee J. Olsenolsen	Miss Olsenolsen has nothing to disclose.
Alexis Garduno, PhD	Dr. Garduno has received personal compensation for serving as an employee of Avalere.
Justin Lee	Justin Lee has received personal compensation for serving as an employee of Alexion.
Lindsey Przybyl	Lindsey Przybyl has received personal compensation for serving as an employee of Alexion, AstraZeneca Rare Disease. Lindsey Przybyl has stock in AstraZeneca.
Jamie Sullivan, MPH	Ms. Sullivan has received personal compensation for serving as an employee of EveryLife Foundation for Rare Diseases. An immediate family member of Ms. Sullivan has received personal compensation for serving as an employee of Takeda. Ms. Sullivan has received personal compensation in the range of $5,000-$9,999 for serving as a Policy Advisor with COPD Foundation.
Jeffrey Yu, PhD	Dr. Yu has received personal compensation for serving as an employee of Alexion. Dr. Yu has stock in AstraZeneca.
Guangming Zhu, MD, PhD	Dr. Zhu has nothing to disclose.
Tanya Lin, MD	Dr. Lin has nothing to disclose.
Claire Simon, DO	Dr. Simon has nothing to disclose.
Vickram Kahlon, DO	Dr. Kahlon has nothing to disclose.
Alexander Dugum, DO	Dr. Dugum has nothing to disclose.
Lisa Hill, PhD	Dr. Hill has nothing to disclose.
Alexandra J. Sinclair, MD	Dr. Sinclair has received personal compensation for serving as an employee of Invex Therapeutics. Dr. Sinclair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex. Dr. Sinclair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orion Pharma. Dr. Sinclair has stock in Invex Therapeutics (unclear what the company is developing but no longer working in the field of Idiopathic Intracranial Hypertension). The institution of Dr. Sinclair has received research support from DOD. The institution of Dr. Sinclair has received research support from MOD.
James Mitchell, MBBS, PhD	Dr. Mitchell has received personal compensation for serving as an employee of Ministry of Defence.
Andreas Yiangou, MBBS	Dr. Yiangou has nothing to disclose.
Ghazala Begum, PhD	Mrs. Begum has nothing to disclose.
Jessica C. Hubbard, MSci	Miss Hubbard has nothing to disclose.
Caroline W. Mugo	Miss Mugo has nothing to disclose.
Hannah Botfield, PhD	Dr. Botfield has nothing to disclose.
Hannah Lyons, MBChB	Dr. Lyons has nothing to disclose.
Mark Thaller, PhD	Dr. THALLER has nothing to disclose.
Olivia Grech, PhD	Dr. Grech has received research support from Sir Jules Thorn.
Susan P. Mollan, MBBS	Prof. Mollan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Teva. Prof. Mollan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Thea pharmaceuticals. Prof. Mollan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Abbvie. The institution of Prof. Mollan has received research support from National Institute of Health Research (UK) . The institution of Prof. Mollan has received research support from Heidelberg Engineering. Prof. Mollan has received publishing royalties from a publication relating to health care. Prof. Mollan has a non-compensated relationship as a Board Member (non-voting) with North American Neuro-ophthalmology Society that is relevant to AAN interests or activities.
Christian Werner	Christian Werner has received personal compensation for serving as an employee of PTC Therapeutics. Christian Werner has stock in PTC Therapeutics.
Eugenio Mercuri	No disclosure on file
Filippo Buccella, PhD	Dr. Buccella has a non-compensated relationship as a Volunteer with Parent Project that is relevant to AAN interests or activities.
Andres Nascimento Osorio	Andres Nascimento Osorio has nothing to disclose.
Mar Tulinius, MD, PhD	No disclosure on file
Isabelle Desguerre	No disclosure on file
Maria Bernadete Resende	Maria Bernadete Resende has nothing to disclose.
Craig McDonald, MD	Dr. McDonald has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sarepta Therapeutics. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PTC Therapeutics. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Solid Biosciences. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Solid Biosciences. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Edgewise Therapeutics. The institution of Dr. McDonald has received research support from Sarepta Therapeutics. The institution of Dr. McDonald has received research support from PTC Therapeutics. The institution of Dr. McDonald has received research support from Edgewise Therapeutics. The institution of Dr. McDonald has received research support from Capricor Therapeutics. The institution of Dr. McDonald has received research support from Italfarmaco. Dr. McDonald has received research support from NS Pharma. The institution of Dr. McDonald has received research support from NIH (NINDS). The institution of Dr. McDonald has received research support from Parent Project Muscular Dystrophy. The institution of Dr. McDonald has received research support from Muscular Dystrophy Association. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Member National Advisory Board for Medical Rehabilitation Research with NIH.
Heather Gordish-Dressman	Heather Gordish-Dressman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AGADA Biosciences. Heather Gordish-Dressman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solid Biosciences. Heather Gordish-Dressman has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for TRiNDS, LLC. Heather Gordish-Dressman has received personal compensation in the range of $500-$4,999 for serving as a Statistical reviewer with TREAT-NMD TACT Committee.
Lauren Morgenroth	Ms. Morgenroth has received personal compensation for serving as an employee of TRiNDS. Ms. Morgenroth has stock in TRiNDS.
Shelley Johnson, MBA	Ms. Johnson has received personal compensation for serving as an employee of PTC Therapeutics. Ms. Johnson has stock in PTC Therapeutics.
Alexis Krolick, DNP	No disclosure on file
Balaji Anbu, SAS programmer	Mr. Anbu has nothing to disclose.
Emelline Liu, MD	Dr. Liu has received personal compensation for serving as an employee of PTC Therapeutics. Dr. Liu has stock in PTC Therapeutics.
Francesco Muntoni, MD	Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sarepta. Dr. Muntoni has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Muntoni has received research support from European Commission. The institution of Dr. Muntoni has received research support from Medical Research Council. The institution of Dr. Muntoni has received research support from Biogen. The institution of Dr. Muntoni has received research support from Muscular Dystrophy UK. The institution of Dr. Muntoni has received research support from MDA USA. The institution of Dr. Muntoni has received research support from Sarepta. The institution of Dr. Muntoni has received research support from Association Francoise Myopathies. Dr. Muntoni has received personal compensation in the range of $0-$499 for serving as a Clinical expert with UK NICE Committee.
Muhammad Osama, MBBS	Dr. Osama has nothing to disclose.
Sufyan Shahid, MBBS	Mr. Shahid has nothing to disclose.
Muhammad Abdullah Ali, MBBS	Dr. Ali has nothing to disclose.
Soban A. Qasim, MBBS	Dr. Qasim has nothing to disclose.
Megha Joshi, MBBS	Dr. Joshi has received personal compensation for serving as an employee of Essen Healthcare. Dr. Joshi has received personal compensation for serving as an employee of CityMD. Dr. Joshi has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for SGS Consulting.
Muhammad Shaheer Bin Faheem, MBBS	Dr. Faheem has nothing to disclose.
Salvador Martinez-Medina, MD	Dr. Martinez-Medina has nothing to disclose.
Fernando Vasquez Lopez, MD	Dr. Vasquez Lopez has nothing to disclose.
Irving Fuentes	Mr. Fuentes has nothing to disclose.
Betsy C. Vazquez, MD	Dr. Vazquez has nothing to disclose.
Jimena Gonzalez Salido, MD	Miss Gonzalez Salido has nothing to disclose.
Jimena Colado, MD	Dr. Colado has nothing to disclose.
Pilar Robles-Lomelin, MD	Dr. Robles-Lomelin has nothing to disclose.
Lilia Jimena J. Gómez Rodríguez, MD	Dr. Gómez Rodríguez has nothing to disclose.
Juan C. Resendiz, MD	No disclosure on file
Mario Sebastian-Diaz, MD, PhD	Dr. Sebastian-Diaz has nothing to disclose.
Iris E. Martinez-Juarez, MD	No disclosure on file
Felipe A. Gouhie	Mr. Gouhie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Marjan Farma.
Ana Clara N. Cezar	Miss Cezar has nothing to disclose.
Davi A. Silva	Mr. Silva has nothing to disclose.
Beatriz R. Parreira	Miss Parreira has nothing to disclose.
Caio L. Nazar Cunha	Mr. Nazar Cunha has nothing to disclose.
Lucas Figueira Vieira	Mr. Figueira Vieira has nothing to disclose.
Cameron Hayes	Mr. Hayes has nothing to disclose.
Marinos G. Sotiropoulos, MD	Dr. Sotiropoulos has or had stock in Moderna.Dr. Sotiropoulos has or had stock in Ikena Oncology.Dr. Sotiropoulos has or had stock in Cassava Sciences.Dr. Sotiropoulos has or had stock in Biogen.Dr. Sotiropoulos has or had stock in Tiziana Life Sciences.Dr. Sotiropoulos has received publishing royalties from a publication relating to health care.
Galina Gheihman, MD	Dr. Gheihman has nothing to disclose.
Tamara B. Kaplan, MD, FAAN	Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono . Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
GyeongMo Sohn, MD	Dr. Sohn has nothing to disclose.
SI EUN KIM, MD	Dr. KIM has nothing to disclose.
C Virginia OHayer, PhD	The institution of Prof. OHayer has received research support from Alexion Pharmaceuticals Inc. The institution of Prof. OHayer has received research support from Boomer Esiason Foundation.
Darcy Esiason, LCSW	Mrs. Esiason has received personal compensation for serving as an employee of Boomer Esiason Foundation.
Emily Wakschal, PsyD	Dr. Wakschal has nothing to disclose.
Patrick J. Smith, PhD	Dr. Smith has nothing to disclose.
Charles Peppers	Mr. Peppers has nothing to disclose.
Leigh A. Andrews, PhD	Dr. Andrews has nothing to disclose.
Hallie Kushner, PhD	Dr. Kushner has nothing to disclose.
Wendy Erler, MBA	Mrs. Erler has received personal compensation for serving as an employee of Alexion Astra Zeneca. Mrs. Erler has stock in Alexion Astra Zeneca.
Stephen T. Hattrich	Mr. Hattrich has nothing to disclose.
Ankita Deshpande, MPH	Miss Deshpande has received personal compensation for serving as an employee of Alexion. Miss Deshpande has received personal compensation for serving as an employee of Moderna. Miss Deshpande has stock in Alexion and Moderna .
Thomas Leist, MD, PhD, FAAN	Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Leist has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Seono. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Expert Wittness with DHHS HRSA.
Chelsi N. Nurse, MS	Ms. Nurse has nothing to disclose.
Alain Z. Lekoubou Looti, MD	Dr. Lekoubou Looti has nothing to disclose.
Siyuan Chen, MSc	Miss Chen has nothing to disclose.
Madhav Sankaranarayanan	Mr. Sankaranarayanan has nothing to disclose.
Maria Donahue	Maria Donahue has nothing to disclose.
Joseph Newhouse	Joseph Newhouse has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for National Committee for Quality Assurance. Joseph Newhouse has received publishing royalties from a publication relating to health care.
Shuo M. Sun, PhD	Dr. Sun has nothing to disclose.
Julianne Brooks	Julianne Brooks has nothing to disclose.
Lee H. Schwamm, MD, FAAN	Dr. Schwamm has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Prime ��ɫ��. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Schwamm has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for lifeimage. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving as a Consultant for mediasphere. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving as a Consultant for medscape/WebMD. Dr. Schwamm has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for medtronic. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Penumbra. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. The institution of Dr. Schwamm has received research support from NINDS. The institution of Dr. Schwamm has received research support from PCORI. Dr. Schwamm has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Schwamm has received publishing royalties from a publication relating to health care. Dr. Schwamm has a non-compensated relationship as a Board of directors with American heart association that is relevant to AAN interests or activities.
Deborah Blacker	Deborah Blacker has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Belvoir inc. The institution of Deborah Blacker has received research support from NIH.
Sebastien Haneuse	Sebastien Haneuse has received personal compensation for serving as an employee of Harvard University. Sebastien Haneuse has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Medical Association.
Lidia Maria V. Moura, MD, PhD, MPH, FAAN	Dr. Moura has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Moura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. The institution of Dr. Moura has received research support from Centers for Diseases Control and Prevention (CDC SIP20-007) . The institution of Dr. Moura has received research support from Epilepsy Foundation of America . The institution of Dr. Moura has received research support from NIH - NIA and NINDS. Dr. Moura has received personal compensation in the range of $50,000-$99,999 for serving as a Expert Advisor with Epilepsy Foundation .
John Hsu	No disclosure on file
Yahaira Rivera	Mrs. Rivera has nothing to disclose.
Alexis Kline	No disclosure on file
Darion Banister, MPA	Mr. Banister has nothing to disclose.
Diana Marzouk, DO	Dr. Marzouk has nothing to disclose.
Christine B. Baca, MD, FAAN	Dr. Baca has nothing to disclose.
Kelly Jernigan, NP	Ms. Jernigan has nothing to disclose.
Jessica Johns, MD	Dr. Johns has nothing to disclose.
Shraddha Mainali, MD	Dr. Mainali has received personal compensation for serving as an employee of Virginia commonwealth University.
Karissa Arthur, MD	Dr. Arthur has nothing to disclose.
Rashid S. Hussain, MD	Dr. Hussain has nothing to disclose.
Jason Gandhi, MD	Dr. Gandhi has nothing to disclose.
Gurleen Kaur, MD	Dr. Kaur has nothing to disclose.
Thomas F. Scott, MD	Dr. Scott has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme-Sanofi. Dr. Scott has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Serono. Dr. Scott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Scott has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Scott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genzyme.
James P. Valeriano, MD	Dr. Valeriano has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for ucb. Dr. Valeriano has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for neurilis.
Nicole Rigler, MD	Dr. Rigler has nothing to disclose.
Rachel Heschke, MD	Dr. Heschke has nothing to disclose.
Audrey Blazek Ramsay, MD	Dr. Blazek Ramsay has nothing to disclose.
Abigail N. Schwaede, MD	Dr. Schwaede has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Schwaede has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen .
Nancy L. Kuntz, MD, FAAN	Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenyx. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Audentes Therapeutics. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Kuntz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. The institution of Dr. Kuntz has received research support from Argenx. The institution of Dr. Kuntz has received research support from Astellas. The institution of Dr. Kuntz has received research support from Biogen. The institution of Dr. Kuntz has received research support from Catalyst. The institution of Dr. Kuntz has received research support from Genentech. The institution of Dr. Kuntz has received research support from Scholar Rock. The institution of Dr. Kuntz has received research support from Regenx-Bio. The institution of Dr. Kuntz has received research support from Solid Biosciences. The institution of Dr. Kuntz has received research support from AMO. The institution of Dr. Kuntz has received research support from Novartis. The institution of Dr. Kuntz has received research support from BioHaven. Dr. Kuntz has received personal compensation in the range of $50,000-$99,999 for serving as a Sarepta Express post gene therapy advisor with Sarepta.
Anna Bogatyreva, MD, PhD	Dr. Anna has received personal compensation for serving as an employee of argenx BV.
Flavia H. Menezes, MD	Dr. Menezes has received personal compensation for serving as an employee of argenx.
Juliette Giacobbe, PhD	Dr. Giacobbe has received personal compensation for serving as an employee of argenx. Dr. Giacobbe has stock in argenx.
Tonke van Bragt, MSc	The institution of Mrs. van Bragt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for argenx. Mrs. van Bragt has stock in argenx.
Anna Kostera-Pruszczyk	Prof. Kostera-Pruszczyk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Prof. Kostera-Pruszczyk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Kostera-Pruszczyk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Kostera-Pruszczyk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Prof. Kostera-Pruszczyk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Prof. Kostera-Pruszczyk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Prof. Kostera-Pruszczyk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneka. Prof. Kostera-Pruszczyk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx.
Sithara Ramdas, MD, MBBS	Dr. Ramdas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Ramdas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for pfizer. Dr. Ramdas has received personal compensation in the range of $0-$499 for serving as a Consultant for Italfarmaco. Dr. Ramdas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Ramdas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Ramdas has received research support from Myaware . The institution of Dr. Ramdas has received research support from Norman Collison Foundation. .
Bhairavi Vajaria, PhD	Dr. Vajaria has received personal compensation for serving as an employee of Quest Diagnostics .
Hai-rong Li, Scientist	Mrs. Li has received personal compensation for serving as an employee of Quest Diagnostics. Mrs. Li has stock in Quest Diagnostics.
Catherine Kemp	Miss Kemp has received personal compensation for serving as an employee of Quest Diagnostics Inc..
Olga S. Zhukov, MS	Ms. Zhukov has received personal compensation for serving as an employee of Quest Diagnostics Inc.. Ms. Zhukov has stock in Quest Diagnostics Inc..
Christian Tagwerker, PhD	Dr. Tagwerker has received personal compensation for serving as an employee of Quest Diagnostics Inc. . Dr. Tagwerker has stock in Quest Diagnostics Inc..
Robert Fekete, MD	Dr. Fekete has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine Biosciences, Inc.. Dr. Fekete has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acorda, Inc.. Dr. Fekete has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Fekete has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva Neuroscience, Inc.. Dr. Fekete has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acadia Pharmaceutical, Inc.. Dr. Fekete has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin, Inc.. Dr. Fekete has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Adamas Pharmaceutical, Inc.. Dr. Fekete has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine Biosciences, Inc.. Dr. Fekete has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal Pharmaceuticals, Inc.. Dr. Fekete has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda Therapeutics, Inc.. Dr. Fekete has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion, Inc.. Dr. Fekete has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink, Inc.. The institution of Dr. Fekete has received research support from Lundbeck. Dr. Fekete has received publishing royalties from a publication relating to health care. Dr. Fekete has a non-compensated relationship as a Neurological Working Group Member with Alliance for Patient Access that is relevant to AAN interests or activities.
Zain U. Abideen, MBBS	Dr. Abideen has nothing to disclose.
Hassan Waseem	Hassan Waseem has nothing to disclose.
Brandon Lucke-Wold	Mr. Lucke-Wold has nothing to disclose.
Sania Aimen, MBBS	Dr. Aimen has nothing to disclose.
Muhammad Fawad Tahir, MBBS	Dr. Fawad Tahir has nothing to disclose.
Muhammad H. Khan	Mr. Khan has nothing to disclose.
Marium Khan	Marium Khan has nothing to disclose.
Sami Ullah Khan, MBBS	Dr. Khan has nothing to disclose.
Muhammad Ahmed Ayaz, MBBS	Dr. Ayaz has nothing to disclose.
Zoe Landau, MD	Dr. Landau has nothing to disclose.
Vicki Shanker, MD, FAAN	Dr. Shanker has received personal compensation in the range of $0-$499 for serving as a Consultant for The Insighters.
Beth Emerson, MD	Dr. Emerson has received personal compensation for serving as an employee of Biohaven. Dr. Emerson has received personal compensation for serving as an employee of Pfizer. Dr. Emerson has stock in Biohaven. Dr. Emerson has stock in Pfizer.
Anne Pieters	The institution of Mrs. Pieters has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Qubes SRL.
Beth A. Morris, BA	Ms. Morris has received personal compensation for serving as an employee of Biohaven. Ms. Morris has stock in Biohaven.
Andrew Lucas, PharmD, MS, MS	Dr. Lucas has nothing to disclose.
Volkan Granit, MD	Dr. Granit has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Granit has stock in Biohaven. Dr. Granit has received personal compensation in the range of $10,000-$49,999 for serving as a Faculty Member with University of Miami.
Christopher Jensen, PharmD	Dr. Jensen has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Jensen has stock in Biohaven Pharmaceuticals.
Joris Vriens	Joris Vriens has received intellectual property interests from a discovery or technology relating to health care.
Thomas Voets	Thomas Voets has received intellectual property interests from a discovery or technology relating to health care.
Irfan Qureshi, MD	Dr. Qureshi has received personal compensation for serving as an employee of Biohaven. Dr. Qureshi has stock in Biohaven Pharmaceuticals.
Vladimir Coric	Vladimir Coric has received personal compensation for serving as an employee of Biohaven. Vladimir Coric has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Bioahven. Vladimir Coric has stock in Biohaven. Vladimir Coric has received intellectual property interests from a discovery or technology relating to health care.
Richard B. Lipton, MD, FAAN	Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Mohammad Jahangiri, MD	Dr. Jahangiri has nothing to disclose.
John N. Soltys, MD	Dr. Soltys has nothing to disclose.
Ali M. Al-Salahat, MBBS	Dr. Al-Salahat has nothing to disclose.
Alexander Hall, MS	Mr. Hall has nothing to disclose.
Yu-Ting Chen, MD	Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam.
Ram N. Narayan, MD, FAAN	Dr. Narayan has nothing to disclose.
Aishwarya Koppanatham, MBBS	Ms. Koppanatham has nothing to disclose.
Aisha Rizwan Ahmed, MBBS	Dr. Rizwan Ahmed has nothing to disclose.
Mrinal M. Murali Krishna, MBBS	Dr. Murali Krishna has nothing to disclose.
Meghna Joseph, MBBS	Dr. Joseph has nothing to disclose.
Issa Salha, MD, MBBS	Dr. Salha has nothing to disclose.
Rabbia Jabbar, MBBS	Dr. Jabbar has nothing to disclose.
Rafael R. Oliveira	Mr. Oliveira has nothing to disclose.
Sana Ahmed, MD	Dr. Ahmed has nothing to disclose.
Wajid M. Mir, MBBS	Dr. Mir has nothing to disclose.
Jovana Ristic, Medical student	Ms. Ristic has nothing to disclose.
Gokul Rajith, MBBS	Mr. Rajith has nothing to disclose.
Maryam Rizwan, Lab scientist	Mrs. Rizwan has nothing to disclose.
Natalia Arturo, MD	Ms. Arturo has nothing to disclose.
Paweł Chochoł, MD	Mr. Chochol has nothing to disclose.
Thomas C. Varkey, MD	Dr. Varkey has nothing to disclose.
Tuqa Asedi, MD	Dr. Asedi has nothing to disclose.
Sai Kumar Reddy Pasya, MD, MBBS	Dr. Pasya has nothing to disclose.
Hussein Alsadi	Hussein Alsadi has nothing to disclose.
Mohammed Qussay Ali Al-Sabbagh, MD	Dr. Al-Sabbagh has nothing to disclose.
Prasanna Venkatesan Eswaradass, MD	Dr. Eswaradass has nothing to disclose.
Maryam Q. Al sabbagh	Dr. Al sabbagh has nothing to disclose.
Jonathan Santoro, MD	Dr. Santoro has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Santoro has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cycle Pharma. Dr. Santoro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Santoro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Down Syndrome Society.
Neetha Paul Eduthan, MS	Ms. Paul Eduthan has nothing to disclose.
Mellad Khoshnood, MD	Dr. Khoshnood has nothing to disclose.
Saba Jafarpour, MD	Dr. Jafarpour has nothing to disclose.
Natalie Boyd	Natalie Boyd has nothing to disclose.
Benjamin Vogel	Benjamin Vogel has nothing to disclose.
Lina Nguyen	Lina Nguyen has nothing to disclose.
Lilia Kazerooni, BS	Miss Kazerooni has nothing to disclose.
Eleanor Britton	Miss Britton has nothing to disclose.
Hannah Lyford	Miss Lyford has nothing to disclose.
Matthew Galbraith, PhD	The institution of Dr. Galbraith has received research support from NIH.
Angela Rachubinski, PhD	The institution of Dr. Rachubinski has received research support from NIH.
Joaquin Espinosa	Joaquin Espinosa has received personal compensation in the range of $0-$499 for serving as a Consultant for Biohaven.
Margil Ranpariya, MBBS	Dr. Ranpariya has nothing to disclose.
Osman Farooq, MD	Dr. Farooq has nothing to disclose.
Mohamed A. Aldemerdash, MBBS	Dr. A. Aldemerdash has nothing to disclose.
Ahmed A. Aledmerdash, Jr., MD	Dr. Aledmerdash has nothing to disclose.
Ahmed S. Osman	Mr. Osman has nothing to disclose.
Esraa M. Jasim, MD	Dr. Jasim has nothing to disclose.
Abdallah Khatatbeh, MD	Dr. Khatatbeh has nothing to disclose.
Salma Allam, MD	Dr. Allam has nothing to disclose.
Abdallah Abbas, MD	Dr. Abbas has nothing to disclose.
Amro Elrefaei, MD	Dr. Elrefaei has nothing to disclose.
Xi Wang	Ms. Wang has nothing to disclose.
Rui Li, MD	Dr. Li has received research support from the National Natural Science Foundation of China(NO.81901229).
Shengfei Hu	Dr. Hu has nothing to disclose.
Quoc Bao Nguyen, MD	Mr. Nguyen has nothing to disclose.
Mhd Majd Mardini, MD	Dr. Mardini has nothing to disclose.
Jorge G. Ortiz-Garcia, MD, FAAN	Dr. Ortiz-Garcia has nothing to disclose.
Leila Gachechiladze, MD	Dr. Gachechiladze has nothing to disclose.
Ahmad Al-Awwad, MD	Dr. Al-Awwad has nothing to disclose.
Janet Nguyen	Ms. Nguyen has nothing to disclose.
Mio Jiang	Ms. Jiang has nothing to disclose.
Victoria Stewart, MS2	Mrs. Stewart has nothing to disclose.
Jessica Martin	Miss Martin has nothing to disclose.
Claudia Mayela Torres Romero, MD	Dr. Torres Romero has nothing to disclose.
Paulina Romaña Espiritu, MD	Dr. Romaña Espiritu has nothing to disclose.
Nived Jayaraj Ranjini, MBBS	Dr. Jayaraj Ranjini has nothing to disclose.
Victor H. Gomez Arias, MD	Dr. Gomez Arias has nothing to disclose.
Juan H. Macias, PhD	Dr. Macias has nothing to disclose.
Lilia Nuñez Orozco, MD, FAAN	Dr. Nunez-Orozco has nothing to disclose.
Andrea R. Rodriguez Herrera, MD	Dr. Rodriguez Herrera has nothing to disclose.
Megan A. Waldrop, MD	Dr. Waldrop has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sarepta Therapeutics. Dr. Waldrop has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Gene Therapies.
Madhuri Hegde, PhD	Dr. Hegde has nothing to disclose.
Joseph F. Hagan, MD	Dr. hagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sarepta.
Paul H. Lipkin, MD	Dr. Lipkin has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Inc.. Dr. Lipkin has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Lipkin has received research support from PCORI.
Ann S. Martin, MS, CGC	Ms. Martin has received personal compensation for serving as an employee of Parent Project Muscular Dystrophy. Ms. Martin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics.
Eric C. Strong, MD	Dr. Strong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta.
Jodie Burton, MD, FAAN	Dr. Burton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Burton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Burton has received personal compensation in the range of $0-$499 for serving as a Consultant for Horizon. The institution of Dr. Burton has received research support from Roy and Joan Allen Professorship for Sight. Dr. Burton has a non-compensated relationship as a Advisor with CADTH that is relevant to AAN interests or activities. Dr. Burton has a non-compensated relationship as a Advisor with Alexion that is relevant to AAN interests or activities. Dr. Burton has a non-compensated relationship as a Advisor with Horizon that is relevant to AAN interests or activities. Dr. Burton has a non-compensated relationship as a ��ɫ��al Chair with EMD Serono that is relevant to AAN interests or activities.
Dustin Cavida	Mr. Cavida has received personal compensation for serving as an employee of Amgen. Mr. Cavida has stock in Amgen.
Liu Zhang, PhD	Dr. Zhang has received personal compensation for serving as an employee of Cytel.
Kristina R. Patterson, MD, PhD	Dr. Patterson has received personal compensation for serving as an employee of Amgen. Dr. Patterson has stock in Amgen.
Haridarshan Patel	Haridarshan Patel has received personal compensation for serving as an employee of Amgen.
Jenny Y. Park, PharmD, MS	Dr. Park has received personal compensation for serving as an employee of Amgen Inc.. Dr. Park has or had stock in Amgen Inc..
Atef Hulliel, MD	Dr. Hulliel has nothing to disclose.
Nataly Al-Zu’be, MD	Dr. Al-Zu’be has nothing to disclose.
Basheer S. Alghizzawi, MD	Dr. Alghizzawi has nothing to disclose.
Eman M. Ghawanmeh, MD	Dr. Ghawanmeh has nothing to disclose.
Sara Mataineh, MD	Dr. Mataineh has nothing to disclose.
Batool W. Bataineh, MD	Miss Bataineh has nothing to disclose.
Youssef R. Raoof	Youssef R. Raoof has nothing to disclose.
Snigdha Kanadibhotla, BS	Ms. Kanadibhotla has nothing to disclose.
Priya Aggarwal	Miss Aggarwal has nothing to disclose.
Bridget A. Leone, MD	Dr. Leone has nothing to disclose.
Shantel Apeseche, MD	Dr. Apeseche has nothing to disclose.
Simona Treidler, MD	Dr. Treidler has nothing to disclose.
Zhao Zhong Chong	Zhao Zhong Chong has nothing to disclose.
Nizar Souayah, MD, FAAN	Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Faddi G. Saleh Velez, MD	Dr. Saleh Velez has nothing to disclose.
Camila Bonin Pinto	Camila Bonin Pinto has nothing to disclose.
Gary K. Lau, MBBS	Dr. Lau has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Lau has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Lau has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Daiichi Sankyo. Dr. Lau has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Amgen. Dr. Lau has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Boehringer Ingelheim. Dr. Lau has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Daiichi Sankyo. Dr. Lau has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Pfizer. Dr. Lau has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Eisai. Dr. Lau has stock in ReMobility. The institution of Dr. Lau has received research support from Croucher Foundation. The institution of Dr. Lau has received research support from Research Fund Secretariat of the Food and Health Bureau, Hong Kong. The institution of Dr. Lau has received research support from Innovation and Technology Bureau, Hong Kong. The institution of Dr. Lau has received research support from Research Grants Council, Hong Kong. Dr. Lau has received publishing royalties from a publication relating to health care.
Elton H. Yeung, MBBS	Mr. Yeung has stock in ReMobility Limited. The institution of Mr. Yeung has received research support from World Stroke Organization Future Leader Project. Mr. Yeung has received intellectual property interests from a discovery or technology relating to health care.
Leonardo Carbonera	Leonardo Carbonera has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allm. The institution of Leonardo Carbonera has received research support from World Stroke Organization . The institution of Leonardo Carbonera has received research support from Boehringer Ingelheim.
Gustavo Saposnik, MD	Dr. Saposnik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Saposnik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIHSS. The institution of Dr. Saposnik has received research support from Roche. The institution of Dr. Saposnik has received research support from Heart and Stroke Foundation of Canada.
Matias Alet	Matias Alet has nothing to disclose.
Bogdan Ciopleias, MD	Dr. Ciopleias has nothing to disclose.
Abdul Hanif Khan Yusof Khan, MD	Prof. Yusof Khan has nothing to disclose.
Zhe Kang Law, MD, PhD	Dr. Law has nothing to disclose.
Radhika Lotlikar, MD	Dr. Lotlikar has nothing to disclose.
Tsei Mei Ling	No disclosure on file
Roxanna K. Liu, RN	Ms. Liu has nothing to disclose.
Ching Hei So	Mr. So has nothing to disclose.
Yin Hei Chan, MBBS	Mr. Chan has nothing to disclose.
Gloria C. Poon, MBBS	Ms. Poon has nothing to disclose.
Laura Boada Robayo, MD	Laura Boada Robayo, MD has nothing to disclose.
Demian Rudyk, MD	Dr. Rudyk has nothing to disclose.
Pawel Kiper, PhD	Dr. Kiper has nothing to disclose.
Valeria Caso, MD, PhD	Dr. Caso has nothing to disclose.
Sean I. Savitz, MD	Dr. Savitz has nothing to disclose.
Andriy Yabluchanskiy	Andriy Yabluchanskiy has nothing to disclose.
Lu LUO	Mr. LUO has nothing to disclose.
Wilton W. Fok, PhD	Dr. Fok has received personal compensation for serving as an employee of The University of Hong Kong. The institution of Dr. Fok has received research support from Innovation Technology Fund.
Carol Chen, PhD	Miss Chen has nothing to disclose.
Wun Yin Lam	Mr. Lam has nothing to disclose.
Benny Leung	Mr. Leung has nothing to disclose.
David G. Coughlin, MD	Dr. Coughlin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. The institution of Dr. Coughlin has received research support from ��ɫ��. The institution of Dr. Coughlin has received research support from NIA. The institution of Dr. Coughlin has received research support from NINDS.
Lavanya Jain	No disclosure on file
Maria Khrestian	No disclosure on file
Karen MacLeod, BA	Ms. MacLeod has received personal compensation for serving as an employee of Amprion Inc..
Andrea Bozoki, MD, FAAN	Dr. Bozoki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Creative Biopeptides. Dr. Bozoki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics. The institution of Dr. Bozoki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AviadoBio. The institution of Dr. Bozoki has received research support from Cognition Therapeutics. The institution of Dr. Bozoki has received research support from EIP Pharma. The institution of Dr. Bozoki has received research support from Transposon Therapeutics. The institution of Dr. Bozoki has received research support from Alector .
James E. Galvin, MD, MPH	Dr. Galvin has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cognivue. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Biogen. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eisai. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Galvin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GE Healthcare. Dr. Galvin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Galvin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PassageBio. The institution of Dr. Galvin has received research support from National Institutes of Health. Dr. Galvin has received intellectual property interests from a discovery or technology relating to health care. Dr. Galvin has a non-compensated relationship as a Board of Directors with Alzheimer Association Southeast Florida Chapter that is relevant to AAN interests or activities. Dr. Galvin has a non-compensated relationship as a Board of Directors with Lewy Body Dementia Association that is relevant to AAN interests or activities. Dr. Galvin has a non-compensated relationship as a Board of Directors with Lewy Body Dementia Resource Center that is relevant to AAN interests or activities.
David Irwin, MD	The institution of Dr. Irwin has received research support from NIH. The institution of Dr. Irwin has received research support from Prevail. The institution of Dr. Irwin has received research support from Passage Bio. The institution of Dr. Irwin has received research support from Alector. The institution of Dr. Irwin has received research support from Transposon. The institution of Dr. Irwin has received research support from Denali. The institution of Dr. Irwin has received research support from Cervo Med.
Carol F. Lippa, MD	Dr. Lippa has nothing to disclose.
Irene Litvan, MD, FAAN	Dr. Litvan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aprinoia. Dr. Litvan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Litvan has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology. Dr. Litvan has received personal compensation in the range of $50,000-$99,999 for serving as a Chief Editor with Frontiers in Neurology.
Oscar L. Lopez, MD, FAAN	Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acumen.
Sarah Berman, MD	The institution of Dr. Berman has received research support from NIH.
Debby W. Tsuang, MD	Dr. Tsuang has nothing to disclose.
Cyrus P. Zabetian, MD	The institution of Dr. Zabetian has received research support from American Parkinson Disease Association. The institution of Dr. Zabetian has received research support from Department of Veterans Affairs. The institution of Dr. Zabetian has received research support from NIH. Dr. Zabetian has a non-compensated relationship as a Member, Scientific Advisory Council with Lewy Body Dementia Association that is relevant to AAN interests or activities.
Jori Fleisher, MD, MSCE, FAAN	The institution of Dr. Fleisher has received research support from Parkinson's Foundation. The institution of Dr. Fleisher has received research support from NIH/NINDS. The institution of Dr. Fleisher has received research support from NIH/NINDS. The institution of Dr. Fleisher has received research support from NIA/NINDS. The institution of Dr. Fleisher has received research support from NIA/NINDS. Dr. Fleisher has received publishing royalties from a publication relating to health care. Dr. Fleisher has received personal compensation in the range of $0-$499 for serving as a Speaker with Parkinson's Foundation. Dr. Fleisher has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Lewy Body Dementia Association. Dr. Fleisher has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Davis Phinney Foundation. Dr. Fleisher has a non-compensated relationship as a Editorial Board Member with AAN Brain & Life Magazine that is relevant to AAN interests or activities.
Angela Taylor	Mrs. Taylor has received personal compensation for serving as an employee of Lewy Body Dementia Association.
James B. Leverenz, MD, FAAN	Dr. Leverenz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Leverenz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Leverenz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai.
Lynn Bekris	No disclosure on file
Douglas Galasko, MD	Dr. Galasko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly, Inc. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Diagnostics. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognition THeraprutics. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Artery Therapeutics.
Erin D'Agostino, MD	Dr. D'Agostino has nothing to disclose.
John S. Taylor, Jr., MD	Dr. Taylor has nothing to disclose.
Dianna Higgins Cronin, MA	Ms. Higgins Cronin has nothing to disclose.
Scott F. Cooper, MD	Dr. Cooper has nothing to disclose.
Ayesha Quadri	Ms. Quadri has nothing to disclose.
Hafiz Fadl, MD	Dr. Fadl has nothing to disclose.
Sheena K. Aurora, MD	Dr. Aurora has received personal compensation for serving as an employee of Alzheimer's Association.
Justine Coppinger, Other	Ms. Coppinger has received personal compensation for serving as an employee of C2N Diagnostics, LLC. Ms. Coppinger has stock in C2N Diagnostics, LLC.
Sutapa Ray, PhD	Dr. Ray has received personal compensation for serving as an employee of C2N Diagnostics.
Joel Braunstein	Dr. Braunstein has received personal compensation for serving as an employee of C2N Diagnostics. Dr. Braunstein has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for C2N Diagnositcs.
Tim West, PhD	Dr. West has received personal compensation for serving as an employee of C2N Diagnostics, LLC. Dr. West has stock in C2N Diagnostics, LLC.
Phillip Verghese	No disclosure on file
Kevin W. Dang, MD	Dr. Dang has nothing to disclose.
Justin Hoskin, MD	Dr. Hoskin has nothing to disclose.
Kumaravelu Somasundaram, DM	Prof. Somasundaram has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boringer Ingelheim and Pfizer . Prof. Somasundaram has received research support from Intas Pharmaceuticals.
Vijaya Pamidimukkala, Sr., MD	Dr. Pamidimukkala has nothing to disclose.
Balakrishna Sanampudi, MBBS	Dr. Sanampudi has nothing to disclose.
Usha Kiran Behera	Usha Kiran Behera has nothing to disclose.
Sujatha Manjunathan, MD	Sujatha Manjunathan has nothing to disclose.
Naveen Sankhyan, MD, MBBS, DM	The institution of Dr. Sankhyan has received research support from PTC Therapeutics for a Multicentric RCT. Dr. Sankhyan has received research support from Institute Grant, PGIMER, (Goverment Entity).
Renu Suthar, MD	Dr. Suthar has nothing to disclose.
Arushi Saini, MD	Dr. Saini has nothing to disclose.
Jitendra Sahu, MD	Jitendra Sahu has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Indian Journal of Pediatrics. The institution of Jitendra Sahu has received research support from Indian Council of Medical Research.
Sameer Vyas, MD	Prof. VYAS has nothing to disclose.
Arun Bansal, Jr., MD	Prof. Bansal has nothing to disclose.
Amit Rawat, MD	The institution of Prof. Rawat has received research support from Indian Council of Medical Research. The institution of Prof. Rawat has received research support from Department of Science and Technology, Government of India. Prof. Rawat has received publishing royalties from a publication relating to health care.
Emma Streveler, MD	Dr. Streveler has nothing to disclose.
Francis Lauzier, MD	Ms. Lauzier has nothing to disclose.
Syeda Maria Muzammil, MD	Dr. Muzammil has nothing to disclose.
Wazim Mohamed, MD	Dr. Mohamed has nothing to disclose.
Scott Millis	Scott Millis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Taylor & Francis. The institution of Scott Millis has received research support from NIH & NIDILRR.
Deepti Zutshi, MD, FAAN	Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon pharmaceuticals. An immediate family member of Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aucta Pharmaceuticals. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aucta.
Shruti N. Iyer, MBBS	Dr. Iyer has nothing to disclose.
Gabriela Figueiredo Pucci, MD	Dr. Figueiredo Pucci has nothing to disclose.
Alex Israel, MD	Dr. Israel has nothing to disclose.
Wesley Kerr, MD, PhD	Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Lifesciences. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kerr has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for QurAlis. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Pharmaceuticals. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. The institution of Dr. Kerr has received research support from NINDS. The institution of Dr. Kerr has received research support from American Epilepsy Society. The institution of Dr. Kerr has received research support from ��ɫ��. The institution of Dr. Kerr has received research support from SK Life Science. The institution of Dr. Kerr has received research support from Biohaven Pharmaceuticals. Dr. Kerr has received publishing royalties from a publication relating to health care.
Brittany W. Concilus, LCSW	Miss Concilus has nothing to disclose.
LIANNE G. Vighetti, DHCE, HEC-C, LCSW	Dr. Vighetti has nothing to disclose.
DANIELLE R. CARNS, PsyD	Dr. CARNS has nothing to disclose.
Katherine McFarlane, MS	Ms. McFarlane has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Ms. McFarlane has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuropace.
Matine Azadian	Dr. Azadian has nothing to disclose.
Paul M. George, MD, PhD, MSE, FAAN	Dr. George has received personal compensation in the range of $0-$499 for serving as a Consultant for ConductiveBio. Dr. George has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Law firms. The institution of Dr. George has received research support from Conductive Bio. The institution of Dr. George has received research support from NIH. Dr. George has received intellectual property interests from a discovery or technology relating to health care. Dr. George has received personal compensation in the range of $10,000-$49,999 for serving as a Adjudicator with Baim Insititute. Dr. George has a non-compensated relationship as a Board Member with ��ɫ�� that is relevant to AAN interests or activities. Dr. George has a non-compensated relationship as a International Stroke Council Program committee member with American Heart Association that is relevant to AAN interests or activities.
Sepideh Kiani Shabestari, PhD	Dr. Kiani Shabestari has nothing to disclose.
Haya Bakdounes	Miss Bakdounes has nothing to disclose.
Grace Jiang	Miss Jiang has nothing to disclose.
Nicholas Macedo	Mr. Macedo has nothing to disclose.
Jeffrey M. Kaplan, MD	Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biohaven. Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Kaplan has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Allergan. Dr. Kaplan has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lilly. Dr. Kaplan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Kaplan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Kaplan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Kaplan has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Kaplan has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Amgen. Dr. Kaplan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Viela. Dr. Kaplan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck.
Dana Beenstock, NP	Mrs. Beenstock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Mrs. Beenstock has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Meyer Squibb. Mrs. Beenstock has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen.
Martin I. Belkin, DO	Dr. Belkin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Belkin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Belkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Belkin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Belkin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Belkin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD serono. Dr. Belkin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Belkin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Belkin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Belkin has received stock or an ownership interest from Biogen.
Heidi J. Crayton, MD	The institution of Dr. Crayton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. The institution of Dr. Crayton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Crayton has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Crayton has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BMS. The institution of Dr. Crayton has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Crayton has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sandoz. The institution of Dr. Crayton has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Crayton has received research support from EMD Serono. The institution of Dr. Crayton has received research support from Sanofi. The institution of Dr. Crayton has received research support from Atara.
Christopher P. Eckstein, MD	The institution of Dr. Eckstein has received research support from Biogen. The institution of Dr. Eckstein has received research support from Genzyme.
Ruth K. Fredericks, MD	Dr. Fredericks has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Fredericks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion.
Boyang Bian	Boyang Bian has received personal compensation for serving as an employee of Biogen. Boyang Bian has stock in Biogen.
Nicholas Belviso, PhD, PharmD	Dr. Belviso has received personal compensation for serving as an employee of Biogen.
Daphne Ni, PharmD	Dr. Ni has received personal compensation for serving as an employee of Biogen. Dr. Ni has stock in Biogen.
Danette J. Rutledge, PhD	Ms. Rutledge has received personal compensation for serving as an employee of Biogen. Ms. Rutledge has stock in Biogen.
William J. Laxen	Mr. Laxen has nothing to disclose.
Matthew Schultz, PhD	Mr. Schultz has nothing to disclose.
Devin Oglesbee, PhD	Dr. Oglesbee has nothing to disclose.
Dimitar Gavrilov, MD	Dr. Gavrilov has nothing to disclose.
Silvia Tortorelli, MD, PhD	Dr. Tortorelli has nothing to disclose.
Patricia Hall, PhD	Dr. Hall has nothing to disclose.
Dietrich Matern, MD, PhD	Prof. Matern has received intellectual property interests from a discovery or technology relating to health care. Prof. Matern has received publishing royalties from a publication relating to health care.
Amy White, MS	Ms. White has nothing to disclose.
Apoorva Vedula, MBBS	Miss Vedula has nothing to disclose.
VINAY KUMAR CHOPPA, MD, MBBS	Dr. CHOPPA has nothing to disclose.
Yu Guo, PhD	Dr. Guo has nothing to disclose.
Jintai Yu	No disclosure on file
Justin Abbatemarco, MD	Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech . Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics, Inc.. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. The institution of Dr. Abbatemarco has received research support from Amgen.
Martin Kleman	Mr. Kleman has received personal compensation for serving as an employee of Alexion, AstraZeneca Rare Disease. Mr. Kleman has stock in AstraZeneca.
Kelley H. Myers, PhD	Dr. Myers has nothing to disclose.
Christine Poulos, PhD	Ms. Poulos has nothing to disclose.
Devon Conway, MD	Dr. Conway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Conway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Conway has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Conway has received research support from Novartis. The institution of Dr. Conway has received research support from BMS. The institution of Dr. Conway has received research support from Biogen.
Saami Zakaria, MD	Dr. Zakaria has nothing to disclose.
Kara R. Melmed, MD	Dr. Melmed has nothing to disclose.
Benjamin Brush, MD	Dr. Brush has nothing to disclose.
Aaron Lord, MD	Dr. Lord has nothing to disclose.
Lindsey Gurin, MD	Dr. Gurin has received personal compensation in the range of $0-$499 for serving as a physician reviewer with Healthcare Quality Strategies, Inc. Dr. Gurin has received personal compensation in the range of $500-$4,999 for serving as a consultant with Human Services Research Institute.
Jennifer A. Frontera, MD	Dr. Frontera has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FirstKindMedical. Dr. Frontera has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Physician ��ɫ�� Resource. The institution of Dr. Frontera has received research support from NIH. The institution of Dr. Frontera has received research support from Alexion. Dr. Frontera has received publishing royalties from a publication relating to health care.
Koto Ishida, MD, FAAN	Dr. Ishida has received publishing royalties from a publication relating to health care.
Jose L. Torres, MD	Dr. Torres has nothing to disclose.
Cen Zhang, MD	Dr. Zhang has nothing to disclose.
Leah P. Dickstein, MD	Dr. Dickstein has nothing to disclose.
David E. Kahn, MD	An immediate family member of Dr. Kahn has received personal compensation for serving as an employee of Essai.
Ting Zhou, MD	Dr. Zhou has nothing to disclose.
Ariane Lewis, MD, FAAN	Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Seminars in Neurology. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neuroscience.
Hamza Ahmed, student	Mr. Ahmed has nothing to disclose.
Veronica Bohl	Ms. Bohl has nothing to disclose.
Tyler M. Bielinski	Mr. Bielinski has nothing to disclose.
Kelsey Kline, BS	Miss Kline has nothing to disclose.
Grant N. Badger	Mr. Badger has nothing to disclose.
Prateeka Koul, MD	Dr. Koul has nothing to disclose.
Anthony Noto, MD	Dr. Noto has nothing to disclose.
Clemens M. Schirmer, MD, PhD	Dr. Schirmer has received personal compensation for serving as an employee of Geisinger. Dr. Schirmer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Balt. Dr. Schirmer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medtronic. Dr. Schirmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stryker. Dr. Schirmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viz.ai. Dr. Schirmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Microvention. Dr. Schirmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Werfen. Dr. Schirmer has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Schirmer has stock in NTI. Dr. Schirmer has stock in REIST. The institution of Dr. Schirmer has received research support from NIH. The institution of Dr. Schirmer has received research support from Medtronic. The institution of Dr. Schirmer has received research support from Cerenovus. The institution of Dr. Schirmer has received research support from MIVI. The institution of Dr. Schirmer has received research support from Balt. The institution of Dr. Schirmer has received research support from Microvention. The institution of Dr. Schirmer has received research support from Stryker. The institution of Dr. Schirmer has received research support from Penumbra. The institution of Dr. Schirmer has received research support from NICO. The institution of Dr. Schirmer has received research support from Route 92.
Philipp Hendrix, MD, PhD	Dr. Hendrix has nothing to disclose.
Victoria Mazo, MD	Dr. Mazo has nothing to disclose.
Stephen L. Hofmann, DO	Dr. Hofmann has nothing to disclose.
Priyanka Atit, DO	Dr. Atit has nothing to disclose.
Lisa Calvo, MD	Dr. Calvo has nothing to disclose.
Carola Wagner	Carola Wagner has received personal compensation for serving as an employee of Novartis Pharma GmbH.
Gereon Nelles, MD, PhD, FAAN	Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Memodio. Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Industrial. Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Industry. Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for German Neurologists Professional Organization. Dr. Nelles has received publishing royalties from a publication relating to health care.
Steffen Pfeuffer, MD	Dr. Pfeuffer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SANOFI. Dr. Pfeuffer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MERCK. Dr. Pfeuffer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE. Dr. Pfeuffer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NOVARTIS. Dr. Pfeuffer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIOGEN. Dr. Pfeuffer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HEXAL. Dr. Pfeuffer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ALEXION. The institution of Dr. Pfeuffer has received research support from MERCK. The institution of Dr. Pfeuffer has received research support from BIOGEN. The institution of Dr. Pfeuffer has received research support from NOVARTIS.
Sabrina Bitar, MD	Ms. Bitar has nothing to disclose.
Abigail E. Connor	Ms. Connor has nothing to disclose.
Paola Martinez, MD	Dr. Martinez has nothing to disclose.
Patrick Isaac	Mr. Isaac has nothing to disclose.
Kevin W. Chen, MD	Dr. Chen has nothing to disclose.
Lacy Lichtenhan, BS	Miss Lichtenhan has nothing to disclose.
James Kelbert	Mr. Kelbert has nothing to disclose.
Cherry J. Barragan	Mrs. Barragan has nothing to disclose.
Naria S. Quazi, MD	Miss Quazi has nothing to disclose.
Rachel L. Schuurs, MD	Miss Schuurs has nothing to disclose.
Nicole Varda	Ms. Varda has nothing to disclose.
Joshua Tobin, MD, FAAN	An immediate family member of Dr. Tobin has received personal compensation for serving as an employee of Amgen. Dr. Tobin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Tobin has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AbbVie.
Robin Garrett, PsyD	Dr. Garrett has nothing to disclose.
Alan Wang, MD, FAAN	Dr. Wang has stock in AbbVie.
Ganesh Murthy, MD	Dr. Murthy has nothing to disclose.
Stephen Jaworski, MD	Dr. Jaworski has nothing to disclose.
Connie G. Tang, MD	Dr. Tang has nothing to disclose.
Todd R. Garber, MD	Dr. Garber has nothing to disclose.
Juan P. Vázquez, MD	Dr. Vazquez has nothing to disclose.
Anja Soldan, PhD	Dr. Soldan has nothing to disclose.
Corinne Pettigrew, PhD	Dr. Pettigrew has received research support from NIH/NIA.
Paul Worley	No disclosure on file
Yuxin Zhu, PhD	Dr. Zhu has nothing to disclose.
Abhay Moghekar, MD	Dr. Moghekar has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Deluca and Weizenbaum. Dr. Moghekar has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Silver Golub and Tieteel. The institution of Dr. Moghekar has received research support from NIH. Dr. Moghekar has a non-compensated relationship as a Medical Advisory Board member with Hydrocephalus Association that is relevant to AAN interests or activities. Dr. Moghekar has a non-compensated relationship as a Medical Advisory Board member with Spinal CSF Leak Foundation that is relevant to AAN interests or activities.
Sungtaek Oh	Mr. Oh has nothing to disclose.
Chan-Hyun Na, PhD	Dr. Na has nothing to disclose.
Marilyn Albert	Marilyn Albert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Marilyn Albert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Marilyn Albert has received personal compensation in the range of $500-$4,999 for serving as a Chair with Global Council on Brain Health.
Claire L. Anderson, MHS	The institution of Miss Anderson has received research support from National Institute on Aging (NIA).
Rebeca O. Silva, Student	Miss Silva has nothing to disclose.
Filipi F. Andreão	Mr. Andreão has nothing to disclose.
Karlos Daniell A. dos Santos, Sr., Medical student	Mr. dos Santos has nothing to disclose.
Lucas M. Nascimento, MS	Mr. Nascimento has nothing to disclose.
Helvécio N. Filho, Sr.	Mr. Filho has nothing to disclose.
Leandro V. Lessa	Mr. Lessa has nothing to disclose.
Diogo Haddad Santos, MD	Dr. Haddad Santos has nothing to disclose.
Lorenzo F. Anselmi, MS	Mr. Anselmi has nothing to disclose.
Pinky Chhatterpal, DM Neurology	Dr. Chhatterpal has nothing to disclose.
Deepti Vibha, MD	Dr. Vibha has nothing to disclose.
Manjari Tripathi, MD	Dr. Tripathi has nothing to disclose.
Rohit Bhatia, MD, MBBS, DM	Dr. Bhatia has nothing to disclose.
Achal K. Srivastava, MD, FAAN	Dr. Srivastava has nothing to disclose.
Awadh Kishor Pandit, MD, MBBS, DM	Dr. Pandit has nothing to disclose.
Rajesh Kumar Singh	Rajesh Kumar Singh has nothing to disclose.
Ajay Garg	Ajay Garg has nothing to disclose.
Shailesh Gaikwad	Shailesh Gaikwad has nothing to disclose.
Leve Joseph Devarajan Sebastian, DM	Dr. Sebastian has nothing to disclose.
Venugopalan Y. Vishnu, MD	The institution of Dr. Vishnu has received research support from Department of Health Research.
M.V.Padma Srivastava	No disclosure on file
Bivek Singh	Mr. Singh has nothing to disclose.
hedi An	Miss An has nothing to disclose.
Ran Xiong, PhD	Miss Xiong has nothing to disclose.
hongrong xie, PhD	Miss xie has nothing to disclose.
YOU YIN, MD, PhD	Prof. YIN has nothing to disclose.
ROBERTO MANFREDINI, MD, PhD	Prof. MANFREDINI has nothing to disclose.
dongya huang, MD, PhD	Prof. huang has nothing to disclose.
Gwendolyn E. Niebler, DO	Dr. Niebler has received personal compensation for serving as an employee of Alexion. Dr. Niebler has stock in AstraZeneca.
Sarbesh Pandeya, PhD	Dr. Pandeya has nothing to disclose.
Sourish Chakravarty, PhD	Dr. Chakravarty has received personal compensation for serving as an employee of Alexion-AstraZeneca Rare Disease. An immediate family member of Dr. Chakravarty has received personal compensation for serving as an employee of Beam Therapeutics. Dr. Chakravarty has stock in Alexion-Astrazeneca Rare Disease. An immediate family member of Dr. Chakravarty has stock in Beam Therapeutics.
Glen Frick, MD, PhD	Dr. Frick has received personal compensation for serving as an employee of AstraZeneca/Alexion Rare Disease. Dr. Frick has stock in AstraZeneca/Alexion Rare Disease.
Jackson A. Narrett, MD	Mr. Narrett has nothing to disclose.
Sebastian Sanchez Herrera, MD	Sebastian Sanchez Herrera has nothing to disclose.
Jeremy Moeller, MD, FAAN	Dr. Moeller has received publishing royalties from a publication relating to health care.
Melissa Funaro	Melissa Funaro has nothing to disclose.
Kaitlyn Stoehr, MS5	Ms. Stoehr has nothing to disclose.
Waleed Khan, MD	Dr. Khan has nothing to disclose.
Carrie M. Hersh, DO, MSc, FAAN	Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech_GN41791. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb . Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Hersh has received research support from Biogen. The institution of Dr. Hersh has received research support from Novartis. The institution of Dr. Hersh has received research support from Genentech_GN41791. The institution of Dr. Hersh has received research support from PCORI. The institution of Dr. Hersh has received research support from Bristol Myers Squibb.
Edward Fox, MD, PhD, FAAN	Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharmaceuticals. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Fox has received research support from Biogen. The institution of Dr. Fox has received research support from Genentech. The institution of Dr. Fox has received research support from Celgene - BMS. The institution of Dr. Fox has received research support from Chugai. The institution of Dr. Fox has received research support from Novartis. The institution of Dr. Fox has received research support from EMD-Serono. The institution of Dr. Fox has received research support from TG Therapeutics. The institution of Dr. Fox has received research support from AbbVie. The institution of Dr. Fox has received research support from Sanofi Genzyme. The institution of Dr. Fox has received research support from AbbVie.
Jackie Parker, MPH	Ms. Parker has received personal compensation for serving as an employee of TG Therapeutics. Ms. Parker has stock in TG Therapeutics.
Karthik Bodhinathan, PhD	Dr. Bodhinathan has received personal compensation for serving as an employee of TG Therapeutics. Dr. Bodhinathan has stock in TG Therapeutics.
Peter Sportelli, BS	Mr. Sportelli has received personal compensation for serving as an employee of TG Therapeutics. Mr. Sportelli has stock in TG Therapeutics, Inc.
Hari Miskin	Hari Miskin has received personal compensation for serving as an employee of TG Therapeutics, Inc.. Hari Miskin has stock in TG Therapeutics, Inc..
Michele Potashman, PhD	Dr. Potashman has received personal compensation for serving as an employee of Biohaven Pharmaceuticals.
Samuel Dickson	Mr. Dickson has nothing to disclose.
Basia Rogula	Basia Rogula has received personal compensation for serving as an employee of Broadstreet HEOR.
Jordan S. Dubow, MD	Dr. Dubow has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Revalesio .
Nick Kozauer	Dr. Kozauer has received personal compensation for serving as an employee of Biohaven. Dr. Kozauer has stock in Biohaven.
Lauren Powell	Lauren Powell has nothing to disclose.
Patrick O'Keefe	Patrick O'Keefe has received personal compensation for serving as an employee of Pentara.
Ellen Korol	Ellen Korol has received personal compensation for serving as an employee of Broadstreet HEOR.
Fernanda Nagase	Fernanda Nagase has nothing to disclose.
Vlad Coric	No disclosure on file
Liana Rosenthal, MD	Dr. Rosenthal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Rosenthal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Reata Pharmaceuticals. Dr. Rosenthal has received research support from NIH. Dr. Rosenthal has received research support from Gordon and Marilyn Macklin Foundation. Dr. Rosenthal has received research support from The Daniel B. and Florence E. Green Foundation. Dr. Rosenthal has received research support from National Ataxia Foundation. Dr. Rosenthal has received research support from Michael J. Fox Foundation. Dr. Rosenthal has received research support from Pfizer. Dr. Rosenthal has received research support from Biohaven Pharmaceuticals. Dr. Rosenthal has a non-compensated relationship as a Medical Director, ex-officio Member of the Board with National Ataxia Foundation that is relevant to AAN interests or activities.
Suzanne Hendrix, PhD	Dr. Hendrix has received personal compensation for serving as an employee of Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pentara Corporation. The institution of Dr. Hendrix has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pentara Corporation. Dr. Hendrix has or had stock in Pentara.
Gilbert J. L'Italien	Gilbert J. L'Italien has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Gilbert J. L'Italien has stock in biohaven pharmaceuticals.
Madeleine Crabtree	Madeleine Crabtree has nothing to disclose.
Brianna Brun	Dr. Brun has received research support from National Institute of Neurological Disorders and Stroke.
Shawn P. Jorgensen, MD	Dr. Jorgensen has nothing to disclose.
Alexander Tran, Medical Student	Mr. Tran has nothing to disclose.
Lauren B. Adams, Undergraduate Student	Miss Adams has received research support from NIH SURF Grant summer 2024.
Riddhi Patira, MD	Dr. Patira has nothing to disclose.
Marissa A. Gogniat, PhD	Dr. Gogniat has nothing to disclose.
Beth Snitz, PhD	Beth Snitz has nothing to disclose.
Eithel A. Valenzuela Mendivil	Eithel A. Valenzuela Mendivil has nothing to disclose.
Mijail A. Rivas, Sr., MD	Dr. Rivas has nothing to disclose.
Gerardo Méndez Suárez, Sr., MD	Dr. Méndez Suárez has nothing to disclose.
Angel A. Ruiz-Chow, Sr., MD	Dr. Ruiz-Chow has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for J&J. Dr. Ruiz-Chow has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for J&J.
Daniel Crail-Melendez, MD	Prof. Crail-Melendez has nothing to disclose.
Nohela Rehman	Miss Rehman has nothing to disclose.
Muhammad W. Ansari, MD	Dr. Ansari has nothing to disclose.
Rowaid Ahmad, MBBS	Dr. Ahmad has nothing to disclose.
Clara Abouelsaad, DO	Dr. Abouelsaad has nothing to disclose.
Marvin Braun, MD, PhD	Dr. Braun has nothing to disclose.
Artur Menegaz de Almeida, MS	Mr. Menegaz de Almeida has nothing to disclose.
Juan D. Martinez Lemus, MD	Dr. Martinez Lemus has nothing to disclose.
Maria I. Reyes, MD	Dr. Reyes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Reyes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Reyes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Reyes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Reyes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Reyes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
Maria Eduarda Souza	Maria Eduarda Souza has nothing to disclose.
Francisco de Moraes	Francisco de Moraes has nothing to disclose.
Fernando Luiz Westphal Filho, MS	Mr. Westphal Filho has nothing to disclose.
Paulo M. Lopes, Medical student	Mr. Lopes has nothing to disclose.
Ítalo B. Andrade	Mr. Andrade has nothing to disclose.
Clara Rocha Dantas	Miss Rocha Dantas has nothing to disclose.
Mariana R. Reis, Medical Student	Miss Reis has nothing to disclose.
Kristen Sandefer, MD	Dr. Sandefer has nothing to disclose.
Shaila Kamal, Project Manager	Ms. Kamal has nothing to disclose.
Logan D. Hilton, MD	Dr. Hilton has nothing to disclose.
Melissa Gazi, MS, MPH	Miss Gazi has nothing to disclose.
Sana Somani, MD, MBBS	Dr. Somani has nothing to disclose.
Shannon W. Stephens, EMTP	Mr. Stephens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Mr. Stephens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Infrascan. The institution of Mr. Stephens has received research support from CSL Behring. The institution of Mr. Stephens has received research support from MTEC / DOD. The institution of Mr. Stephens has received research support from NIH / NHLBI.
Ronald M. Lazar, PhD, FAHA, FAAN, FAAN	Dr. Lazar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DiaMedica Therapeutics Inc. . The institution of Dr. Lazar has received research support from National Institutes of Health. Dr. Lazar has received publishing royalties from a publication relating to health care.
Toby I. Gropen, MD	Dr. Gropen has nothing to disclose.
Mark Beasley	No disclosure on file
Chris Garner	Chris Garner has received personal compensation for serving as an employee of TG Therapeutics Inc.. Chris Garner has stock in TG Therapeutics, Inc..
Shima Shahjouei, MD, MPH	Dr. Shahjouei has nothing to disclose.
Charles S. Specht, MD	Dr. Specht has nothing to disclose.
Mansoureh Mamarabadi, MD	Dr. Mamarabadi has nothing to disclose.
Kellyann Niotis, MD	Dr. Niotis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with PAREF.
Richard S. Isaacson, MD, FAAN	Dr. Isaacson has stock in Retain Health. The institution of Dr. Isaacson has received research support from National Institutes of Health. The institution of Dr. Isaacson has received research support from Aces for Alzheimer's. The institution of Dr. Isaacson has received research support from BrainMind. Dr. Isaacson has received publishing royalties from a publication relating to health care.
Hollie Hristov, NP	Mrs. Hristov has nothing to disclose.
Christopher Janney	Christopher Janney has received personal compensation for serving as an employee of Parkinson's Research & ��ɫ�� Foundation, Institute for Neurodegenerative Diseases. Christopher Janney has received intellectual property interests from a discovery or technology relating to health care.
Shannon Helfman	Shannon Helfman has received personal compensation for serving as an employee of Institute for Neurodegenerative Diseases.
Daniel Angerbauer, MD	Dr. Angerbauer has nothing to disclose.
Corey Saperia	Corey Saperia has nothing to disclose.
John G. Westine II	Mr. Westine has nothing to disclose.
Alon Seifan, MD	Dr. Seifan has received personal compensation in the range of $100,000-$499,999 for serving as a Chief Science Officer with HB Biotech.
Juan Melendez-Herencia	Juan Melendez-Herencia has nothing to disclose.
Praveen Parthasarathy	Praveen Parthasarathy has nothing to disclose.
Helena Colvee	Helena Colvee has nothing to disclose.
Beth Lewis, Strength Coach	Ms. Lewis has nothing to disclose.
Sara Murray, PA	Miss Murray has nothing to disclose.
Jessica Lakis	Jessica Lakis has nothing to disclose.
Maia Mossé, MD	Dr. Mossé has nothing to disclose.
Diana E. Saville, none	Mrs. Saville has nothing to disclose.
Michael J. McCullough, MD	Dr. McCullough has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Inflection AI. Dr. McCullough has stock in Regenmed systems. .
Nicholas Clute-Reinig, MS	Mr. Clute-Reinig has nothing to disclose.
Philip E. Sisser	Mr. Sisser has received personal compensation for serving as an employee of PAREF.
Jannatul Dishary, MS	Ms. Dishary has received personal compensation for serving as an employee of The Institute for Neurodegenerative Diseases .
Audree S. Rumberger	Miss Rumberger has received personal compensation for serving as an employee of BrainMind. Miss Rumberger has received personal compensation for serving as an employee of BeAGoodDoctor.
Yoji Hoshina, MD	Dr. Hoshina has nothing to disclose.
Tammy L. Smith, MD, PhD	Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. Smith has received research support from Alexion/AstraZeneca.
Ka-Ho Wong	The institution of Mr. Wong has received research support from The Sumaira Foundation . The institution of Mr. Wong has received research support from The Siegel Rare Neuroimmune Association.
Anastasia Zekeridou, MD, PhD, FAAN	The institution of Dr. Zekeridou has received research support from Roche/Genentech. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care.
Lisa K. Peterson, PhD	Dr. Peterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Werfen. Dr. Peterson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Werfen. Dr. Peterson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AliveDx. Dr. Peterson has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Clinical Biochemistry. Dr. Peterson has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Lab Q for ASCP. Dr. Peterson has a non-compensated relationship as a President with Association of Medical Laboratory Immunologists that is relevant to AAN interests or activities.
Albert Aboseif, DO	Dr. Aboseif has received research support from the Eugene & Marcia Applebaum Fellowship Grant.
Christopher Coffey, PhD, FAAN	Dr. Coffey has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Coffey has received research support from NIH. The institution of Dr. Coffey has received research support from Michael J Fox Foundation.
Melissa A. Wright, MD	Dr. Wright has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis .
Brenda L. Banwell, MD, FAAN	Dr. Banwell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Banwell has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Banwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Banwell has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Banwell has received research support from National MS Society. The institution of Dr. Banwell has received research support from NIH.
Annalisa Dialino-Felix	Ms. Dialino-Felix has received personal compensation for serving as an employee of Amgen.
SUSAN K. FLAVIN	Dr. FLAVIN has received personal compensation for serving as an employee of Horizon Therapeutics. Dr. FLAVIN has received personal compensation for serving as an employee of Amgen, Inc. Dr. FLAVIN has stock in Johnson and Johnson. Dr. FLAVIN has stock in Horizon Therapeutics. Dr. FLAVIN has stock in Amgen, Inc. Dr. FLAVIN has received intellectual property interests from a discovery or technology relating to health care.
Lisa Dill	Lisa Dill has nothing to disclose.
Hyun J. Cho, MD	Dr. Cho has nothing to disclose.
Josep O. Dalmau, MD, PhD, FAAN	Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas Research Institute of America. Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Research & Development . Dr. Dalmau has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. An immediate family member of Dr. Dalmau has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Dalmau has received research support from Sage Therapeutics. The institution of Dr. Dalmau has received research support from Edmond J.Safra Foundation . The institution of Dr. Dalmau has received research support from La Caixa Foundation. The institution of Dr. Dalmau has received research support from Spanish Ministry of Health (ISCIII). The institution of Dr. Dalmau has received research support from Euroimmun, Inc. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care.
Maarten J. Titulaer, MD, PhD	The institution of Dr. Titulaer has received research support from Dutch Epilepsy Foundations (NEF 19-08). The institution of Dr. Titulaer has received research support from CSL Behring. The institution of Dr. Titulaer has received research support from UCB. The institution of Dr. Titulaer has received research support from Netherlands Organisation for Scientific Research (ZonMW, Memorabel initiative and E-RARE UltraAIE) . The institution of Dr. Titulaer has received research support from Horizon Therapeutics / Amgen. The institution of Dr. Titulaer has received research support from Dioraphte (charity). The institution of Dr. Titulaer has received research support from Guidepoint Global LLC. The institution of Dr. Titulaer has received research support from ArgenX. Dr. Titulaer has received intellectual property interests from a discovery or technology relating to health care. Dr. Titulaer has received publishing royalties from a publication relating to health care.
Gregory S. Day, MD, MSc, FAAN	Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has or had stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Amgen Pharmaceuticals. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with ��ɫ��. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing ��ɫ��, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Ionis Pharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a ��ɫ��al Case Development + Presentation (video) with PeerDirect (P\S\L Group). Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development / Presentation (non-CME) with MJH Life Sciences (NeurologyLive). Dr. Day has a non-compensated relationship as a Clinical Director with Anti-NMDA Receptor Encephalitis Foundation that is relevant to AAN interests or activities.
Stacey Clardy, MD, PhD, FAAN	Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Beaumont Health, CCF, Emory, Penn State, Mayo Clinic, Walter Reed.
Fahham Asghar, MD	Mr. Asghar has nothing to disclose.
Gulbudin Muhammad, MD	Dr. Muhammad has nothing to disclose.
Hira Pervez, MD, MBBS	Dr. Pervez has nothing to disclose.
Syed Owais, MD	Dr. Owais has nothing to disclose.
Anum H. Riaz, MD	Dr. Riaz has nothing to disclose.
Naeem Mahfooz, MD	Dr. Mahfooz has nothing to disclose.
Ajaz Sheikh, MD	Dr. Sheikh has nothing to disclose.
Imran I. Ali, MD, FAAN	Dr. Ali has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN.
Gabriel Pardo, MD, FAAN	Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche Genentech. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi Genzyme. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Pardo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen . Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Pardo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Pardo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche Genentech. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Pardo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. Dr. Pardo has or had stock in Progentec Diagnostics.Dr. Pardo has or had stock in Cadenza Bio.
Amit Bar-Or, MD, FRCPC	Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for cabaletta. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech.
Xavier Montalban, MD, PhD, FAAN	The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIAL PD. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVoice. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung Biosys. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas BioPharma. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen Pharmaceuticals. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received research support from BMS/ Celgene.
Jin Nakahara, MD, PhD, FAAN	Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi-Tanabe. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai. Prof. Nakahara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Prof. Nakahara has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Prof. Nakahara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Prof. Nakahara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Chugai. Prof. Nakahara has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Mitsubishi-Tanabe. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Japanese Society for Internal Medicine. The institution of Prof. Nakahara has received research support from Chugai. The institution of Prof. Nakahara has received research support from Japan Society for the Promotion of Science.
Alit Bhatt	Alit Bhatt has nothing to disclose.
Min Wu, PhD	Dr. Wu has nothing to disclose.
Gregory Pearce, MS	Mr. Pearce has received personal compensation for serving as an employee of IQVIA.
Roseanne Sullivan	Roseanne Sullivan has received personal compensation for serving as an employee of Novartis Pharmaceuticals. Roseanne Sullivan has stock in Novartis Pharmaceuticals.
Anil Abeyewickreme, MD, PhD	Dr. Abeyewickreme has received personal compensation for serving as an employee of Novartis Pharmaceuticals.
Jerome De Seze	Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma.
Heinz Wiendl, MD, FAAN	Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson&Johnson / Janssen. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Idorsia. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LTS. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for INmune Bio_Syneos Health. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Muna Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Myrobalan Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSL Group. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Red Nucleus. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Swiss Multiple Sclerosis Society. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teladoc Health. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Toleranzia . Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz-Hexal. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocryst. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biontech. The institution of Dr. Wiendl has received research support from Biogen. The institution of Dr. Wiendl has received research support from Roche. The institution of Dr. Wiendl has received research support from Deutsche Forschungsgemeinschaft. The institution of Dr. Wiendl has received research support from European Union. The institution of Dr. Wiendl has received research support from Argenx. The institution of Dr. Wiendl has received research support from CSL Behring. The institution of Dr. Wiendl has received research support from Merck. The institution of Dr. Wiendl has received research support from UCB. Dr. Wiendl has received research support from Alexion Syneos Health iVH UK Ltd.. The institution of Dr. Wiendl has received research support from Deutsche Myasthenie-Gesellschaft. The institution of Dr. Wiendl has received research support from Winicker Norimed GmbH. The institution of Dr. Wiendl has received research support from Novartis. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care.
Stephen L. Hauser, MD	Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NGM Bio. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BD. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pheno Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nurix Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead. Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Accure. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hinge Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Neurona. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Roche that is relevant to AAN interests or activities. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Novartis that is relevant to AAN interests or activities.
Sarah A. Morrow, MD, MSC, FRCPC, FAAN	Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono/Merck. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SanofiGenzyme. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Morrow has received research support from Celgene. The institution of Dr. Morrow has received research support from SanofiGenzyme. The institution of Dr. Morrow has received research support from Novartis.
Rami Abd-Rabu, MD	Dr. Abd-Rabu has nothing to disclose.
Mohammad Almajali, MD	Dr. Almajali has nothing to disclose.
Eyad Almallouhi, MD	Dr. Almallouhi has nothing to disclose.
Shadi Yaghi, MD	Dr. Yaghi has nothing to disclose.
Osama O. Zaidat, MD, FAAN	Dr. Zaidat has nothing to disclose.
Bruno Mourao Pacheco, MD	Dr. Mourao Pacheco has nothing to disclose.
Evelyn Lazar, MD	Dr. Lazar has nothing to disclose.
Nicholas Briski, MD	Dr. Briski has nothing to disclose.
Anuradha Singh, DO	Dr. Singh has nothing to disclose.
Sagari R. Bette, MD	Dr. Bette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Bette has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal. Dr. Bette has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyowa Kirin. Dr. Bette has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merz. Dr. Bette has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Bette has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Bette has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merz. Dr. Bette has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus.
Joyce Z. Qian, PhD	Dr. Qian has received personal compensation for serving as an employee of Kyowa Kirin, Inc..
Hannah Cummings, PhD	Dr. Cummings has received personal compensation for serving as an employee of Kyowa Kirin.
Katsumi Shinoda, PhD	Dr. Shinoda has received personal compensation for serving as an employee of Kyowa Kirin Co., Ltd..
Hiroo Shimoda	Hiroo Shimoda has received personal compensation for serving as an employee of Kyowa Kirin Co., Ltd..
Ashley Thai, MD	Dr. Thai has received personal compensation for serving as an employee of Kyowa Kirin.
Sarah Batson	No disclosure on file
Stephen Mitchell	Stephen Mitchell has nothing to disclose.
Daniel D. Truong, MD, FAAN	The institution of Dr. Truong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus. The institution of Dr. Truong has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. The institution of Dr. Truong has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences. The institution of Dr. Truong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Truong has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Truong has received research support from Abbvie. The institution of Dr. Truong has received research support from Aeon. The institution of Dr. Truong has received research support from Biogen. The institution of Dr. Truong has received research support from Bukwang. The institution of Dr. Truong has received research support from Cerevel. The institution of Dr. Truong has received research support from Eli Lilly. The institution of Dr. Truong has received research support from Enterin. The institution of Dr. Truong has received research support from Ipsen. The institution of Dr. Truong has received research support from Lundbeck. The institution of Dr. Truong has received research support from Neurocrine. The institution of Dr. Truong has received research support from Neuroderm. The institution of Dr. Truong has received research support from Parkinson Foundation. The institution of Dr. Truong has received research support from Prilenia. The institution of Dr. Truong has received research support from Revance. The institution of Dr. Truong has received research support from Sunovion. Dr. Truong has received publishing royalties from a publication relating to health care. Dr. Truong has received publishing royalties from a publication relating to health care. Dr. Truong has a non-compensated relationship as a President with International Association for Parkinsonism and Related Disorders that is relevant to AAN interests or activities.
Gabrielle Redhead	Gabrielle Redhead has nothing to disclose.
Imke Kirste, PhD	Dr. Kirste has received personal compensation for serving as an employee of Roche Diagnostics. Dr. Kirste has stock in Roche Holdings AG.
Sayuri Hortsch, PhD	Dr. Hortsch has received personal compensation for serving as an employee of Roche Diagnostics GmbH.
Sheila M. Baez-Torres, MD	Dr. Baez-Torres has nothing to disclose.
Mercè Boada Rovira, MD, PhD	Dr. Boada Rovira has received personal compensation for serving as an employee of FUNDACIO ACE. ICNA. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GRIFOLS. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ARACLON BIOTECH. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIOGEN. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ZAMBON. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRIFOLS. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARACLON BIOTECH. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LILLY. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ZAMBON. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVO NORDISK. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOIBERICA. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SERVIER. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SCHWABE PHARMA. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ROCHE. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIOGEN. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GRIFOLS. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NUTRICIA. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ARACLON BIOTECH. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SERVIER. Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for ZAMBON.
Monica K. Crane, MD	Dr. Crane has received personal compensation for serving as an employee of Tennessee Memory Disorders Foundation/ Genesis Neuroscience Clinic. An immediate family member of Dr. Crane has received personal compensation for serving as an employee of Knoxville Orthopedic Clinic. Dr. Crane has received research support from Provision - Center for Biomedical Research.
Kristian S. Frederiksen, MD, PhD	Dr. FREDERIKSEN has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer (Nature). Dr. FREDERIKSEN has received research support from AP Møller Fonden. Dr. FREDERIKSEN has received publishing royalties from a publication relating to health care.
Kevin Hanson, MD	Dr. Hanson has nothing to disclose.
Jonathan L. Liss, MD	Dr. Liss has received personal compensation for serving as an employee of Columbus Memory Center & Health ��ɫ�� Foundation. The institution of Dr. Liss has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. The institution of Dr. Liss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Dr. Liss has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai. The institution of Dr. Liss has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Liss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Liss has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai. The institution of Dr. Liss has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Liss has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Ann Gower Esq.
Jeffrey A. Norton, MD	Dr. Norton has nothing to disclose.
Marc Suarez-Calvet, MD, PhD	The institution of Dr. Suarez-Calvet has received research support from ADx Neurosciences. The institution of Dr. Suarez-Calvet has received research support from Alamar Biosciences. The institution of Dr. Suarez-Calvet has received research support from ALZPath. The institution of Dr. Suarez-Calvet has received research support from Avid Radiopharmaceuticals. The institution of Dr. Suarez-Calvet has received research support from Eli Lilly. The institution of Dr. Suarez-Calvet has received research support from Fujirebio. The institution of Dr. Suarez-Calvet has received research support from Janssen Research & Development. The institution of Dr. Suarez-Calvet has received research support from Meso Scale Discovery. The institution of Dr. Suarez-Calvet has received research support from Roche Diagnostics.
Craig W. Ritchie, MBBS, PhD	The institution of Prof. Ritchie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. The institution of Prof. Ritchie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Prof. Ritchie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. The institution of Prof. Ritchie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MSD. The institution of Prof. Ritchie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Prof. Ritchie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Actinogen. Prof. Ritchie has stock in Scottish Brain Sciences.
Stephanie Rutrick, MD	The institution of Dr. Rutrick has received research support from Roche. The institution of Dr. Rutrick has received research support from Lilly. The institution of Dr. Rutrick has received research support from Athira. The institution of Dr. Rutrick has received research support from Abbvie.
David A. Watson, PsyD	Dr. Watson has nothing to disclose.
Kelley Yokum, MD	Dr. Yokum has nothing to disclose.
Clara Quijano Rubio, PhD	Dr. Quijano Rubio has received personal compensation for serving as an employee of Roche Diagnostics International.
Xiaoting Wang, MD	Dr. Wang has nothing to disclose.
Arayamparambil Anilkumar, MD, FAAN	Dr. Anilkumar has received publishing royalties from a publication relating to health care.
Zezheng Sun, MD	Dr. Sun has nothing to disclose.
Jian Wu, PhD	Dr. Wu has nothing to disclose.
Aser F. Alamri	Mr. Alamri has nothing to disclose.
Fahad A. Alturki	Mr. Alturki has nothing to disclose.
Hassan K. Salamatullah, Sr.	Mr. Salamatullah has nothing to disclose.
Ahmed A. Almaghrabi	Mr. Almaghrabi has nothing to disclose.
Basil Alghamdi, MD	Mr. Alghamdi has nothing to disclose.
Matthew Moench, MD	Matthew Moench, MD has nothing to disclose.
Michelle S. Nunes, Sr., MD	Dr. Nunes has nothing to disclose.
Katherine A. Zarroli, MD	Dr. Zarroli has nothing to disclose.
Manali Desai, DO	Dr. Desai has nothing to disclose.
hazal c. manazoglu, MD	Dr. manazoglu has a non-compensated relationship as a Sponsorship for travel and attendance at AAN meeting with Fortius Pharma that is relevant to AAN interests or activities.
ipek gungor dogan, MD	Dr. gungor dogan has nothing to disclose.
Serkan Demir, MD	Dr. Demir has nothing to disclose.
Ahmet Kasim Kilic	Ahmet Kasim Kilic has nothing to disclose.
Serkan Ozakbas, MD	Dr. Ozakbas has nothing to disclose.
Furkan Sarıdaş, MD	Dr. Saridas has nothing to disclose.
Emine Rabia Koc	EMINE RABIA KOC has nothing to disclose.
Fatma Belgin Balci, MD	Dr. Balci has nothing to disclose.
Esra Taşkıran, MD	Dr. Taskiran has nothing to disclose.
Ibrahim Acir, MD	Dr. Acir has nothing to disclose.
Nermin Tepe, MD	No disclosure on file
Nazire P. Acar Ozen, MD	Dr. Acar Ozen has nothing to disclose.
Meryem A. Tuncer, MD	Dr. Tuncer has nothing to disclose.
Ahmed Serkan Emekli	Ahmed Serkan Emekli has nothing to disclose.
Tuncay Gunduz, MD	The institution of Dr. Gunduz has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Pharmaceuticals. Dr. Gunduz has received research support from Turkish Neuroimmunology Society.
Murat Kurtuncu, MD	Dr. Kurtuncu has nothing to disclose.
Bruce A. Cree, MD, PhD, MAS, FAAN	The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. The institution of Dr. Cree has received research support from Kyverna. Dr. Cree has received publishing royalties from a publication relating to health care.
Hans-Peter Hartung, MD, FAAN	Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Enrique Alvarez, MD, PhD	Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Alvarez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/BMS. The institution of an immediate family member of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon.
Peiqing Qian, MD	Dr. Qian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Qian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Qian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Qian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS.
Sibyl E. Wray, MD	Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb/Celgene. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche/Genentech. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi/Genzyme. The institution of Dr. Wray has received research support from Biogen. The institution of Dr. Wray has received research support from Atara Biotherapeutics. The institution of Dr. Wray has received research support from Bristol Myers Squibb/Celgene. The institution of Dr. Wray has received research support from Novartis. The institution of Dr. Wray has received research support from Roche/Genentech. The institution of Dr. Wray has received research support from Sanofi/Genzyme. The institution of Dr. Wray has received research support from TG Therapeutics. The institution of Dr. Wray has received research support from EMD Serono. The institution of Dr. Wray has received research support from Pharmaceuticals Corp..
Derrick Robertson, MD	Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Greenwich Biosciences. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mallinckrodt. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Robertson has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Robertson has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Genentech. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PRIME CME. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for McVeigh. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Mccumber. Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Goodis. The institution of Dr. Robertson has received research support from Biogen. The institution of Dr. Robertson has received research support from EMD Serono. The institution of Dr. Robertson has received research support from Jansenn. The institution of Dr. Robertson has received research support from Genentech. The institution of Dr. Robertson has received research support from Patient-Centered Outcomes Research Institute. The institution of Dr. Robertson has received research support from Novartis. The institution of Dr. Robertson has received research support from Sanofi Genzyme. The institution of Dr. Robertson has received research support from TG Therapeutics. The institution of Dr. Robertson has received research support from Prime. The institution of Dr. Robertson has received research support from Greenwich Biosciences. The institution of Dr. Robertson has received research support from Atara Biotherapeutics. The institution of Dr. Robertson has received research support from CorEvitas. The institution of Dr. Robertson has received research support from Anokion. The institution of Dr. Robertson has received research support from UCB Biosciences. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Consortium of Multiple Sclerosis Centers. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Multiple Sclerosis Association of America.
Krzysztof W. Selmaj	Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Daniel R. Wynn, MD	Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mylan. Dr. Wynn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Wynn has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Wynn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Banner Life. Dr. Wynn has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Biogen. The institution of Dr. Wynn has received research support from Novartis. The institution of Dr. Wynn has received research support from Sanofi. The institution of Dr. Wynn has received research support from Adamas Pharmaceutics. The institution of Dr. Wynn has received research support from EMD Serono. The institution of Dr. Wynn has received research support from Roche. Dr. Wynn has a non-compensated relationship as a Director, Consultants in Neurology Comprehensive Care Center with National MS Society that is relevant to AAN interests or activities.
Koby Mok, PhD	Dr. Mok has received personal compensation for serving as an employee of TG Therapeutics. Dr. Mok has received stock or an ownership interest from TG Therapeutics.
Yanzhi Hsu, PhD	Dr. Hsu has received personal compensation for serving as an employee of TG Therapeutics Inc. Dr. Hsu has stock in TG Therapeutics Inc.
Yihuan Xu	Yihuan Xu has received personal compensation for serving as an employee of TG Therapeutics.
Chris Rowland	Chris Rowland has received personal compensation for serving as an employee of TG Therapeutics. Chris Rowland has stock in TG Therapeutics.
Lawrence Steinman, MD, FAAN	Dr. Steinman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for 180 Life Sciences. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for BioAtla. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Pasithea. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Atreca. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Wilmer Hale Cutler Pickering. Dr. Steinman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Steinman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Steinman has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for National Academy of Sciences. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Gibson Dunn. The institution of Dr. Steinman has received research support from Roche. The institution of Dr. Steinman has received research support from Novartis. Dr. Steinman has received intellectual property interests from a discovery or technology relating to health care.
Angela A. Hong, MD	Dr. Hong has nothing to disclose.
Mariya Husain, MD	Dr. Husain has nothing to disclose.
Neha M. Kramer, MD	Dr. Kramer has nothing to disclose.
Deepa H. Shankar	Miss Shankar has nothing to disclose.
Sarah Kee	Ms. Kee has nothing to disclose.
Kristin h. Gustashaw, Clinical Dietitian	An immediate family member of Ms. Gustashaw has received personal compensation for serving as an employee of Hormel Health Labs.
Sarah M. Chen, LCSW	Ms. Chen has nothing to disclose.
Grace Hong, RN	Ms. Hong has nothing to disclose.
Bichun Ouyang	Bichum Ouyang has nothing to disclose.
Sakshi Kumari, MBBS	Ms. Kumari has nothing to disclose.
Michael S. Kung, MD	Dr. Kung has nothing to disclose.
Janetta L. Arellano, MD	Dr. Arellano has nothing to disclose.
Darin T. Okuda, MD, FAAN	Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cortechs AI. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Okuda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Bioscience. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Okuda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Zenas BioPharma. The institution of Dr. Okuda has received research support from Novartis. The institution of Dr. Okuda has received research support from Alexion. Dr. Okuda has received intellectual property interests from a discovery or technology relating to health care.
Katy Burgess, PA	Mrs. Burgess has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Mrs. Burgess has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb.
Mahi Patel	Ms. Patel has nothing to disclose.
Morgan McCreary	Morgan McCreary has nothing to disclose.
Tom Punnen	Mr. Punnen has nothing to disclose.
Tatum Moog	Miss Moog has nothing to disclose.
Aksel Siva, MD	Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ali Raif Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanovel Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abdi Ibrahim Ilac - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono . The institution of Dr. Siva has received research support from Turkish MS Society. The institution of Dr. Siva has received research support from The Scientific and Technological Research Council Of Turkey - Health Sciences Research Grants.
Christine Lebrun Frenay, MD, FAAN	Dr. Lebrun Frenay has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Revue Neurologique. The institution of Dr. Lebrun Frenay has received research support from FRANCE SEP.
Jeannette Stankowski, PhD	Dr. Stankowski has nothing to disclose.
Peter Sguigna, MD	Dr. Sguigna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Sguigna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Sguigna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. The institution of Dr. Sguigna has received research support from Genentech. The institution of Dr. Sguigna has received research support from Clene Nanomedicine. The institution of Dr. Sguigna has received research support from The International Progressive Multiple Sclerosis Alliance through the National Multiple Sclerosis Society. The institution of Dr. Sguigna has received research support from PCORI. The institution of Dr. Sguigna has received research support from DOD/CDMRP. The institution of Dr. Sguigna has received research support from Alexion. Dr. Sguigna has received intellectual property interests from a discovery or technology relating to health care.
Fang F, MD	Dr. F has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AJNR. The institution of Dr. F has received research support from Texas Alzheimer's Research and Care Consortium.
Marco Pinho	Marco Pinho has nothing to disclose.
Syed A. Hussain, MBBS	Dr. Hussain has nothing to disclose.
Sean T. Beattie, DO	Dr. Beattie has nothing to disclose.
Husitha Reddy Vanguru, MBBS	Dr. Vanguru has nothing to disclose.
JoBeth D. Bingham, DO	Dr. Bingham has nothing to disclose.
Peter P. Pacut, MD	Dr. Pacut has nothing to disclose.
Kelly G. Gwathmey, MD	Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strongbridge. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Gwathmey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals.
Qihua Fan, MD	Dr. Fan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Fan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnylam.
Lynn Eickholt	Ms. Eickholt has nothing to disclose.
Nabila Dahodwala, MD, FAAN	Dr. Dahodwala has received personal compensation in the range of $0-$499 for serving as a Consultant for Genetech. Dr. Dahodwala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mediflix. Dr. Dahodwala has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Dahodwala has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Post and Schell. Dr. Dahodwala has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for O'Brien & Ryan, LLP. Dr. Dahodwala has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for MotleyRice. The institution of Dr. Dahodwala has received research support from AbbVie. The institution of Dr. Dahodwala has received research support from Medtronic.
Whitley W. Aamodt, MD	Dr. Aamodt has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology.
Zexin Guo, MBBS	Mr. Guo has nothing to disclose.
Manisha Ramprasad	Ms. Ramprasad has nothing to disclose.
Hesham A. Abboud, MD	Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech . Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpine Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cycle Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axonics. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Abboud has received research support from Genentech . The institution of Dr. Abboud has received research support from Novartis. The institution of Dr. Abboud has received research support from BMS. The institution of Dr. Abboud has received research support from Sanofi-Genzyme. The institution of Dr. Abboud has received research support from The Guthy-Jackson Charitable Foundation. The institution of Dr. Abboud has received research support from UCB. Dr. Abboud has received publishing royalties from a publication relating to health care.
Alessandro Serra, MD	Dr. Serra has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Serra has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb.
Han Wang, MD	Dr. Wang has nothing to disclose.
Zain Y. Khan, MBBS	Dr. Khan has nothing to disclose.
Soroush Kakawand, MD	Dr. Kakawand has nothing to disclose.
Laura Thomas, DO	Dr. Thomas has nothing to disclose.
Jenny Huynh	Ms. Huynh has nothing to disclose.
Anderson Brito-Alvarado, MD	Dr. Brito-Alvarado has nothing to disclose.
Milagros Galecio-Castillo, MD	Dr. Galecio-Castillo has nothing to disclose.
Leonardo Cruz, MD	Dr. Cruz has nothing to disclose.
Piyush Kalakoti, MBBS	Dr. Kalakoti has nothing to disclose.
Serdar Geyik	No disclosure on file
Randall G. Krug II, MD, PhD	Dr. Krug has nothing to disclose.
Santiago Ortega Gutierrez, MD	Dr. Ortega Gutierrez has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for stryker. Dr. Ortega Gutierrez has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for medtronic. Dr. Ortega Gutierrez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. The institution of Dr. Ortega Gutierrez has received research support from stryker. The institution of Dr. Ortega Gutierrez has received research support from Medtronic. The institution of Dr. Ortega Gutierrez has received research support from Methinks. The institution of Dr. Ortega Gutierrez has received research support from NIH. The institution of Dr. Ortega Gutierrez has received research support from PCORI.
Arsida Bajrami, MD	Dr. Bajrami has nothing to disclose.
Zhimin Xu, MD, PhD	Dr. Xu has nothing to disclose.
Nishitha Bujala, MBBS	Dr. Bujala has nothing to disclose.
Andy Jiang, BS	Mr. Jiang has nothing to disclose.
Ariel Sacknovitz, Medical Student	Mr. Sacknovitz has nothing to disclose.
Carolin Dohle, MD	Dr. Dohle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion TPharmaceuticals. Dr. Dohle has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics.
Katherine D. Amodeo, MD	The institution of Dr. Amodeo has received research support from Roche. The institution of Dr. Amodeo has received research support from EIP Pharma. The institution of Dr. Amodeo has received research support from Acadia. The institution of Dr. Amodeo has received research support from MJFF. The institution of Dr. Amodeo has received research support from NINDS.
Colleen Bond, PharmD	Mrs. Bond has nothing to disclose.
Maha B. AbuZarifa, MD	Dr. AbuZarifa has nothing to disclose.
khaled A. Zakout, MD	Dr. Zakout has nothing to disclose.
Younis Gaza, MD, MBBS	Dr. Gaza has nothing to disclose.
Siham Alshawamreh, MD	Dr. Alshawamreh has nothing to disclose.
Tayef T. Aldirawi, MBBS	Miss Aldirawi has nothing to disclose.
Abdalmalik Bin Khunayfir, MD	Dr. Bin Khunayfir has nothing to disclose.
David C. Preston, MD, FAAN	Dr. Preston has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for FBI, US Attorney, Insurance Fraud Investigative Units. Dr. Preston has received publishing royalties from a publication relating to health care.
Natasha Maranhao Vieira Rodrigues	Miss Maranhao Vieira Rodrigues has nothing to disclose.
Frederico M. de Sousa Marinho Mendes Filho	Mr. de Sousa Marinho Mendes Filho has nothing to disclose.
Emanuelly L. Barbosa	Ms. Barbosa has nothing to disclose.
Julia F. Cauduro	Mrs. Cauduro has nothing to disclose.
Eva R. Maia, Medical student	Mrs. Maia has nothing to disclose.
Pablo V. Feitoza, MD, PhD	Prof. Feitoza has nothing to disclose.
Chongbo Zhao	Chongbo Zhao has nothing to disclose.
Sanjay N. Rakhade, MBBS, PhD	Dr. Rakhade has received personal compensation for serving as an employee of Alexion Pharmaceuticals . Dr. Rakhade has stock in Alexion Pharmaceuticals. Dr. Rakhade has stock in Astra Zeneca. Dr. Rakhade has received intellectual property interests from a discovery or technology relating to health care.
Joachim Scholz, MD	Dr. Scholz has received personal compensation for serving as an employee of Alexion AstraZeneca Rare Disease. Dr. Scholz has stock in Alexion AstraZeneca Rare Disease. Dr. Scholz has stock in Biogen. Dr. Scholz has received intellectual property interests from a discovery or technology relating to health care.
Alexandra Pelaez, MD	Dr. Pelaez has received intellectual property interests from a discovery or technology relating to health care.
Annie Racine, PhD	Annie Racine has received personal compensation for serving as an employee of Biogen. Annie Racine has received stock or an ownership interest from Biogen.
Alanna McEneny	Alanna McEneny has received personal compensation for serving as an employee of Alexion, AstraZeneca Rare Disease. Alanna McEneny has stock in AstraZeneca.
Shulian Shang, PhD	Dr. Shang has received personal compensation for serving as an employee of Alexion, AstraZeneca Rare Disease. Dr. Shang has stock in Alexion, AstraZeneca Rare Disease.
Tuan H. Vu, MD	Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Dianthus. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen (Horizon). Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Vu has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Alexion. The institution of Dr. Vu has received research support from RA Pharma/UCB. The institution of Dr. Vu has received research support from Mass Gen Hospital/Healy Platform Study. The institution of Dr. Vu has received research support from ARGENX. The institution of Dr. Vu has received research support from Horizon/Amgen. The institution of Dr. Vu has received research support from Woolsey Pharma. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Cartesian Therapeutics. The institution of Dr. Vu has received research support from Janssen/Johnson & Johnson. The institution of Dr. Vu has received research support from Immunovant. The institution of Dr. Vu has received research support from Regeneron. The institution of Dr. Vu has received research support from Dianthus. The institution of Dr. Vu has received research support from COUR.
Katherine Longardner, MD	Dr. Longardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Longardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. An immediate family member of Dr. Longardner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boston Scientific. An immediate family member of Dr. Longardner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Trisalus. An immediate family member of Dr. Longardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZenica. An immediate family member of Dr. Longardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sirtex. An immediate family member of Dr. Longardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Society of Interventional Oncology. An immediate family member of Dr. Longardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for France Foundation. An immediate family member of Dr. Longardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Varian. Dr. Longardner has received research support from NIH.
Catherine W. Liu, PharmD	Dr. Liu has received personal compensation in the range of $10,000-$49,999 for serving as a Fellow with UCSD.
Jeremiah Momper	No disclosure on file
Kuldeep Mahato	Kuldeep Mahato has nothing to disclose.
Hamidreza Ghodsi, MD	Dr. Ghodsi has nothing to disclose.
Joseph Wang	Joseph Wang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for VitalTrace.
Chochanon Moonla	Chochanon Moonla has nothing to disclose.
Han Lee, MD	Dr. Lee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Revance. The institution of Dr. Lee has received research support from Boston Scientific. The institution of Dr. Lee has received research support from Rune Labs.
Carlo Antozzi, MD	Dr. antozzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. antozzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for janssen. Dr. antozzi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argenx. Dr. antozzi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson Johnson.
Sindhu Ramchandren	No disclosure on file
Constantine Farmakidis, MD, FAAN	Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for J&J. Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Muscular Dystrophy Association.
Vera Bril, MD	Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Powell Mansfield. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta (now J&J). Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Bril has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Bril has received research support from UCB. The institution of Dr. Bril has received research support from Argenx. The institution of Dr. Bril has received research support from Momenta (now J&J). The institution of Dr. Bril has received research support from Immunovant. The institution of Dr. Bril has received research support from Alexion. The institution of Dr. Bril has received research support from Takeda. The institution of Dr. Bril has received research support from Grifols. The institution of Dr. Bril has received research support from CSL. The institution of Dr. Bril has received research support from Octapharma. The institution of Dr. Bril has received research support from Akcea. The institution of Dr. Bril has received research support from Ionis. The institution of Dr. Bril has received research support from Viela Bio (now Horizon). Dr. Bril has received intellectual property interests from a discovery or technology relating to health care.
Jan L. De Bleecker, MD, PhD, FAAN	Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgNX. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. De Bleecker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen pharmaceuticals. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro.
Huan Yang	No disclosure on file
Eduard Minks	Eduard Minks has nothing to disclose.
Jin-Sung Park, MD, PhD	Prof. Park has nothing to disclose.
Mariusz P. Grudniak, MD, PhD	Dr. Grudniak has nothing to disclose.
Marek Smilowski	Marek Smilowski has nothing to disclose.
Teresa Sevilla	Teresa Sevilla has nothing to disclose.
Sarah Hoffmann, MD, PhD	Prof. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Prof. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Prof. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Hoffmann has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Prof. Hoffmann has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Prof. Hoffmann has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Prof. Hoffmann has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Grifols. The institution of Prof. Hoffmann has received research support from Janssen. The institution of Prof. Hoffmann has received research support from Argenx.
Kumaraswamy Sivakumar, MD, MRCP	Dr. Sivakumar has nothing to disclose.
Eriene Wasef, PharmD	Dr. Wasef has received personal compensation for serving as an employee of Johnson &Johnson. Dr. Wasef has stock in Johnson & Johnson.
Panna Sanga, MBBS	Dr. Sanga has received personal compensation for serving as an employee of Johnson & Johnson . Dr. Sanga has stock in Johnson & Johnson .
Keith Karcher, MS	Mr. Karcher has received personal compensation for serving as an employee of Janssen Research and Develop,ent. Mr. Karcher has stock in Johnson & Johnson.
Yaowei Zhu, PhD	Dr. Zhu has received personal compensation for serving as an employee of Johnson & Johnson.
John Sheehan, PhD	Dr. Sheehan has received personal compensation for serving as an employee of Johnson and Johnson. An immediate family member of Dr. Sheehan has received personal compensation for serving as an employee of PMVParma. Dr. Sheehan has stock in Johnson and Johnson. An immediate family member of Dr. Sheehan has stock in PMVPharma.
Hong Sun, MD, PhD	Dr. Sun has received personal compensation for serving as an employee of Janssen.
Richard J. Nowak, MD	Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Nowak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio . Dr. Nowak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cour Pharma. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janseen . The institution of Dr. Nowak has received research support from UCB. The institution of Dr. Nowak has received research support from Alexion . The institution of Dr. Nowak has received research support from Janseen. The institution of Dr. Nowak has received research support from Immunovant . The institution of Dr. Nowak has received research support from argenx. The institution of Dr. Nowak has received research support from Amgen. Dr. Nowak has a non-compensated relationship as a Member of the Board of Directors with Myasthenia Gravis Foundation of America (MGFA) that is relevant to AAN interests or activities.
Kenzo Sakurai, MD	Dr. Sakurai has nothing to disclose.
Akiyuki Uzawa, MD, PhD	Dr. Uzawa has nothing to disclose.
Massanori Takahashi, MD, PhD	Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne Therapeutics. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Japan Clinical Research Operations. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nippon Shinyaku. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Pharmaceutical. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argenx. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Japan. Dr. Takahashi has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Myotonic Dystrophy Patients' Group of Japan. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson & Johnson.
Suzuki Shigeaki, MD, PhD	Dr. Shigeaki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. The institution of Dr. Shigeaki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Shigeaki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alexion. Dr. Shigeaki has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argenx. Dr. Shigeaki has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Shigeaki has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for alexion.
Masaki Okuda, Master of Pharmacy	Mr. Okuda has received personal compensation for serving as an employee of Alexion Pharma GK. Mr. Okuda has stock in Alexion Pharmaceuticals.
Benjamin Yungher, PhD	Dr. Yungher has received personal compensation for serving as an employee of Alexion AstraZeneca Rare Disease.
Takanori Yamamoto	Mr. Yamamoto has received personal compensation for serving as an employee of Alexion Pharma Japan.
Kimiaki Utsugisawa, MD, PhD	Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Utsugisawa has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB pharma. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen pharma. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela Bio. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubisi Tanabe pharma. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Utsugisawa has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for argenx. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion phama. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Japan Blood Products Organization. Dr. Utsugisawa has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB.
Hiroyuki Murai, MD	Dr. Murai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Murai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Murai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Murai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chugai Pharmaceutical. Dr. Murai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Murai has received research support from Japan Blood Products Organization.
Stuart H. Isaacson, MD, FAAN	The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for acorda. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for adamas. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neuroderm. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for amneal. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for adamas. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acadia. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie.
Mindy Grall, PhD, NP	Ms. Grall has received personal compensation for serving as an employee of Supernus Pharmaceuticals. Ms. Grall has or had stock in Supernus.
Fiona Gupta, MD	Dr. Gupta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for supernus. Dr. Gupta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for neurocrine. Dr. Gupta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amneal. Dr. Gupta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for abbott. Dr. Gupta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for acadia. Dr. Gupta has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for supernus. Dr. Gupta has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for neurocrine.
Daniel Kremens, MD, JD, FAAN	Dr. Kremens has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. Dr. Kremens has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Neurocrine. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Dr. Kremens has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Teva. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merz. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Kremens has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cerevel. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for UCB.
Cuong Nguyen, MD	Dr. Nguyen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus Pharmaceuticals.
Rajesh Pahwa, MD, FAAN	Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ACADIA. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Insightec. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jaaz. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fasikl. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Photopharmics. The institution of Dr. Pahwa has received research support from Abbott. The institution of Dr. Pahwa has received research support from Abbvie. The institution of Dr. Pahwa has received research support from Biogen. The institution of Dr. Pahwa has received research support from Parkinson Foundation. The institution of Dr. Pahwa has received research support from Roche. The institution of Dr. Pahwa has received research support from Sage. The institution of Dr. Pahwa has received research support from Sun Pharma. The institution of Dr. Pahwa has received research support from Theravance. The institution of Dr. Pahwa has received research support from Neuroderm. The institution of Dr. Pahwa has received research support from Ask Bio. The institution of Dr. Pahwa has received research support from Blue Rock. The institution of Dr. Pahwa has received research support from Cerevance. The institution of Dr. Pahwa has received research support from Fasikl. The institution of Dr. Pahwa has received research support from Scion. The institution of Dr. Pahwa has received research support from UCB. The institution of Dr. Pahwa has received research support from Ono. The institution of Dr. Pahwa has received research support from Intra-cellular Therapies. The institution of Dr. Pahwa has received research support from Ask Bio. The institution of Dr. Pahwa has received research support from Michael J Fox Foundation . The institution of Dr. Pahwa has received research support from Neuron 23. The institution of Dr. Pahwa has received research support from Roche.
Marc Serota	No disclosure on file
Matthew Zirwas	No disclosure on file
Doruk Arslan, MD	Dr. Arslan has nothing to disclose.
utku horzum, PhD	Dr. horzum has nothing to disclose.
Zeynep Ergül Ülger	Zeynep Ergül Ülger has nothing to disclose.
Hamdullah YANIK, PhD	Mr. YANIK has nothing to disclose.
Sakine Ulusoy, MSc	Ms. Ulusoy has nothing to disclose.
Süleyman C. Öztürk, PhD	Dr. Öztürk has nothing to disclose.
Sevim Erdem Ozdamar, MD	Dr. Erdem Ozdamar has nothing to disclose.
Gunes Esendagli	Gunes Esendagli has nothing to disclose.
Ersin Tan, MD	Dr. Tan has nothing to disclose.
Can Ebru Kurt, MD	Can Ebru Kurt, MD has nothing to disclose.
Mustafa Yilmaz	Prof. Yilmaz has nothing to disclose.
Neepa J. Patel, MD, FAAN	Dr. Patel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie Pharmaceuticals. Dr. Patel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernius Pharmaceuticals. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific.
Ramsey A. Falconer, MD, FAAN	Dr. Falconer has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Abbott. Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Falconer has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Amneal. Dr. Falconer has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for GE Health. Dr. Falconer has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Acorda. Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin. Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. Dr. Falconer has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Federal Trade Comission (FTC). Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Justice Department.
Simon Allard, PhD	Dr. Allard has received personal compensation for serving as an employee of Amneal.
Ghazal Banisadr, PhD	Dr. Banisadr has received personal compensation for serving as an employee of Amneal Pharmaceuticals.
Stanley Fisher, MD, FAAN	Dr. Fisher has received personal compensation for serving as an employee of Amneal Pharmaceuticals.
Victor D. Armengol, MD	Dr. Armengol has nothing to disclose.
Danielle S. Shpiner, MD	An immediate family member of Dr. Shpiner has received personal compensation for serving as an employee of University of Miami. Dr. Shpiner has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Mission MSA. The institution of Dr. Shpiner has received research support from American Parkinson's Disease Association. The institution of Dr. Shpiner has received research support from CurePSP. The institution of Dr. Shpiner has received research support from Parkinson's Foundation. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Parkinson's Foundation that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Medtronic that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Boston Scientific that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbott that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbvie that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Ipsen that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Amneal that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Michael J. Fox Foundation that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a CoC Medical Director with CurePSP that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Mission MSA that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Merz that is relevant to AAN interests or activities.
Kristin Wallock, OTD	Mrs. Wallock has nothing to disclose.
Farren Briggs, PhD	The institution of Prof. Briggs has received research support from NIH.
Mary C. Murray, MPH	Mrs. Murray has received personal compensation for serving as an employee of Parkinson's Foundation.
Judith Thompson, PhD	Dr. Thompson has received personal compensation for serving as an employee of UCB, Inc. Dr. Thompson has or had stock in UCB, Inc.
Victoria Mroczek	Mrs. Mroczek has received personal compensation for serving as an employee of Real Chemistry.
Arthi Padmanabhan	Ms. Padmanabhan has received personal compensation for serving as an employee of Real Chemistry. An immediate family member of Ms. Padmanabhan has received personal compensation for serving as an employee of Think Biosciences. An immediate family member of Ms. Padmanabhan has stock in Hoplark HopTea.
Jee Young Lee, MD	Dr. Lee has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Parkinsonism & Related Disorders. The institution of Dr. Lee has received research support from National Research Foundation funded by Ministry of Science and ICT, South Korea. The institution of Dr. Lee has received research support from SMG-SNU Boramae Medical Center multidisciplinary research grant-in-aid.
HYEO-IL MA, MD, PhD	Prof. MA has nothing to disclose.
Daniela Rodrigues, MSc, PharmD	Dr. Rodrigues has received personal compensation for serving as an employee of Bial - Portela & Ca, SA.
Miguel M. Fonseca, PhD	Mr. Fonseca has received personal compensation for serving as an employee of Bial.
Francisco Rocha	Francisco Rocha has received personal compensation for serving as an employee of BIAL - Portela.
Guillermo Castilla-Fernandez, MD	Mr. Castilla-Fernandez has nothing to disclose.
Joerg Holenz, PhD	Mr. Holenz has received personal compensation for serving as an employee of BIAL. Mr. Holenz has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for BIAL RD Investments. Mr. Holenz has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for BIAl Portela SA. Mr. Holenz has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for BIAL Biotech . Mr. Holenz has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. Mr. Holenz has stock in Astra Zeneca. Mr. Holenz has received intellectual property interests from a discovery or technology relating to health care.
Beomseok Jeon, MD	Dr. Jeon has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Jeon has received research support from peptron. The institution of Dr. Jeon has received research support from zemvax & kael. Dr. Jeon has received personal compensation in the range of $500-$4,999 for serving as a expert panel with Aspen Neuroscience.
Werner Poewe, MD	Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Affiris . Werner Poewe, MD has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alterity, AbbVie, BIAL, Biogen, Britannia, Lilly, Lundbeck, Neuroderm, Neurocrine, Denali Pharmaceuticals, ,Roche, Takeda, UCB and Zambon . Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie, Britannia, BIAL, STADA, Lundbeck, Zambon. The institution of Werner Poewe, MD has received research support from MJFF; EU Horizon programme. Werner Poewe, MD has a non-compensated relationship as a Committee member with Movement Disorder Society that is relevant to AAN interests or activities.
Angelo Antonini, MD	Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIAL. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBVIE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Antonini has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for THERAVANCE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ABBVIE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ZAMBON. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BOEHRINGER.
Fabrizio Stocchi	Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bial, Biogen, Sunovion, Lundbeck, UCB, Zambon, Chiesi, Lusofarmaco, Abbvie, Neuroderm, Kyowa, Synegile, Roche, Britannia, Sunovion, Blue Rock. Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIAL, Zambon, Biogen, Roche, Synegile, Sunovion. Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bial, Zambon, UCB, Kyowa, Sunovion.
Olivier Rascol, MD, PhD	Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie, Acorda, Aguettant, Alkahest, AlzProtect, Apopharma, Astrazeneca, Axovant, Bial, Biogen, Britannia, Buckwang, Centogene, Cerevel, Clevexel, Contera, GE Healthcare, Handltherapeutic, Ionis, Irlab, Jazz, Kyowa, LGD Nuvamid, Lundbeck, Merck, Merz, MundiPharma, Neuralight, Neuratris, Neuroderm, Novartis, ONO Pharma, Orion Pharma, Osmotica, Oxford Biomedica, Parexel, PD Neurotechnology, Pfizer, Polycaps, Prexton, Roche Therapeutics, Sanofi, Scienture, Servier,Sombiotech, Sunovion, Supernus, Synagile, Thelonius Mind, Takeda, Théranexus, Teva, Tools4patient, UCB, Vision 2 voice, XenoPort, XO, Zambon . Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie, Acorda, Aguettant, Alkahest, AlzProtect, Apopharma, Astrazeneca, Axovant, Bial, Biogen, Britannia, Buckwang, Centogene, Cerevel, Clevexel, Contera, GE Healthcare, Handltherapeutic, Ionis, Irlab, Jazz, Kyowa, LGD Nuvamid, Lundbeck, Merck, Merz, MundiPharma, Neuralight, Neuratris, Neuroderm, Novartis, ONO Pharma, Orion Pharma, Osmotica, Oxford Biomedica, Parexel, PD Neurotechnology, Pfizer, Polycaps, Prexton, Roche Therapeutics, Sanofi, Scienture, Servier,Sombiotech, Sunovion, Supernus, Synagile, Thelonius Mind, Takeda, Théranexus, Teva, Tools4patient, UCB, Vision 2 voice, XenoPort, XO, Zambon . Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIAL. Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MEDIZIN ACADEMY. The institution of Dr. Rascol has received research support from Agence Nationale de la Recherche (ANR), CHU de Toulouse, France-Parkinson, INSERM-DHOS Recherche Clinique Translationnelle, MJFox Foundation, Programme Hospitalier de Recherche Clinique, European Commission (FP7, H2020).
Joaquim Ferreira	No disclosure on file
Yun Wang, MD	Mr. Wang has nothing to disclose.
Paloma Lapuente, MD	Mrs. Lapuente has received personal compensation for serving as an employee of BIAL .
Helena Brigas, PhD	Dr. Brigas has received personal compensation for serving as an employee of BIAL.
Srikanth Muppidi, MD, FAAN	Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for argenx. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/Ra Pharma. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizont Pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for J & J pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus Pharma. Dr. Muppidi has received publishing royalties from a publication relating to health care.
Stephen Reddel, MBBS, PhD, FRACP	Dr. Reddel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Reddel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for argenx. Dr. Reddel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for novartis.
John Vissing, MD	Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne Therapeutics. Prof. Vissing has received personal compensation in the range of $0-$499 for serving as a Consultant for Denali Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Italfarmaco. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NMD Pharma. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. Prof. Vissing has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sarepta. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson & Johnson (Janssen). Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Edgewise Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. The institution of Prof. Vissing has received research support from Rigshospitalet. The institution of Prof. Vissing has received research support from Avidity. The institution of Prof. Vissing has received research support from Sanofi. The institution of Prof. Vissing has received research support from Roche. The institution of Prof. Vissing has received research support from AnnJi.
Weihua Cao, PhD	Dr. Cao has nothing to disclose.
Bernd C. Kieseier, MD	Dr. Kieseier has received personal compensation for serving as an employee of Novartis. Dr. Kieseier has stock in Novartis.
Svetlana Jevtic, DVM, MSc	Dr. Jevtic has nothing to disclose.
Arseniy Lavrov	Dr. Lavrov has received personal compensation for serving as an employee of Novartis. Dr. Lavrov has stock in Novartis.
Ali A. Habib, MD	Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for argenx. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NMD Pharma. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon/ Amgen. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyverna. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jansen/Johnson & Johnson. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMDSerono/Merck. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH/NINDS. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunis Biomedical. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman-La Roche. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jansen/Joohnson & Johnson. The institution of Dr. Habib has received research support from Alexion. The institution of Dr. Habib has received research support from Horizon/Amgen. The institution of Dr. Habib has received research support from Immunovant. The institution of Dr. Habib has received research support from UCB. The institution of Dr. Habib has received research support from argenx. The institution of Dr. Habib has received research support from CabalettaBio. The institution of Dr. Habib has received research support from Regeneron. The institution of Dr. Habib has received research support from Arcellx. The institution of Dr. Habib has received research support from Novartis. The institution of Dr. Habib has received research support from EMDSerono/Merck. The institution of Dr. Habib has received research support from Cour Pharmaceuticals.
Christopher A. Scheiner, MD, PhD	Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Scheiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals . Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring . Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx Pharmaceuticals. Dr. Scheiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jansssen. Dr. Scheiner has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for CSL Behring . Dr. Scheiner has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals . Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. The institution of Dr. Scheiner has received research support from Alexion Pharmaceuticals .
Lida Zeinali, MD	Dr. Zeinali has received personal compensation for serving as an employee of Alexion Pharmaceuticals, AstraZeneca Rare Disease. Dr. Zeinali has stock in AstraZeneca.
Michael T. Pulley, MD, PhD, FAAN	Dr. Pulley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amylyx. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for csl/behring. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta. Dr. Pulley has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Multiple law firms.
Chuang Liu, PhD	Dr. Liu has received personal compensation for serving as an employee of Alexion.
Andrew J. Gordon, MD	Dr. Gordon has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Catalyst. Dr. Gordon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Gordon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion . Dr. Gordon has received personal compensation in the range of $0-$499 for serving as a Consultant for Vertex. Dr. Gordon has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Gordon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Gordon has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Gordon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Cassiday.
Ashley Yegin	Ashley Yegin has received personal compensation for serving as an employee of Alexion Pharmaceuticals. Ashley Yegin has stock in Alexion Pharmaceuticals.
Pushpa Narayanaswami, MD, MBBS, FAAN	Dr. Narayanaswami has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for UCB. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Narayanaswami has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx USA. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Narayanaswami has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Narayanaswami has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NMD pharma. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD-Serono (Merck usa). Dr. Narayanaswami has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Immuneabs. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viridian. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta-Bio. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Narayanaswami has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vor Bio. Dr. Narayanaswami has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Muscle and Nerve, Wiley. Dr. Narayanaswami has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Narayanaswami has or had stock in Dr. Reddys laboratories.Dr. Narayanaswami has or had stock in Doximity. The institution of Dr. Narayanaswami has received research support from Alexion. The institution of Dr. Narayanaswami has received research support from NIH. The institution of Dr. Narayanaswami has received research support from Argenx. The institution of Dr. Narayanaswami has received research support from Cabaletta Bio. Dr. Narayanaswami has received publishing royalties from a publication relating to health care. Dr. Narayanaswami has a non-compensated relationship as a Member, Finance Committee with AANEM that is relevant to AAN interests or activities.
Zhao Wang	Dr. Wang has received personal compensation for serving as an employee of Supernus Pharmaceuticals Inc. Dr. Wang has stock in Supernus Pharmaceuticals Inc.
Roberto Gomeni	Roberto Gomeni has nothing to disclose.
Robert A. Hauser, MD, MBA, FAAN	Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoparkinson. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Abbvie. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Intrance. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NanoPharmasolutions. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll BioPharma. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cerevance. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clario. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sumitomo. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Taurus Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sorriddi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Contera. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alterity Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Convatec Inc. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Knight Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biorasi. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medicure Pharma. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BlueRock. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. The institution of Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoparkinson. The institution of Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Photopharmics. The institution of Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal . Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Supernus. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Hauser has or had stock in Inhibikase.Dr. Hauser has or had stock in Axial Therapeutics.Dr. Hauser has or had stock in Enterin.Dr. Hauser has or had stock in Photopharmics. The institution of Dr. Hauser has received research support from Annovis Bio, Inc.. The institution of Dr. Hauser has received research support from Inhibikase Therapeutics. The institution of Dr. Hauser has received research support from AbbVie, Inc.. The institution of Dr. Hauser has received research support from Biogen MA. The institution of Dr. Hauser has received research support from Cavion, Inc.. The institution of Dr. Hauser has received research support from Cerevance Beta, Inc.. The institution of Dr. Hauser has received research support from Cerevel Therapeutics. The institution of Dr. Hauser has received research support from Enterin, Inc.. The institution of Dr. Hauser has received research support from Genentech. The institution of Dr. Hauser has received research support from Global Kinetics Corporation. The institution of Dr. Hauser has received research support from Hoffman-La Roche Inc. The institution of Dr. Hauser has received research support from Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Hauser has received research support from National Parkinson's Foundation. The institution of Dr. Hauser has received research support from Neuroderm. The institution of Dr. Hauser has received research support from Sage Therapeutics. The institution of Dr. Hauser has received research support from Scion NeuroStim. The institution of Dr. Hauser has received research support from UCB BioPharma. The institution of Dr. Hauser has received research support from UCB. The institution of Dr. Hauser has received research support from Amneal Pharmaceuticals. The institution of Dr. Hauser has received research support from Motric Bio, Inc.. The institution of Dr. Hauser has received research support from Sun Pharma Advanced Research Company. The institution of Dr. Hauser has received research support from Teva Branded Pharmaceuticals. The institution of Dr. Hauser has received research support from Truebinding, Inc.. The institution of Dr. Hauser has received research support from Jazz Pharmaceuticals. The institution of Dr. Hauser has received research support from Ipsen. Dr. Hauser has received intellectual property interests from a discovery or technology relating to health care.
Andrea Formella, PharmD, BCPP	Dr. Formella has received personal compensation for serving as an employee of Supernus Pharmaceuticals, Inc. Dr. Formella has stock in Supernus Pharmaceuticals, Inc..
Himanshu Upadhyaya	Dr. Upadhyaya has received personal compensation for serving as an employee of Supernus Pharmaceuticals. Dr. Upadhyaya has received personal compensation for serving as an employee of Eli Lilly & Co.. Dr. Upadhyaya has stock in Supernus Pharmaceuticals. Dr. Upadhyaya has stock in Eli Lilly & Co.
Jonathan Rubin, MD	Dr. Rubin has received personal compensation for serving as an employee of Supernus Pharmaceuticals. Dr. Rubin has stock in Supernus Pharmaceuticals. Dr. Rubin has stock in Atentiv. Dr. Rubin has received intellectual property interests from a discovery or technology relating to health care.
Qian Cai	Qian Cai has received personal compensation for serving as an employee of Johnson & Johnson. Qian Cai has stock in Johnson & Johnson.
Kavita Gandhi, MS, BSPharm	Ms. Gandhi has received personal compensation for serving as an employee of Johnson and Johnson . Ms. Gandhi has stock in Johnson and Johnson .
Nurgul Batyrbekova	Mrs. Batyrbekova has nothing to disclose.
Gabriel L. Isheden, PhD	Dr. Isheden has received personal compensation for serving as an employee of Intelligent Decision Analytics AB. The institution of Dr. Isheden has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cytel. Dr. Isheden has stock in Camurus. Dr. Isheden has stock in Calliditas Therapeutics. Dr. Isheden has stock in Oncozenge.
Maria Ait Tihyaty	Dr. Ait Tihyaty has received personal compensation for serving as an employee of Dianthus Therapeutics.
Winghan J. Kwong, PhD	Dr. Kwong has received personal compensation for serving as an employee of Johnson & Johnson. Dr. Kwong has stock in Johnson & Johnson.
John M. Acquaviva	Mr. Acquaviva has nothing to disclose.
Jessica Terrizzi, PhD	Dr. Terrizzi has nothing to disclose.
Yaqian Xu, MD, MPH	Dr. Xu has nothing to disclose.
Zachary Lodato, DO	Dr. Lodato has nothing to disclose.
Elizabeth H. de Farias II, medical academic	Mrs. de Farias has nothing to disclose.
Leonardo J. Cardoso, MS	Mr. Cardoso has nothing to disclose.
Altair P. de Melo Neto, Student	Mr. de Melo Neto has nothing to disclose.
Raphael Besborodco, MD	Dr. Besborodco has nothing to disclose.
Murilo L. Geremias, Sr., Medical Student	Mr. Geremias has nothing to disclose.
Yangyu Huang, MD	Dr. Huang has nothing to disclose.
Ying Tan, MD	Dr. Tan has nothing to disclose.
Jingwen Yan, MD	Dr. Yan has nothing to disclose.
Jiayu Shi, MD	Dr. Shi has nothing to disclose.
Yuzhou Guan, MD	Prof. Guan has nothing to disclose.
Ahmed Farid, MD	Dr. Farid has nothing to disclose.
Ayah Abdulgadir	Dr. Abdulgadir has nothing to disclose.
Yaser Hamam, MD	Mr. Hamam has nothing to disclose.
Sara A. Nasr, MD	Dr. Nasr has nothing to disclose.
Divya Menghani, MBBS	Dr. Menghani has nothing to disclose.
Lauren N. Williams	Miss Williams has nothing to disclose.
Nakul Katyal, MD	Dr. Katyal has nothing to disclose.
Morten Blaabjerg, MD	Dr. Blaabjerg has nothing to disclose.
Tsao-Wei Liang, MD	The institution of Dr. Liang has received research support from Bial R&D Investments S.A.. The institution of Dr. Liang has received research support from Parkinson's Foundation. The institution of Dr. Liang has received research support from AbbVie. The institution of Dr. Liang has received research support from Neuroderm. Dr. Liang has received publishing royalties from a publication relating to health care.
Elizabeth L. Peckham, DO	The institution of Dr. Peckham has received research support from abbvie. The institution of Dr. Peckham has received research support from lilly. The institution of Dr. Peckham has received research support from Amlyx. The institution of Dr. Peckham has received research support from Cerevel. The institution of Dr. Peckham has received research support from Sage. The institution of Dr. Peckham has received research support from Annovis. The institution of Dr. Peckham has received research support from AriBio. The institution of Dr. Peckham has received research support from Ferrer. The institution of Dr. Peckham has received research support from Biogen. The institution of Dr. Peckham has received research support from UCB. The institution of Dr. Peckham has received research support from Roche. The institution of Dr. Peckham has received research support from Cerevance. The institution of Dr. Peckham has received research support from Aptinyx.
Sarah E. Zauber, MD, FAAN	Dr. Zauber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ascel Health. The institution of Dr. Zauber has received research support from Abbive. The institution of Dr. Zauber has received research support from Abbott. Dr. Zauber has received personal compensation in the range of $500-$4,999 for serving as a Site Visitor with Parkinson Foundation.
Lars Bergmann, MD	Lars Bergmann has received personal compensation for serving as an employee of Abbvie. Lars Bergmann has stock in Abbvie.
Resmi Gupta	Resmi Gupta has nothing to disclose.
Linda Harmer, Other	Ms. Harmer has received personal compensation for serving as an employee of AbbVie. Ms. Harmer has stock in AbbVie.
Megha Shah	Megha Shah has received personal compensation for serving as an employee of AbbVie. Megha Shah has stock in AbbVIe .
Filip Bergquist	The institution of Filip Bergquist has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Filip Bergquist has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Arvid Carlsson Research AB. The institution of Filip Bergquist has received research support from Swedish Government. The institution of Filip Bergquist has received research support from Parkinsonfonden. The institution of Filip Bergquist has received research support from Neuro Sweden. The institution of Filip Bergquist has received research support from Swedish Research Council. Filip Bergquist has received publishing royalties from a publication relating to health care. Filip Bergquist has received publishing royalties from a publication relating to health care. Filip Bergquist has a non-compensated relationship as a Advisor with Sense4Care that is relevant to AAN interests or activities.
Rosa H. Jimenez, MD, PhD	Dr. Jimenez has nothing to disclose.
Fien Gistelinck	Mrs. Gistelinck has nothing to disclose.
Sophie Steeland	Sophie Steeland has received personal compensation for serving as an employee of argenx. Sophie Steeland has stock in argenx.
Jeff Guptill, MD, FAAN	Dr. Guptill has received personal compensation for serving as an employee of argenx. Dr. Guptill has or had stock in argenx.
Haseeb B. Najeeb, MBBS	Dr. Najeeb has nothing to disclose.
ARMAN AMIR, MBBS	Dr. AMIR has nothing to disclose.
Muhammad Sameer Butt, MBBS	Dr. Butt has nothing to disclose.
Eisha Moazzam, MBBS	Dr. Moazzam has nothing to disclose.
Hiba A. Omer, MBBS	Dr. Omer has nothing to disclose.
Azka Ijaz, MBBS	Miss Ijaz has nothing to disclose.
Ali E. Mohamed, MBBS	Dr. Mohamed has nothing to disclose.
Shreesha Niraula, MBBS	Dr. Niraula has nothing to disclose.
Ayesha Azhar	Miss Azhar has nothing to disclose.
Alieu Kanu, MD	Dr. Kanu has nothing to disclose.
Aiden Haghikia, MD	Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. The institution of Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyverna. Dr. Haghikia has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neuraxpharm. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Biogen. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Sanofi. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Novartis. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Merck Serono. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Celgene.
Dominic Borie	Dominic Borie has received personal compensation for serving as an employee of Kyverna Therapeutics. Dominic Borie has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Kyverna Therapeutics. Dominic Borie has stock in Kyverna.
James Chung, MD, PhD	Dr. Chung has received personal compensation for serving as an employee of Kyverna Therapeutics. Dr. Chung has stock in Kyverna Therapeutics.
Ralf Gold, MD	Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen.
Anna K. Bonkhoff, MD	Dr. Bonkhoff has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NeuroImage Clinical (Elsevier).
Frederic Schaper, MD, PhD	Dr. Schaper has nothing to disclose.
Shan Siddiqi, MD	Dr. Siddiqi has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Magnus Medical. Dr. Siddiqi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Brainsway Ltd. Dr. Siddiqi has stock in Brainsway Ltd. Dr. Siddiqi has stock in Magnus Medical. Dr. Siddiqi has received intellectual property interests from a discovery or technology relating to health care.
Alexander L. Cohen, MD, PhD, FAAN	The institution of Dr. Cohen has received research support from NIH. The institution of Dr. Cohen has received research support from Simons Foundation.
William Drew	Mr. Drew has nothing to disclose.
Michael Ferguson	Michael Ferguson has nothing to disclose.
Christopher Lin	No disclosure on file
Anne-Katrin Giese, MD	Dr. Giese has nothing to disclose.
Robert W. Regenhardt, MD, PhD	Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genomadix. Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rapid Medical. Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Johnson and Bell Trial Lawyers. Dr. Regenhardt has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Buckley, Theroux, Kline, & Cooley Trial Lawyers. The institution of Dr. Regenhardt has received research support from National Institutes of Health. The institution of Dr. Regenhardt has received research support from Society of Vascular and Interventional Neurology. The institution of Dr. Regenhardt has received research support from Heitman Foundation.
Markus D. Schirmer, PhD	The institution of Dr. Schirmer has received research support from National Institute of Aging.
Christina Jern, MD, PhD	Prof. Jern has nothing to disclose.
Arne Lindgren, MD, PhD	Prof. Lindgren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arega. Prof. Lindgren has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurologi i Sverige Journal. Prof. Lindgren has received publishing royalties from a publication relating to health care. Prof. Lindgren has received publishing royalties from a publication relating to health care. Prof. Lindgren has received publishing royalties from a publication relating to health care.
Jane Maguire	No disclosure on file
Ona Wu	The institution of Ona Wu has received research support from NIH. Ona Wu has received intellectual property interests from a discovery or technology relating to health care. Ona Wu has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH.
Sahar Zafar, MD	Dr. Zafar has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Zafar has received research support from NIH. Dr. Zafar has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker for a lecture with Marinus.
John Y. Rhee, MD, MPH	Dr. Rhee has stock in NTAP. Dr. Rhee has stock in TSLA. Dr. Rhee has stock in BABA. Dr. Rhee has stock in ZM. Dr. Rhee has stock in GM. Dr. Rhee has stock in PFF. Dr. Rhee has stock in AMZN. Dr. Rhee has stock in META. Dr. Rhee has stock in GE. The institution of Dr. Rhee has received research support from ��ɫ��. Dr. Rhee has received personal compensation in the range of $0-$499 for serving as a Director of the Hippocratic Forum with Hippocratic Society.
Andrew M. Naidech, MD, FAAN	Dr. Naidech has received publishing royalties from a publication relating to health care.
Amy Brodtmann, MBBS, PhD, FRACP	Prof. Brodtmann has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Prof. Brodtmann has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NovoNordisk. Prof. Brodtmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Prof. Brodtmann has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medicines Australia. Prof. Brodtmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lilly. Prof. Brodtmann has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Macpherson Kelley. The institution of Prof. Brodtmann has received research support from National Health and Medical Research Council. The institution of Prof. Brodtmann has received research support from Medical Research Future Fund. The institution of Prof. Brodtmann has received research support from National Heart Foundation. The institution of Prof. Brodtmann has received research support from Victorian Medical Research Acceleration Fund. Prof. Brodtmann has a non-compensated relationship as a Honorary Medical Advisor with Dementia Australia that is relevant to AAN interests or activities. Prof. Brodtmann has a non-compensated relationship as a Brain Health Initiative with Australian Football League that is relevant to AAN interests or activities.
Natalia Egorova	No disclosure on file
Sophia Gozzi	An immediate family member of Miss Gozzi has stock in LiveHire Ltd.
Thanh Phan, MD	Dr. Phan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer.
Maurizio Corbetta, MD	Dr. Corbetta has nothing to disclose.
Jordan Grafman, PhD	Dr. Grafman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Grafman has received research support from NIH. Dr. Grafman has received publishing royalties from a publication relating to health care.
Natalia S. Rost, MD, MPH, FAAN, FAHA	Dr. Rost has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for ��ɫ��. Dr. Rost has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke - AHA/ASA Journal. The institution of Dr. Rost has received research support from NIH. Dr. Rost has received publishing royalties from a publication relating to health care.
Michael D. Fox, MD, PhD	Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley.
Sean Lee, MD	Dr. Lee has nothing to disclose.
Firas Kaddouh, MD	Dr. Kaddouh has nothing to disclose.
Medha Tandon, MBBS	Dr. Tandon has nothing to disclose.
Yohanna Idsabella Rossi	Miss Rossi has nothing to disclose.
Letícia Torres da Silva	Letícia Torres da Silva has nothing to disclose.
Mariam Hull, MD	Dr. Hull has received publishing royalties from a publication relating to health care.
Sujal Manohar, MD	Dr. Manohar has nothing to disclose.
Jennifer L. Jacobe, Medical Student	Miss Jacobe has nothing to disclose.
Rebecca Berger, Medical Student	Ms. Berger has nothing to disclose.
Nader Yamout, PharmD, RPh	Mr. Yamout has received personal compensation for serving as an employee of Kyowa Kirin.
Catherine Norise, MD	Dr. Norise has nothing to disclose.
Christine Smith	The institution of Dr. Smith has received research support from B.J. and Eve Wilder Excellence in Epilepsy Research Fund. The institution of Dr. Smith has received research support from National Institutes of Health. Dr. Smith has received personal compensation in the range of $100,000-$499,999 for serving as a Staff Physician with Department of Veterans Affairs.
Deborah Rose, MD	Dr. Rose has nothing to disclose.
Ashley Madera, MD	Dr. Madera has nothing to disclose.
Xaida Wright, MD	Miss Wright has nothing to disclose.
Daria Hoang, BA	Ms. Hoang has nothing to disclose.
Courtney N. Nguyen	Ms. Nguyen has nothing to disclose.
Kiran K. Sankarappan, BS	Mr. Sankarappan has received research support from Burroughs Wellcome Fund.
Zeeshan Mansuri, MD, MBBS, DM, FSCAI	Dr. Mansuri has nothing to disclose.
Lubna Al-Sharif, MSc	Ms. Al-Sharif has nothing to disclose.
Natasha Qutab, MD	Dr. Qutab has nothing to disclose.
Ping Li, MD	Dr. Li has nothing to disclose.
Kehan Zhao, MD	Dr. Zhao has nothing to disclose.
Benjamin J. Meyer, MD	No disclosure on file
Ahmed Negida, MD, PhD	Dr. Negida has nothing to disclose.
Joaquim J. Ferreira	The institution of Joaquim J. Ferreira has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bial, Neurocrine, AbbVie, Biogen and Lundbeck. The institution of Joaquim J. Ferreira has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine, AbbVie, BIAL, Biogen, Lundbeck . The institution of Joaquim J. Ferreira has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie, BIAL, Nordic Infucare, ONO and SK Chemicals.
Katherine Sommer	Katherine Sommer has received personal compensation for serving as an employee of AbbVie. Katherine Sommer has stock in AbbVie.
Joseph S. Kass, MD, JD, FAAN	Dr. Kass has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ�� . Dr. Kass has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Kass has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple Law Firms . Dr. Kass has received publishing royalties from a publication relating to health care.
Shermila Pia, MD	Dr. Pia has nothing to disclose.
Katherine Sommer, PhD	Dr. Sommer has received personal compensation for serving as an employee of Ipsen.
Helena Huhmar	Helena Huhmar has nothing to disclose.
Per Sjögren	Per Sjögren has nothing to disclose.
Bo Bertilson	The institution of Bo Bertilson has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medect Clinical AB.
Björn Bragée	Björn Bragée has nothing to disclose.
Lauri S. Soinne, MD, PhD, FAAN	Dr. Soinne has nothing to disclose.
Annabelle Abramowitz	No disclosure on file
John Acquaviva, DO	No disclosure on file
Kristin Heerlein	Ms. Heerlein has received personal compensation for serving as an employee of argenx. Ms. Heerlein has received personal compensation for serving as an employee of JNJ. Ms. Heerlein has or had stock in argenx.Ms. Heerlein has or had stock in JNJ.
Jin-Tai Yu, PhD	Prof. Yu has nothing to disclose.

��ɫ����

��ɫ����

��ɫ��

��ɫ��